10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended December 31, 2013

OR

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from           to          .

Commission File Number: 001-34818

RealD Inc.

(Exact name of registrant as specified in its charter)

Delaware	77-0620426
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
100 N. Crescent Drive, Suite 200 Beverly Hills, CA	90210
(Address of principal executive offices)	(Zip Code)

(310) 385-4000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes    x     No    o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes    x    No    o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o  (Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   o        No      x

On January 29, 2014, the registrant had 49,267,815 shares of common stock, par value $0.0001 per share, outstanding.

RealD Inc.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED

December 31, 2013

TABLE OF CONTENTS

		Page
		Number
ITEM 1.	Financial statements	3
	Condensed consolidated balance sheets as of December 31, 2013 (unaudited) and March 31, 2013	3
	Condensed consolidated statements of operations (unaudited) for the three and nine months ended December 31, 2013 and December 31, 2012	4
	Condensed consolidated statements of comprehensive income (loss) (unaudited) for the three and nine months ended December 31, 2013 and December 31, 2012	5
	Condensed consolidated statements of cash flows (unaudited) for the nine months ended December 31, 2013 and December 31, 2012	6
	Notes to condensed consolidated financial statements (unaudited)	7
ITEM 2.	Management’s discussion and analysis of financial condition and results of operations	17
ITEM 3.	Quantitative and qualitative disclosures about market risk	34
ITEM 4.	Controls and procedures	35
	PART II – OTHER INFORMATION
ITEM 1.	Legal proceedings	36
ITEM 1A.	Risk factors	36
ITEM 2.	Unregistered sales of equity securities and use of proceeds	48
ITEM 3.	Defaults upon senior securities	49
ITEM 4.	Mine safety disclosures	49
ITEM 5.	Other information	49
ITEM 6.	Exhibits	49

2

PART I – FINANCIAL INFORMATION

ITEM 1. – FINANCIAL STATEMENTS

RealD Inc.

Condensed consolidated balance sheets

(in thousands, except per share data)

	December 31,		March 31,
	2013		2013
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	29,621	$	31,020
Accounts receivable, net	50,831		45,472
Inventories	9,351		15,430
Deferred costs – eyewear	472		538
Prepaid expenses and other current assets	5,782		3,973
Total current assets	96,057		96,433
Property and equipment, net	23,913		25,002
Cinema systems, net	113,728		125,379
Digital projectors, net-held for sale	128		728
Goodwill	10,657		10,657
Other intangibles, net	6,468		7,417
Deferred income taxes	3,001		3,001
Other assets	4,917		5,031
Total assets	$	258,869	$	273,648
Liabilities and equity
Current liabilities:
Accounts payable	$	6,856	$	22,737
Accrued expenses and other liabilities	26,608		25,013
Deferred revenue	8,171		9,916
Income taxes payable	1,668		603
Deferred income taxes	2,895		2,860
Current portion of Credit Agreement	12,500		1,042
Total current liabilities	58,698		62,171
Credit Agreement, net of current portion	36,875		46,458
Deferred revenue, net of current portion	7,309		10,392
Other long-term liabilities and customer deposits	5,106		5,438
Total liabilities	107,988		124,459
Commitments and contingencies
Equity (deficit)
Common stock, $0.0001 par value, 200,000 shares authorized; 49,259 and 49,365 shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively	347,976		332,694
Accumulated deficit	(196,813)		(182,846)
Accumulated other comprehensive income	391		115
Total RealD Inc. stockholders’ equity	151,554		149,963
Noncontrolling interest	(673)		(774)
Total equity	150,881		149,189
Total liabilities and equity	$	258,869	$	273,648

See accompanying notes to condensed consolidated financial statements

3

RealD Inc.

Condensed consolidated statements of operations (unaudited)

(in thousands, except per share data)

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
	2013		2012		2013		2012
Revenue:
License	$	35,619	$	30,334	$	103,901	$	106,499
Product and other	19,819		16,605		54,685		63,604
Total revenue	55,438		46,939		158,586		170,103
Cost of revenue:
License	11,472		10,523		33,981		34,819
Product and other	16,696		15,497		49,248		65,366
Total cost of revenue	28,168		26,020		83,229		100,185
Gross profit	27,270		20,919		75,357		69,918
Operating expenses:
Research and development	5,236		5,376		15,465		14,866
Selling and marketing	6,842		6,053		20,295		18,872
General and administrative	13,161		12,346		39,533		35,797
Total operating expenses	25,239		23,775		75,293		69,535
Operating income (loss)	2,031		(2,856)		64		383
Interest expense, net	(525)		(426)		(1,765)		(1,027)
Other income (loss)	(47)		(183)		227		(557)
Income (loss) before income taxes	1,459		(3,465)		(1,474)		(1,201)
Income tax expense	1,614		694		4,881		4,242
Net loss	(155)		(4,159)		(6,355)		(5,443)
Net (income) loss attributable to noncontrolling interest	(116)		(1)		(101)		89
Net loss attributable to RealD Inc. common stockholders	$	(271)	$	(4,160)	$	(6,456)	$	(5,354)
Loss per common share:
Basic	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)
Diluted	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)
Shares used in computing loss per common share:
Basic	49,325		51,062		49,459		53,157
Diluted	49,325		51,062		49,459		53,157

See accompanying notes to condensed consolidated financial statements

4

RealD Inc.

Condensed consolidated statements of comprehensive income (loss) (unaudited)

(in thousands)

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
	2013		2012		2013		2012
Net loss	$	(155)	$	(4,159)	$	(6,355)	$	(5,443)
Other comprehensive income, net of tax:
Foreign currency translation gains	71		-		276		-
Other comprehensive income, net of tax	71		-		276		-
Comprehensive loss	$	(84)	$	(4,159)	$	(6,079)	$	(5,443)

See accompanying notes to condensed consolidated financial statements

5

RealD Inc.

Condensed consolidated statements of cash flows (unaudited)

(in thousands)

	Nine months ended
	December 31,		December 31,
	2013		2012
Cash flows from operating activities
Net loss	$	(6,355)	$	(5,443)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation and amortization	30,082		24,130
Deferred income tax	35		(49)
Non-cash interest expense	281		342
Non-cash stock compensation	13,605		13,965
Gain on sale of fixed assets	103		44
Impairment of long-lived assets and related purchase commitments	3,547		6,581
Changes in operating assets and liabilities:
Accounts receivable	(5,359)		6,361
Inventories	6,079		26,465
Prepaid expenses and other current assets	(1,809)		(2,372)
Deferred costs - eyewear	66		581
Other assets	114		(661)
Accounts payable	(15,848)		(5,595)
Accrued expenses and other liabilities	1,314		(2,092)
Other long-term liabilities and customer deposits	(572)		1,767
Income taxes receivable/payable	1,065		(176)
Deferred revenue	(4,828)		(865)
Net cash provided by operating activities	21,520		62,983
Cash flows from investing activities
Purchases of property and equipment	(3,805)		(11,665)
Purchases of cinema systems and related components	(15,646)		(12,774)
Proceeds from sale of fixed assets	215		2,474
Net cash used in investing activities	(19,236)		(21,965)
Cash flows from financing activities
Proceeds from credit facility	37,500		47,500
Repayments on credit facility	(35,625)		(37,500)
Payments of debt issuance costs	–		(1,167)
Proceeds from exercise of stock options	1,374		1,070
Proceeds from employee stock purchase plan	303		611
Repurchases of common stock	(7,511)		(47,759)
Distributions to noncontrolling interests	–		(1,000)
Net cash used in financing activities	(3,959)		(38,245)
Effect of currency exchange rate changes on cash and cash equivalent	276		–
Net increase (decrease) in cash and cash equivalents	(1,399)		2,773
Cash and cash equivalents, beginning of period	31,020		24,894
Cash and cash equivalents, end of period	$	29,621	$	27,667

See accompanying notes to condensed consolidated financial statements

6

RealD Inc.

Notes to condensed consolidated financial statements (unaudited)

1. Business and basis of presentation

RealD Inc. is a leading global licensor of 3D and other visual technologies. Except where specifically noted or the context otherwise requires, the use of terms such as the “Company” or “RealD” in this Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2013 refers to RealD Inc. and its subsidiaries.

The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and include all adjustments (consisting of only normal recurring adjustments, unless otherwise indicated), necessary for a fair presentation of our condensed consolidated financial statements. Interim results are not necessarily indicative of results for any subsequent quarter, the full fiscal year or any future periods. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended March 31, 2013.

The condensed consolidated financial statements include the accounts of RealD, its wholly owned subsidiaries and its majority owned subsidiaries. We do not have any interests in variable interest entities. For consolidated subsidiaries that are not wholly owned but are majority owned, the subsidiaries’ assets, liabilities, and operating results are included in their entirety in the accompanying condensed consolidated financial statements. The noncontrolling interests in those assets, liabilities, and operations are reflected as non-controlling interest in the condensed consolidated balance sheets under equity and condensed consolidated statements of operations.

All significant intercompany balances and transactions have been eliminated in consolidation.

2. Summary of significant accounting policies

Accounting period

On November 14, 2012, our Board of Directors approved a change in our accounting periods from the previous configuration of four 13-week periods for a total of 52 weeks per year to calendar quarter end accounting periods. This change in accounting period commenced in the third quarter ended December 31, 2012 of fiscal year 2013.

Our fiscal year 2014 began on April 1, 2013, consisting of four 3-month periods for a total of 12 months, and will end on March 31, 2014 as compared to fiscal year 2013, which began on March 24, 2012 and ended on March 31, 2013. The fiscal 2014 third quarter began on October 1, 2013 and ended on December 31, 2013 as compared to the fiscal 2013 third quarter, which began on September 22, 2012 and ended on December 31, 2012. As a result, the three months and nine months ended December 31, 2013 are nine days shorter and eight days shorter than the three months and nine months ended December 31, 2012, respectively.

Use of estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.

Earnings (loss) per share of common stock

Basic income per share of common stock is computed by dividing the net income (loss) attributable to our common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income attributable to our common stockholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under our employee stock purchase plan and unvested restricted stock units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method.

7

The calculation of the basic and diluted loss per share of common stock for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands, except share and per share data)	2013		2012		2013		2012
Numerator:
Net loss	$	(155)	$	(4,159)	$	(6,355)	$	(5,443)
Net (income) loss attributable to noncontrolling interest	(116)		(1)		(101)		89
Net loss attributable to RealD Inc. common stockholders	$	(271)	$	(4,160)	$	(6,456)	$	(5,354)
Denominator:
Weighted-average common shares outstanding (basic)	49,325		51,062		49,459		53,157
Effect of dilutive securities	–		–		–		–
Weighted-average common shares outstanding (diluted)	49,325		51,062		49,459		53,157
Loss per common share:
Basic	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)
Diluted	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)

The weighted-average number of anti-dilutive shares excluded from the calculation of diluted loss per common share for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended		Nine months ended
	December 31,	December 31,	December 31,	December 31,
(in thousands)	2013	2012	2013	2012
Options, employee stock purchase plan, restricted stock units and warrants to purchase common stock	9,144	9,439	9,538	8,095

Due to the loss attributable to our common stockholders in the three and nine months ended December 31, 2013, basic loss per share of common stock and diluted loss per share of common stock are the same because the effect of potentially dilutive securities would be antidilutive.

Derivative instruments

Our derivative instruments are recorded at fair value in other current assets and other liabilities, respectively, in the condensed consolidated balance sheets. Changes in fair value are reported as a component of other income or loss on our condensed consolidated statements of operations. For all periods presented, none of our derivative instruments were designated as hedging instruments. We do not use foreign currency option or foreign exchange forward contracts for speculative or trading purposes.

We purchase foreign currency forward contracts, generally with maturities of six months or less, to reduce the volatility of cash flows primarily related to forecasted payments and expenses denominated in certain foreign currencies. As of December 31, 2013, we had no outstanding forward contracts. As of March 31, 2013, the carrying amounts of our foreign currency forward contracts were not significant and were classified as Level 2 fair value instruments, which was determined based on observable inputs that were corroborated by market data. For both the three months ended December 31, 2013 and December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant. For both the nine months ended December 31, 2013 and December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant. Foreign currency master agreements typically allow the netting of receivables and payables. The gross receivable balances and the gross payable balances were $0 as of December 31, 2013 and not significant as of March 31, 2013.

Accounts receivable

Accounts receivable consists of trade receivables, value-added tax (VAT) receivables and other receivables. We extend credit to our customers, who are primarily in the movie production and exhibition businesses. We provide for the estimated accounts receivable that will not be collected. These estimates are based on an analysis of historical bad debts, customer concentrations, customer creditworthiness, current economic trends and changes in the customers’ payment terms and their economic condition. Collection of accounts receivable may be affected by changes in economic or other industry conditions and may, accordingly, impact our overall credit risk. The allowance for doubtful accounts and customer credits totaled $3.7 million and $2.6 million as of December 31, 2013 and March 31, 2013, respectively.

8

Inventories and deferred costs-eyewear

Inventories and deferred costs-eyewear represent RealD eyewear and are substantially all finished goods. Inventories and deferred costs-eyewear are valued at the lower of cost (first-in, first-out method) or market value. At each balance sheet date, we evaluate ending inventories and deferred costs-eyewear for net realizable value. We also evaluate inventories for excess quantities and obsolescence. These evaluations include analyses of expected future average selling prices, projections of future demand and technology changes. In order to state inventories at the lower of cost or market, we maintain reserves against such inventories. If our analyses indicate that market is lower than cost, a write-down of inventories is recorded in cost of revenue in the period the loss is identified. As of December 31, 2013 and March 31, 2013, the inventory reserve as a result of our net realizable value analyses was $0.2 million and $0.4 million, respectively.

Domestically, we provide our RealD eyewear free of charge to motion picture exhibitors and then receive a fee from the motion picture studios for the usage of that RealD eyewear by the motion picture exhibitors’ consumers.

For RealD eyewear located at a motion picture exhibitor, we do not believe that it is operationally practical to perform physical counts or request the motion picture exhibitor to perform physical counts and confirm quantities held to ensure that losses due to damage, destruction and shrinkage are specifically recognized in the period incurred due to the number of domestic RealD-enabled screens and the related usage of RealD eyewear. We believe that the cost to monitor shrinkage or usage significantly outweighs the financial reporting benefits of using a specific identification methodology of expensing. We believe that utilizing a composite method of expensing RealD eyewear inventory costs provides a rational and reasonable approach to ensuring that shrinkage is provided for in the period incurred and that inventory costs are expensed in the periods that reasonably reflect the periods in which the related revenue is recognized. In doing so, we believe the following methodology reasonably and generally reflects periodic income or loss under these facts and circumstances:

·For an estimated period of time following shipment to domestic motion picture exhibitors, no expense is recognized from the time of shipment until the delivery is made because the eyewear is in transit and unused.

·The inventory cost is expensed on a straight-line basis over an estimated usage period beginning with initial usage of the eyewear shipped. In estimating the expensing start date and related expense period, we consider various factors including, but not limited to, those relating to a 3D motion picture’s opening release date, a 3D motion picture’s expected release period, the number of currently playing 3D motion pictures, and the motion picture exhibitor’s buying and stocking patterns and practices.

We believe that the expensing methodology described above rationally and reasonably approximates the period the related usage occurs resulting in our RealD eyewear product revenue. The expensing start date following the date of shipment is meant to approximate the date at which usage begins. Additionally, as the expense recognition period has been and is expected to continue to be short, we believe it adequately recognizes inventory impairments due to loss and damage on a timely basis. We further believe that exposures due to loss or damage, if any, are considered normal shrinkage and a necessary and expected cost to generate the revenue per 3D motion picture earned through RealD eyewear usage. We continue to monitor the reasonableness of this methodology to ensure that it approximates the period over which the related RealD eyewear product revenue is earned and realizable. Costs of RealD eyewear that has shipped but has not yet been used and expensed per this methodology are reported as deferred costs-eyewear.

Impairment of long-lived assets

We review long-lived assets, such as property and equipment, cinema systems, digital projectors and intangibles, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Factors or circumstances that could indicate the occurrence of such events include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing operating or cash flow losses, or incurring costs in excess of amounts originally expected to acquire or construct an asset. If the asset is not recoverable, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.

During the nine months ended December 31, 2012, we determined that a non-cancelable purchase commitment for certain cinema systems configurations in the aggregate amount of $3.5 million were not fully recoverable, primarily due to the initial investment costs which are expected to exceed the anticipated future cash flows for the related cinema systems. For the nine months ended December 31, 2012, impairment charged to cost of revenue for the related outstanding purchase commitment totaled $3.5 million.

For the three months ended December 31, 2013 and December 31, 2012, impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $0.8 million and $0.7 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $3.5 million and $6.6 million, respectively.

9

Revenue recognition

We derive substantially all of our revenue from the license of our RealD Cinema Systems and the product sale of our RealD eyewear. We evaluate revenue recognition for transactions using the criteria set forth by the SEC in Staff Accounting Bulletin No. 104, Revenue Recognition (SAB 104) and Accounting Standards Codification Topic 605, Revenue Recognition (ASC 605). The revenue recognition guidance states that revenue is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed or determinable and collectability is reasonably assured. We record revenue net of estimated allowances.

License revenue

License revenue is accounted for as an operating lease. License revenue is primarily derived under per-admission, periodic fixed fee, or per-motion picture basis with motion picture exhibitors. Amounts received up front, less estimated allowances, are deferred and recognized over the lease term using the straight-line method. Additional lease payments that are contingent upon future events outside our control, including those related to admission and usage, are recognized as revenues when the contingency is resolved and we have no more obligations to our customers specific to the contingent payment received. Certain of our license revenue from leasing our RealD Cinema Systems is earned upon admission by the motion picture exhibitor’s consumers. Our licensees, however, do not report and pay for such license revenue until after the admission has occurred, which may be received subsequent to our fiscal period end. We estimate and record licensing revenue related to motion picture exhibitor consumer admissions in the quarter in which the admission occurs, but only when reasonable estimates of such amounts can be made. We determine that there is persuasive evidence of an arrangement upon the execution of a license agreement or upon the receipt of a licensee’s admissions report. Revenue is deemed fixed or determinable upon receipt of a licensee’s admissions report or evidence of a RealD box office showing by licensee. We determine collectability based on an evaluation of the licensee’s recent payment history.

Product revenue

We recognize product revenue, net of allowances, when title and risk of loss have passed and when there is persuasive evidence of an arrangement, the payment is fixed or determinable, and collectability of payment is reasonably assured. In the United States and Canada, certain of our product revenue from the sale of our RealD eyewear is earned upon admission and usage by the motion picture exhibitor’s consumers. Our customers, however, do not report admission or usage information until after the admission and usage has occurred, and such information may be received subsequent to our fiscal period end. We estimate and record such product revenue in the quarter in which the admission and usage occurs, but only when reasonable estimates of such amounts can be made.

Comprehensive income (loss)

Comprehensive income (loss) is comprised of net income (loss) and other comprehensive income (loss). The only component of other comprehensive income or loss is unrealized foreign currency translation gains (losses). There were no reclassifications out of accumulated other comprehensive income (loss) during the three and nine months ended December 31, 2013 and December 31, 2012.

Shipping and handling costs

Amounts billed to customers for shipping and handling costs are included in revenue. Shipping and handling costs that we incur consist primarily of packaging and transportation charges and are recorded in cost of revenue. Shipping and handling costs recognized in cost of revenue were $1.6 million and $1.6 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Shipping and handling costs recognized in cost of revenue were $5.5 million and $6.3 million for the nine months ended December 31, 2013 and December 31, 2012, respectively.

Recent accounting pronouncements

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-10, “Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (Or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. The objective of ASU 2013-10 is to provide for the inclusion of the Fed Funds Effective Swap Rate (OIS) as a U.S. benchmark interest rate for hedge accounting purposes, in addition to direct Treasury obligations of the U.S. government (UST) and, for practical reasons, the London Interbank Offered Rate (LIBOR) swap rate. ASU 2013-10 is effective prospectively for qualifying new or redesignated hedging relationship entered into on or after July 17, 2013. Adoption of ASU 2013-10 did not have a material impact on our consolidated financial statements.

In July 2013, the FASB issued ASU 2013-11, “Income Taxes (Topic 740) Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which concludes that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset when settlement in this manner is available under the tax law.  The Company will adopt this amendment as of our 2015 fiscal year. The result of adoption may be to reclassify certain long term liabilities to long term deferred tax assets and the adoption will not result in a change to the tax provision. We do not expect the adoption of ASU 2013-11 to have a material impact on our consolidated financial statements.

10

3. Property and equipment, RealD Cinema Systems and digital projectors

Property and equipment, RealD Cinema Systems and digital projectors consist of the following:

	December 31,		March 31,
(in thousands)	2013		2013
RealD Cinema Systems	$	204,706	$	194,527
Digital projectors - held for sale	436		1,634
Leasehold improvements	17,373		14,442
Machinery and equipment	6,297		6,198
Furniture and fixtures	1,310		1,122
Computer equipment and software	9,604		7,628
Construction in process	1,136		2,637
Total	$	240,862	$	228,188
Less accumulated depreciation	(103,093)		(77,079)
Property and equipment, RealD Cinema Systems and digital projectors, net	$	137,769	$	151,109

Depreciation expense amounted to $10.0 million and $8.2 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Depreciation expense amounted to $29.1 million and $24.0 million for the nine months ended December 31, 2013 and December 31, 2012, respectively.

During the nine months ended December 31, 2013, we received $0.2 million in cash from motion picture exhibitor customers for the sale of digital projectors. During the nine months ended December 31, 2012, we received $2.5 million in cash from motion picture exhibitor customers for the sale of digital projectors that was included in accounts receivable as of March 23, 2012.

4. Cost reduction plan

During fiscal year 2014, we implemented a plan to reduce the overall costs of our global operations while continuing to make significant research and development investments and build the framework for our future growth. This cost reduction plan is primarily a response to the 3D box office performance of certain motion pictures due to consumer preference and the fact that our 3D cinema business is maturing in many markets like the United States where we expect equipment installations to begin to slow, and the resulting impact on our financial results and operations. We are also re-scoping and making other changes to certain research and development projects, reducing general and administrative expenses and streamlining certain manufacturing operations. These actions are intended to rationalize the further expansion of our global cinema platform by focusing on emerging growth markets, streamlining our manufacturing facilities to achieve cost efficiencies while meeting the future commercial demands of our customers and focusing our research and development efforts on technologies that will enable us to expand our visual technology product offerings.

An element of that plan is to reduce our workforce by approximately 20%, resulting in termination charges of approximately $4.9 million. Further, we expect to incur approximately $0.5 million in other charges principally related to the accrual of losses for a lease for certain manufacturing facilities that will no longer be used in our operations. Therefore, the total charges associated with the cost reduction plan currently are estimated to be approximately $5.4 million. The following table summarizes the currently estimated charges resulting from implementation of the cost reduction plan:

	Estimated termination and implementation charges
(in thousands)	Personnel		Lease		Impairment		Total
Cost of revenue	$	842	$	435	$	66	$	1,343
Research and development	755		0		0		755
Selling and marketing	1,995		0		0		1,995
General and administrative	1,256		0		0		1,256
Total	$	4,848	$	435	$	66	$	5,349

Total expenses incurred in relation to the cost reduction plan were $3.7 million for both the three months and nine months ended December 31, 2013. The following table summarizes the activity resulting from implementation of the cost reduction plan within accrued expenses and other liabilities:

	Three and nine months ended December 31, 2013
(in thousands)	Beginning liability		Expensed		Paid		Ending liability
Cost reduction plan liabilities	$	-	$	3,657	$	2,005	$	1,652

11

We have initiated many of the above-noted cost reduction actions and plan to act on the remaining areas by the end of fiscal year 2014. We estimate that most of the remaining expenses will be incurred during the fourth quarter of fiscal year 2014 but lease and impairment charges might not occur until fiscal year 2015. Certain office space includes approximately $7.0 million in leasehold improvements within fixed assets, which could become subject to an impairment assessment upon a future change in circumstances.

	Termination and implementation expenses
	Q3 FY2014 Actual		Q4 FY2014 Estimate
(in thousands)	Personnel		Personnel		Lease		Impairment
Cost of revenue	$	842	$	-	$	435	$	66
Research and development	755		-		-		-
Selling and marketing	1,104		891		-		-
General and administrative	956		300		-		-
Total	$	3,657	$	1,191	$	435	$	66

The cash payments are estimated as follows:

	Payments excluding non-cash impairment
(in thousands)	Personnel		Lease
Q3 FY2014 Actual	$	2,005	$	-
Q4 FY2014 Estimate	1,843		32
FY2015 Estimate	667		227
FY2016 Estimate	333		132
FY2017 Estimate	-		44
Total	$	4,848	$	435

Capital expenditures for leasehold improvements, net of landlord allowance, are estimated to total $0.3M during the next two quarters for the relocated manufacturing operations. The resultant estimated annual effect on cost of revenue through June 30, 2024 is insignificant.

There is no guarantee that termination and implementation costs will not exceed the estimates, or that any net cost reduction will actually be achieved.

The Company records the cost reduction plan activities in accordance with the Accounting Standards Codification (ASC), including ASC 420 Exit or Disposal Cost Obligations, ASC 712 Compensation—Nonretirement Postemployment Benefits and ASC 360 Property, Plant, and Equipment (Impairment or Disposal of Long-Lived Assets).

5. Borrowings and Credit Agreement

On April 19, 2012, we entered into a credit agreement (the “Credit Agreement”) with City National Bank, a national banking association (“City National”).  Pursuant to the Credit Agreement, the lenders thereunder will make available to us:

·a revolving credit facility (including a letter of credit sub-facility) in a maximum amount not to exceed $75 million (the “Revolving Facility”); and

·a delayed-draw term loan facility in a maximum amount not to exceed $50 million (the “Term Loan Facility”). During the first quarter of fiscal year 2013, we borrowed $25 million under the Term Loan Facility, resulting in $25 million being available for future draws. During the second quarter of fiscal 2014, we borrowed an additional $25 million, fully drawing down the Term Loan Facility. During the second quarter of fiscal 2013, we repaid $12.5 million of the Term Loan Facility. On December 31, 2013, we commenced the first of 12 quarterly installments of $3.1 million to pay off the Term Loan Facility by September 30, 2016.

The Revolving Facility and the Term Loan Facility replaced existing revolving and term loan facilities provided under our pre-existing credit and security agreement with City National, which had been most recently amended on December 6, 2011.

Debt issuance costs related to the completion of the Credit Agreement totaled $1.2 million and were recorded as a deferred charge.  The issuance costs are being amortized over the contractual life of the agreement and recorded as interest expense.

Our obligations under the Credit Agreement are secured by a first priority security interest in substantially all of our tangible and intangible assets and are fully and unconditionally guaranteed by our subsidiaries, ColorLink Inc., a Delaware corporation (“ColorLink”), and Stereographics Corporation, a California corporation (“Stereographics”). In connection with our execution of the Credit Agreement, on April 19, 2012, each of ColorLink and Stereographics entered into a general continuing guaranty (the “Guaranty”) in favor of City National and the lenders under the Credit Agreement, pursuant to which they irrevocably and unconditionally guaranteed our obligations under the Credit Agreement and all related loan documents. In addition, on April 19, 2012, we, ColorLink and Stereographics entered into a security agreement in favor of City National and the lenders under the Credit Agreement, pursuant to which they granted a security interest in substantially all of their assets to secure their obligations under the Credit Agreement, the Guaranty and the related loan documents.

12

As of December 31, 2013, there were $49.4 million in borrowings under the Credit Agreement. The current and non-current portions of the Credit Agreement due as of December 31, 2013 and March 31, 2013 were as follows:

	December 31,		March 31,
	2013		2013
(in thousands)	(unaudited)
Current portion of Credit Agreement	$	12,500	$	1,042
Credit Agreement, net of current portion	36,875		46,458
Total Credit Agreement	$	49,375	$	47,500

The Revolving Facility matures on April 17, 2015 with $15.0 million drawn as of December 31, 2013. Through December 31, 2013, the aggregate Term Loan Facility commitment of $50 million had been drawn in full and $15.6 million had been repaid, resulting in an outstanding balance of $34.4 million to be repaid in 11 remaining quarterly installments of $3.1 million through September 30, 2016.

At December 31, 2013, our future minimum Credit Agreement obligations were as follows:

(in thousands)
Fiscal year 2014	$	3,125
Fiscal year 2015	12,500
Fiscal year 2016	27,500
Fiscal year 2017	6,250
Total	$	49,375

Under the Credit Agreement, our business is subject to certain limitations, including limitations on our ability to incur additional debt, make certain investments or acquisitions, enter into certain merger and consolidation transactions, and sell our assets other than in the ordinary course of business. We are also required to maintain compliance with certain financial covenants, including a minimum fixed charge coverage ratio and a maximum leverage ratio. As of December 31, 2013, we were in compliance with all financial covenants in our Credit Agreement. If we fail to comply with any of the covenants or if any other event of default, as defined in our Credit Agreement, should occur, the bank lenders could elect to prevent us from borrowing and declare the indebtedness to be immediately due and payable.

The Revolving Facility provides for, at our option, Eurodollar Rate Loans, which bears interest at the London Interbank Offered Rate (“LIBOR”) plus two and one-half percent (2.50%) or Base Rate Loans, which bear interest at one and one-half percent (1.5%) plus the greatest of (a) the Federal Funds Rate plus 1/2 of 1%, (b) the Prime Rate, and (c) the Eurodollar Rate for a one month Interest Period on such day plus 1.00%.

The borrowings outstanding under the Credit Agreement bear interest at approximately 2.79%. Interest expense related to our borrowings under our Credit Agreement was $0.5 million and $0.4 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Interest expense related to our borrowings under our Credit Agreement was $1.8 million and $1.0 million for the nine months ended December 31, 2013 and December 31, 2012, respectively. Interest expense for fiscal year 2013 includes that expensed under the previous credit and security agreements.

13

6. Commitments and contingencies

Indemnities and commitments

During the ordinary course of business, we make certain indemnities and commitments under which we may be required to make payments in relation to certain transactions. These indemnities include indemnities of certain customers and licensees of our technologies, and indemnities to our directors and officers to the maximum extent permitted under the laws of the State of California. The duration of these indemnities and commitments varies, and in certain cases, is indefinite. The majority of these indemnities and commitments do not provide for any limitation of the maximum potential future payments we could be obligated to make. We have not recorded any liability for these indemnities and commitments in the accompanying condensed consolidated balance sheets. We do, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is reasonably probable and estimable.

We have entered into contracts with certain of our vendors. Future obligations under such contracts totaled $8.0 million at December 31, 2013 and include revolving 90-day supply commitments. Many of the contracts contain cancellation penalty provisions requiring payment of up to 20.0% of the unused contract.

Contingencies and assessments

We are subject to various loss contingencies and assessments arising in the course of our business, some of which relate to litigation, claims, property taxes and sales and use tax or goods and services tax assessments. We consider the likelihood of the loss or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies and assessments. An estimated loss contingency or assessment is accrued when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted. Based on the information presently available, including discussion with counsel and other consultants, management believes that resolution of these matters will not have a material adverse effect on our business, consolidated results of operations, financial condition or cash flows.

7. Share-based compensation

We account for share-based payment awards granted to employees and directors by recording compensation expense based on estimated fair values. We estimate the fair value of share-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statements of operations. Share-based awards are attributed to expense using the straight-line method over the vesting period. We determine the value of each option award that contains a market condition using a Monte Carlo Simulation valuation model, while all other option awards are valued using the Black-Scholes valuation model as permitted under ASC 718,  Compensation — Stock Compensation. The assumptions used in calculating the fair value of share-based payment awards represent our best estimates. Our estimates of the fair values of stock options granted and the resulting amounts of share-based compensation recognized may be impacted by certain variables including stock price volatility, employee stock option exercise behaviors, additional stock option grants modifications, estimates of forfeitures, and the related income tax impact.

Share-based compensation expense for all share-based arrangements for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands)	2013		2012		2013		2012
Share-based compensation
Cost of revenue	$	181	$	120	$	722	$	565
Research and development	632		608		2,107		1,577
Selling and marketing	1,608		1,369		4,189		4,068
General and administrative	2,066		2,774		6,587		7,755
Total	$	4,487	$	4,871	$	13,605	$	13,965

Stock options granted generally vest over a four-year period, with 25% of the shares vesting after one year and monthly vesting thereafter. The options generally expire ten years from the date of grant. For the nine months ended December 31, 2013, we granted 0.7 million stock options at a weighted average grant date fair value of $7.22 per share. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to stock options and our employee stock purchase plan was $3.2 million and $3.8 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to stock options and our employee stock purchase plan was $10.3 million and $10.8 million, respectively.

14

Certain of our management-level employees receive performance stock options, which gives the recipient the right to receive common stock that is contingent upon achievement of specified pre-established performance goals over the performance period, which is generally three years subject to the recipient’s continued service with us. The performance goals for the performance stock options are based on the measurement of our total stockholder return, on a percentile basis, compared to a comparable group of companies. Depending on the outcome of the performance goals, the recipient may ultimately earn performance stock options equal to or less than the number of performance stock options granted. In June 2013, our Chief Executive Officer’s fiscal year 2013 stock option grant was amended to retroactively change the vesting schedule of the stock option so that it now vests based upon the achievement of performance goals rather than based solely upon Mr. Lewis’ continued service with the Company. The performance goal is based on the measurement of our total stockholder return, on a percentile basis, compared to a comparable group of companies. The performance period for this performance stock option is between three and five years. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to performance stock options was $0 and $0.5 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to performance stock options was $0.5 million and $1.4 million, respectively.

Certain of our management-level employees also receive performance stock units, which gives the recipient the right to receive common stock that is contingent upon achievement of specific pre-established performance goals over the performance period, which is generally two years subject to the recipient’s continued service with us. The performance goals are based on achieving certain levels of total licensing revenue over the performance period.  Depending on the outcome of the performance goals, the recipient may ultimately earn performance stock units between 0% and 200% of the number of performance stock units granted. For the three and nine months ended December 31, 2013, there was no share-based compensation expense related to performance stock units. For the three and nine months ended December 31, 2012, there was no share-based compensation expense related to performance stock units.

Certain of our employees, including certain management level employees, receive time-based restricted stock units. These restricted stock units vest over one to three years based upon a recipient’s continued service with us. For the nine months ended December 31, 2013, we granted 0.6 million restricted stock units at a weighted average grant date fair value of $12.29 per restricted stock unit. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to restricted stock units was $0.9 million and $0.5 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to restricted stock units was $2.2 million and $1.7 million, respectively.

8. Income taxes

Our income tax expense for the three months ended December 31, 2013 and December 31, 2012 was $1.6 million and $0.7 million, respectively. Our income tax expense for the nine months ended December 31, 2013 and December 31, 2012 was $4.9 million and $4.2 million, respectively. We have net operating losses that may potentially be offset against future earnings. We file federal income tax returns and income tax returns in various state and foreign jurisdictions. Due to the net operating loss carryforwards, our United States federal and state returns are open to examination by the Internal Revenue Service and state jurisdictions for all years since inception.

As of December 31, 2013, we have determined based on the weight of the available evidence, both positive and negative, to provide for a valuation allowance against substantially all of the net deferred tax assets. The current deferred tax assets not reserved for by the valuation allowance are those in foreign jurisdictions or amounts that may be carried back in future years. If there is a change in circumstances that causes a change in judgment about the realizability of the deferred tax assets, we will adjust all or a portion of the applicable valuation allowance in the period when such change occurs.

15

9. Equity

A summary of the changes in total equity for the nine months ended December 31, 2013 was as follows:

	RealD Inc.
	stockholders’		Noncontrolling		Total
(in thousands)	deficit		interest		equity (deficit)
Balance, March 31, 2013	$	149,963	$	(774)	$	149,189
Share-based compensation	13,605		-		13,605
Exercise of stock options	1,374		-		1,374
Purchase and distribution of stock under employee stock purchase plan	303		-		303
Purchases of treasury stock	(7,511)		-		(7,511)
Other comprehensive loss, net of tax	276		-		276
Net loss	(6,456)		101		(6,355)
Balance, December 31, 2013	$	151,554	$	(673)	$	150,881

On April 20, 2012, we announced that our board of directors had approved an authorization to repurchase up to $50 million of our common stock. On December 14, 2012, our board of directors approved a $25 million increase in our stock repurchase plan, increasing the $50 million repurchase plan announced on April 20, 2012 to $75 million. The number of shares to be repurchased and the timing of any potential repurchases will depend on factors such as the Company’s stock price, economic and market conditions, alternative uses of capital, and corporate and regulatory requirements. Repurchases of common stock may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when RealD might otherwise be precluded from doing so under insider trading laws, and a variety of other methods, including open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The repurchase program may be suspended or discontinued at any time.

Pursuant to the stock repurchase plan authorized by our board of directors, we have repurchased a total of 6,599,726 shares of common stock at an average price per share of $10.30, including sales commissions, for an aggregate cost of $68.0 million inception to date. For the three months period ended December 31, 2013, there were no stock repurchases. For the nine months period ended December 31, 2013, we repurchased a total of 671,997 shares of common stock at an average price per share of $11.18, including sales commissions, for an aggregate cost of $7.5 million.

10. Related-party transactions

On May 19, 2011, we entered into a separation agreement and general release of claims with Joshua Greer, a former director and executive officer of the Company. Pursuant to the terms of the separation agreement, Mr. Greer will receive the following benefits: (i) cash severance of $450,000 paid in ten equal installments, with the first such installment paid on October 15, 2011; (ii) reimbursement from us for insurance coverage under COBRA for 18 months following July 15, 2011 or such earlier time as Mr. Greer becomes eligible for insurance through another employer; (iii) a pro-rated cash performance bonus for fiscal year 2012 (to be paid no later than June 15, 2012), in an amount equal to 30% of 80% of Mr. Greer’s salary, computed assuming that Mr. Greer had remained as our president through the end of fiscal year 2012; and (iv) acceleration of a time-based vesting stock option for 105,000 shares granted to Mr. Greer on July 15, 2010 as of July 15, 2011, which will remain exercisable for 6 months following the end of the term of the consulting agreement that we entered into with Mr. Greer on the same date.  A second stock option for 105,000 shares granted to Mr. Greer on July 15, 2010 was entirely forfeited and cancelled without consideration.  We entered into a consulting agreement with Mr. Greer pursuant to which Mr. Greer will be paid $275,000 per year commencing as of July 16, 2011.  The consulting agreement with Mr. Greer expired on July 16, 2012. On June 21, 2012, Mr. Greer notified us of his resignation from our board of directors to be effective on July 16, 2012 upon the expiration of the consulting agreement.

For the three months and nine months ended December 31, 2012, we paid Mr. Greer $0 and $225,000 pursuant to his separationagreement and $0 and $148,958 pursuant to his consulting agreement, respectively.

We entered into a consulting agreement, effective as of May 29, 2012 (the “DCH Agreement”), with DCH Consultants LLC (“DCH”), an entity controlled by Mr. David Habiger. Mr. Habiger is a member of the Company’s Board of Directors, its Nominating and Corporate Governance Committee, and its Compensation Committee.

Pursuant to the DCH Agreement, DCH provided certain consulting services regarding the application of one or more of our technologies in the consumer electronics industry. The DCH Agreement had a term of 4 months and DCH was entitled to receive aggregate fixed compensation of $20,000 per month during the term of the DCH Agreement. Although we had the right to extend the engagement for up to two additional months on the same terms, by providing DCH with 10 days written notice prior to the end of the original term, we did not extend the DCH Agreement and it expired as of September 29, 2012.

During the year ended March 31, 2013, we paid DCH $80,239 pursuant to the DCH Agreement.

16

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary note on forward-looking statements

The following discussion and analysis should be read in conjunction with our interim condensed consolidated financial statements and the related notes that appear elsewhere in this Form 10-Q. These discussions contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as “intends,” “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology, but the absence of these words does not necessarily mean that a statement is not forward-looking. Forward-looking statements include, but are not limited to: statements regarding the extent and timing of future licensing, products and services revenue levels and mix, expenses, margins, net income (loss) per diluted share, income taxes, tax benefits, acquisition costs and related amortization, and other measures of results of operations; our expectations regarding demand and acceptance for our technologies; 3D motion picture releases and conversions scheduled for fiscal year 2014 ending March 31, 2014 and beyond, their commercial success and consumer preferences that, in recent periods, have trended in favor of 2D over 3D; our ability to increase the number of RealD-enabled screens in domestic and international markets and market share; our ability to supply our products to our customers on a timely basis; RealD relationships with exhibitor and studio partners and the business model for 3D eyewear in North America; the progress, timing and amount of expenses associated with our research and development activities; market and industry growth opportunities and trends in the markets in which we operate, including in 3D content; our plans, strategies and expected opportunities; the deployment of and demand for our products and products incorporating our technologies; competitive pressures in domestic and international cinema markets impacting licensing and product revenues; and our ability to execute and achieve anticipated savings or other benefits from our cost reduction efforts. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including the risks set forth in the section entitled “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q and elsewhere in this filing. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of these forward-looking statements. We are under no duty to update any of the forward-looking statements after the date of this Quarterly Report on Form 10-Q to conform our prior statements to actual results.

Overview

We are a leading global licensor of 3D and other visual technologies. Our extensive intellectual property portfolio is used in applications that enable a premium 3D viewing experience in the theater, the home and elsewhere. We license our RealD Cinema Systems to motion picture exhibitors that show 3D motion pictures and alternative 3D content. We also provide our RealD Display, active and passive eyewear, and RealD Format technologies to consumer electronics manufacturers, content providers and distributors to enable the delivery and viewing of 3D content on a variety of visual displays and devices.

For financial reporting purposes, we currently have one reportable segment. We have three operating segments: cinema, consumer electronics and professional within which we market our various applications. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is our Chief Executive Officer. We aggregate our three operating segments into one reportable segment based on qualitative factors, including similar economic characteristics and the nature of the products and services. Our product portfolio is used in applications that enable a premium 3D viewing experience across these segments. We currently generate substantially all of our revenue from the license of our RealD Cinema Systems and the use and sale of our eyewear.

17

As the result of 3D box office performance of certain motion pictures due to consumer preferences and the fact that our 3D cinema business is maturing in many markets like the United States where we expect equipment installations to begin to slow, we recently implemented a plan to reduce overall costs of our global operations while continuing to make significant research and development (R&D) investments and build the framework for our future growth. As part of our cost reduction plan, we are reducing our workforce by approximately 20%, re-scoping and making other changes to certain R&D projects, reducing general and administrative expenses and streamlining certain manufacturing operations. Termination and implementation charges are currently estimated to be approximately $4.9 million to $5.8 million. The total annual cost savings are estimated to be $15.0 million after the plan is fully implemented. As a result of our cost reduction plan, we expect to reduce costs beginning in fiscal year 2014 and fully implement the remaining actions by the beginning of fiscal year 2015.  There is no guarantee that implementation costs will not exceed the estimates, or that the planned savings will actually be achieved.  Details for our cost reduction plan are presented below under the caption “Cost reduction plan”.

Key business metrics

Our management regularly reviews a number of business metrics, including the following key metrics to evaluate our business, monitor the performance of our business model, identify trends affecting our business, determine the allocation of resources, make decisions regarding corporate strategies and evaluate forward-looking projections. The measures that we believe are the primary indicators of our quarterly and annual performance are as follows:

·RealD box office. Estimated domestic box office on RealD-enabled screens represents the estimated 3D box office generated on RealD-enabled domestic screens.  Estimated international box office on RealD-enabled screens is the estimated 3D box office generated on RealD-enabled international screens. RealD’s estimates of box office on RealD-enabled screens rely on box office tracking data.  International box office reflects RealD’s estimates of international box office generated on RealD-enabled screens in 19 foreign countries where box office tracking is available.  RealD estimates these countries represent approximately 85% of RealD’s international license revenues.

·Number of 3D motion pictures. Total 3D motion pictures are the number of 3D motion pictures released domestically in North America during the relevant period.

·Number of screens. Domestic screens are motion picture theater screens in the United States or Canada enabled with our RealD Cinema Systems. International screens are motion picture theater screens outside the United States and Canada enabled with our RealD Cinema Systems.

·Number of locations. Domestic locations are motion picture exhibition complexes in the United States or Canada with one or more screens enabled with our RealD Cinema Systems. International locations are motion picture exhibition complexes outside the United States and Canada with one or more screens enabled with our RealD Cinema Systems.

·Adjusted EBITDA. We use Adjusted EBITDA as a supplemental measure of our performance. We define Adjusted EBITDA as net income (loss) plus expenses for interest, income taxes, depreciation, amortization, impairment and stock-based compensation plus net foreign exchange loss (gain) plus expenses under our Credit Agreement for the non-U.S. GAAP category “restructuring charges, severance costs and reserves”. We do not consider the preceding adjustments to be indicative of our core operating performance. We consider our core operating performance to be that which can be affected by our managers in any particular period through their management of the resources that affect our underlying revenue and profit generating operations for that period. However, Adjusted EBITDA is not a recognized measurement under U.S. GAAP and should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. For a reconciliation of Adjusted EBITDA to U.S. GAAP net income (loss) and for further discussion regarding Adjusted EBITDA, see ‘‘Non-U.S. GAAP discussion.’’

18

The following table sets forth additional performance highlights of key business metrics for the periods presented (approximate numbers):

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(approximate numbers, in millions)	2013		2012		2013		2012
Estimated box office on RealD screens (generated during the period)
Estimated box office on RealD domestic screens	$	341	$	299	$	1,031	$	1,029
Estimated box office on RealD international screens	411		344		1,149		1,256
Total estimated box office on RealD screens	$	752	$	643	$	2,180	$	2,285
	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(approximate numbers)	2013		2012		2013		2012
Number of 3D motion pictures (released domestically during period)	8		9		27		28
	December 31,		December 31,
	2013		2012
Number of RealD enabled screens (at period end)
Total domestic RealD enabled screens	13,400		12,600
Total international RealD enabled screens	11,400		9,600
Total RealD enabled screens	24,800		22,200
Number of locations with RealD enabled screens (at period end)
Total domestic locations with RealD enabled screens	3,000		2,800
Total international locations with RealD enabled screens	2,900		2,700
Total locations with RealD enabled screens	5,900		5,500

Performance highlights for Adjusted EBITDA, another key business metric and a Non-U.S. GAAP financial measure, are presented below under the caption “Non-U.S. GAAP discussion.”

Beginning in the first quarter of fiscal year 2014, we modified our definition of Adjusted EBITDA for financial reporting purposes to align with the Adjusted EBITDA definition under the Credit Agreement (see “Liquidity and capital resources” caption below).  As a result, we no longer add back sales and use tax and property tax to calculate Adjusted EBITDA for financial reporting purposes.

Opportunities, trends and factors affecting comparability

We have rapidly evolved and expanded our business since we acquired ColorLink in March 2007. This expansion has included hiring most of our senior management team, acquiring and growing our research and development facilities in Boulder, Colorado, and building infrastructure to support our business. These investments in and changes to our business have allowed us to significantly increase our revenue and key business metrics. Almost all of our revenue is currently dependent upon both the number of 3D motion pictures released and the commercial success of those 3D motion pictures. We expect to continue to invest for the foreseeable future in expanding our business as we increase our direct sales and marketing presence in the United States, Europe, Asia, Latin America, Russia and other geographic regions, enhance and expand our technology and product offerings and pursue strategic acquisitions.  For example, in 2012, we established a RealD sales and operating presence in Russia and, in 2013, we established a RealD sales and operating presence in Latin America.

Cinema

The shift in the motion picture industry from analog to digital over the past decade has created an opportunity for new and transformative 3D technologies. As of December 31, 2013, there were approximately 24,800 RealD-enabled screens worldwide as compared to approximately 22,200 RealD-enabled screens worldwide as of December 31, 2012, an increase of 2,600 RealD-enabled screens or 12%. Based on the slate announced by motion picture studios, we anticipate that approximately 35 3D motion pictures will be released worldwide in our fiscal year 2014, including sequels to successful major motion picture franchises, such as  Iron Man, Thor, The Hobbit, Star Trek, 300, Monsters, Despicable Me, The Smurfs and Cloudy with a Chance of Meatballs.

Other visual display technologies

We have made available our RealD Display, active and passive eyewear, and RealD Format technologies to consumer electronics manufacturers and content distributors to enable 3D in high definition televisions, laptops, tablets, smartphones and other displays in the home and elsewhere.

Accounting period

On November 14, 2012, our Board of Directors approved a change in our accounting periods from the previous configuration of four 13-week periods for a total of 52 weeks per year to calendar quarter end accounting periods. This change in accounting period commenced in the third quarter ended on December 31, 2012 of fiscal year 2013. As a result, the three months and nine months ended December 31, 2013 are nine days (8.9%) shorter and eight days (2.8%) shorter than the three months and nine months ended December 31, 2012, respectively. The three months and nine months ended December 31, 2012 are nine days (9.8%) longer and eight days (2.9%) longer than the three months and nine months ended December 31, 2013, respectively.

19

Results of operations

The following table sets forth our condensed consolidated statements of operations and other data for each of the periods indicated:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands)	2013		2012		2013		2012
Consolidated statements of operations data:
Revenue	$	55,438	$	46,939	$	158,586	$	170,103
Cost of revenue	28,168		26,020		83,229		100,185
Gross margin	27,270		20,919		75,357		69,918
Operating expenses:
Research and development	5,236		5,376		15,465		14,866
Selling and marketing	6,842		6,053		20,295		18,872
General and administrative	13,161		12,346		39,533		35,797
Total operating expenses	25,239		23,775		75,293		69,535
Operating income (loss)	2,031		(2,856)		64		383
Interest expense, net	(525)		(426)		(1,765)		(1,027)
Other income (loss)	(47)		(183)		227		(557)
Income (loss) before income taxes	1,459		(3,465)		(1,474)		(1,201)
Income tax expense	1,614		694		4,881		4,242
Net loss	(155)		(4,159)		(6,355)		(5,443)
Net (income) loss attributable to noncontrolling interest	(116)		(1)		(101)		89
Net loss attributable to RealD Inc.
common stockholders	$	(271)	$	(4,160)	$	(6,456)	$	(5,354)
Other data:
Adjusted EBITDA (1)	$	21,257	$	10,889	$	50,955	$	45,059

(1)Adjusted EBITDA is not a recognized measurement under U.S. GAAP.  For a definition of Adjusted EBITDA and reconciliation to net income (loss), the comparable U.S. GAAP item, see “Non-U.S. GAAP discussion”.

Cost reduction plan

During fiscal year 2014, we implemented a plan to reduce the overall costs of our global operations while continuing to make significant research and development investments and build the framework for our future growth. This cost reduction plan is primarily a response to the 3D box office performance of certain motion pictures due to consumer preference and the fact that our 3D cinema business is maturing in many markets like the United States where we expect equipment installations to begin to slow, and the resulting impact on our financial results and operations. We are also re-scoping and making other changes to certain research and development projects, reducing general and administrative expenses and streamlining certain manufacturing operations.  These actions are intended to rationalize the further expansion of our global cinema platform by focusing on emerging growth markets, streamlining our manufacturing facilities to achieve cost efficiencies while meeting the future commercial demands of our customers and focusing our research and development efforts on technologies that will enable us to expand our visual technology product offerings. The total annual cost savings are estimated to be $15.0 million, of which $9.7 million is detailed below for personnel and facilities. The remainder results from a variety of the changes mentioned above. The itemized rent savings that we project are $1.2 million less than originally estimated. We nevertheless anticipate that we will achieve a total of $15.0 million in savings under our cost reduction plan.

An element of that plan is to reduce our workforce by approximately 20%, resulting in termination charges of approximately $4.9 million. Further, we expect to incur approximately $0.5 million in other charges principally related to the accrual of losses for a lease for certain manufacturing facilities that will no longer be used in our operations. Therefore, the total charges associated with the cost reduction plan currently are estimated to be approximately $5.4 million. The following table summarizes the currently estimated charges resulting from implementation of the cost reduction plan:

	Estimated termination and implementation charges
(in thousands)	Personnel		Lease		Impairment		Total
Cost of revenue	$	842	$	435	$	66	$	1,343
Research and development	755		0		0		755
Selling and marketing	1,995		0		0		1,995
General and administrative	1,256		0		0		1,256
Total	$	4,848	$	435	$	66	$	5,349

20

Total expenses incurred in relation to the cost reduction plan were $3.7 million for both the three months and nine months ended December 31, 2013. The following table summarizes the activity resulting from implementation of the cost reduction plan within accrued expenses and other liabilities:

	Three and nine months ended December 31, 2013
(in thousands)	Beginning liability		Expensed		Paid		Ending liability
Cost reduction plan liabilities	$	-	$	3,657	$	2,005	$	1,652

We have initiated many of the above-noted cost reduction actions and plan to act on the remaining areas by the end of fiscal year 2014. We estimate that most of the remaining expenses will be incurred during the fourth quarter of fiscal year 2014 but lease and impairment charges might not occur until fiscal year 2015. Certain office space includes approximately $7.0 million in leasehold improvements within fixed assets, which could become subject to an impairment assessment upon a future change in circumstances.

	Termination and implementation expenses
	Q3 FY2014 Actual		Q4 FY2014 Estimate
(in thousands)	Personnel		Personnel		Lease		Impairment
Cost of revenue	$	842	$	-	$	435	$	66
Research and development	755		-		-		-
Selling and marketing	1,104		891		-		-
General and administrative	956		300		-		-
Total	$	3,657	$	1,191	$	435	$	66

The cash payments are estimated as follows:

	Payments excluding non-cash impairment
(in thousands)	Personnel		Lease
Q3 FY2014 Actual	$	2,005	$	-
Q4 FY2014 Estimate	1,843		32
FY2015 Estimate	667		227
FY2016 Estimate	333		132
FY2017 Estimate	-		44
Total	$	4,848	$	435

Capital expenditures for leasehold improvements, net of landlord allowance, are estimated to total $0.3M during the next two quarters for the relocated manufacturing operations. The resultant estimated annual effect on cost of revenue through June 30, 2024 is insignificant.

There is no guarantee that termination and implementation costs will not exceed the estimates, or that any net cost reduction will actually be achieved.

The Company records the cost reduction plan activities in accordance with the Accounting Standards Codification (ASC), including ASC 420 Exit or Disposal Cost Obligations, ASC 712 Compensation—Nonretirement Postemployment Benefits and ASC 360 Property, Plant, and Equipment (Impairment or Disposal of Long-Lived Assets).

As a result of the reduction in workforce, we anticipate annual personnel and rent savings of approximately $9.7 million, which includes $6.7 million in salaries and benefits, $2.8 million in stock-based compensation and approximately $0.2 million in rent expense. We currently anticipate these estimated annual savings to fully commence in the first quarter of fiscal year 2015. The following table summarizes the estimated savings in personnel costs and rent calculated from estimated costs for the 12 months ended October 31, 2014 as if the personnel and facility space continued in service:

	Estimated annual savings upon full implementation
	Salaries &		Stock-based
(in thousands)	benefits		compensation		Rent		Total
Cost of revenue	$	1,372	$	482	$	252	$	2,106
Research and development	1,416		316		-		1,732
Selling and marketing	1,950		1,642		-		3,592
General and administrative	1,940		393		-		2,333
Total	$	6,678	$	2,833	$	252	$	9,763

There is no guarantee that the planned savings will actually be achieved.

21

Three months ended December 31, 2013 compared to three months ended December 31, 2012

Revenue

	Three months ended
	December 31,			December 31,
(in thousands)	2013			2012			Amount		Percentage
Revenue:	Amount		% of Total	Amount		% of Total	change		change
License revenue
Domestic	$	11,787	21%	$	12,333	26%	$	(546)	(4%)
International	23,832		43%	18,001		39%	5,831		32%
Total license revenue	$	35,619	64%	$	30,334	65%	$	5,285	17%
Product and other
Domestic	$	13,218	24%	$	10,907	23%	$	2,311	21%
International	6,601		12%	5,698		12%	903		16%
Total product and other revenue	$	19,819	36%	$	16,605	35%	$	3,214	19%
Total revenue	$	55,438	100%	$	46,939	100%	$	8,499	18%

The increase in revenue recorded during the three months ended December 31, 2013 compared to the three months ended December 31, 2012 was primarily due to an increase in international license revenue resulting from an increase in box office performance and higher domestic and international eyewear sales. Our international markets comprised approximately 55% of total revenue for the three months ended December 31, 2013 as compared to 50% for the three months ended December 31, 2012.

For the three months ended December 31, 2013, there were five motion pictures that contributed greater than $1.0 million of admission-based fees to license revenue. License revenue for the three months ended December 31, 2013 includes admission-based fees related to the following motion pictures: Gravity ($8.1 million), The Hobbit 2: The Desolation of Smaug ($4.6 million), Thor: The Dark World ($4.0 million), Frozen ($3.3 million) and Cloudy with a Chance of Meatballs 2 ($1.5 million).

For the three months ended December 31, 2012, there were seven motion pictures that contributed greater than $1.0 million of admission-based fees to net license revenue. Net license revenue for the three months ended December 31, 2012 includes admission-based fees related to the following motion pictures: The Hobbit: An Unexpected Journey ($5.3 million), Life of Pi ($2.7 million), Hotel Transylvania ($2.4 million), Wreck It Ralph ($2.2 million), Rise of the Guardians ($1.8 million), Madagascar 3: Europe’s Most Wanted ($1.3 million) and Resident Evil: Retribution ($1.3 million).

License revenues comprised 64% and 65% of total revenues for the three months ended December 31, 2013 and December 31, 2012, respectively. International license revenues comprised of $23.8 million, or 67% of total license revenues and $18.0 million, or 59% of total license revenue for the three months ended December 31, 2013 and December 31, 2012, respectively.

The increase in our product and other revenue in the three months ended December 31, 2013 as compared to the three months ended December 31, 2012, was primarily a result of an increase in the volume of RealD eyewear consumed or sold to our domestic and international markets, which is partially offset by a reduction in average eyewear revenue per unit sold. The increase in RealD eyewear volume both domestically and internationally compared to the prior period resulted from international exhibitor buying patterns relative to the film slate and purchases by certain international exhibitors from alternative suppliers, including authorized resellers of RealD eyewear. International product revenues comprised of $6.6 million, or 33% of total product revenues and $5.7 million, or 34% of total product revenues for the three months ended December 31, 2013 and December 31, 2012, respectively. International product and other revenues were 28% of international license revenue for the three months ended December 31, 2013 as compared to 32% for the three months ended December 31, 2012.

22

We expect our future revenue, particularly in our license business, will be driven by the number of RealD-enabled screens and motion pictures released in 3D and the box office performance of those films.

Cost of Revenue

	Three months ended
	December 31,			December 31,
(in thousands)	2013			2012			Amount		Percentage
	Amount		% of Revenue	Amount		% of Revenue	change		change
Revenue:
License revenue	$	35,619	64%	$	30,334	65%	$	5,285	17%
Product and other	19,819		36%	16,605		35%	3,214		19%
Total revenue	$	55,438	100%	$	46,939	100%	$	8,499	18%
Cost of revenue:
License	$	11,472	32%	$	10,523	35%	$	949	9%
Product and other	16,696		84%	15,497		93%	1,199		8%
Total cost of revenue	$	28,168	51%	$	26,020	55%	$	2,148	8%
Gross profit (loss):
License	$	24,147	68%	$	19,811	65%	$	4,336	22%
Product and other	3,123		16%	1,108		7%	2,015		182%
Total gross profit (loss)	$	27,270	49%	$	20,919	45%	$	6,351	30%

The three months ended December 31, 2013 includes expenses discussed under the caption “Cost reduction plan”.

For the three months ended December 31, 2013, our cost of revenue increased primarily due to higher demand of eyewear as a result of improved box office performance.  Cost of revenue decreased, as a percentage of revenue, to 51% for the three months ended December 31, 2013, as compared to 55% for the three months ended December 31, 2012.

License cost of revenue increased $0.9 million quarter-over-quarter primarily as a result of a $1.0 million increase in depreciation expense resulting from an increase in RealD-enabled screens, $0.7 million in manufacturing costs resulting from severance payments made to employees impacted by cost reduction plan and partially offset by $0.4 million decrease in inventory obsolescence expense and $0.3 million decrease in field support costs. Included in license cost of revenue for the three months ended December 31, 2013 and December, 2012 is depreciation expense of $8.3 million and $7.4 million, respectively. Depreciation expense as a percentage of total license revenue was 24% for the three months ended December 31, 2013 as compared to 24% for the three months ended December 31, 2012.

Product and other gross profit increased $2.0 million quarter-over-quarter, primarily as a result of optimizing eyewear product mix and increased demand of eyewear products. Product and other gross margin increased to 16% for the three months ended December 31, 2013 as compared to 7% for the three months ended December 31, 2012.

Costs associated with our eyewear recycling program have been expensed in the period incurred.  Recycling costs totaled $1.5 million for the three months ended December 31, 2013 and $1.4 million for the three months ended December 31, 2012, and included the cost to transport RealD eyewear between theaters and the recycling production facility and costs to process the RealD eyewear for reuse. The percentage of usage of recycled eyewear may decrease in future periods resulting in lower gross profit and gross margin.

Our cost of revenue as a percentage of revenue, as well as our gross profit and gross margin, will be affected in the future by the relative mix of license and product revenue, the mix of domestic and international product revenues, the relative mix of products and any new revenue sources, impairment charges and the percentage usage of recycled eyewear. Impairment charges in future periods may increase as a result of system upgrades and replacements as well as changes in product offerings and new technology. As the number of RealD-enabled screens and the number of 3D motion pictures and attendance increase, our total cost of revenue may continue to increase.

Operating Expenses

	Three months ended
	December 31,		December 31,		Amount		Percentage
(in thousands)	2013		2012		change		change
Research and development	$	5,236	$	5,376	$	(140)	(3%)
Selling and marketing	6,842		6,053		789		13%
General and administrative	13,161		12,346		815		7%
Total operating expenses	$	25,239	$	23,775	$	1,464	6%

The three months ended December 31, 2013 includes expenses discussed under the caption “Cost reduction plan”.

Research and development. Our research and development expenses decreased primarily due to $1.5 million lower non-recurring engineering and prototype expenses, which was largely offset by $0.8 million higher personnel costs as a result of the cost reduction plan, $0.3 million higher outside services and $0.3 million higher amortization and depreciation expenses. We expect to continue to support our research and development expenses to support our anticipated growth in consumer electronics projects and initiatives, primarily for additional personnel, consultants and prototype and materials costs, as well as for continued investment in our cinema business.

23

Selling and marketing. Our selling and marketing expenses increased primarily due to $1.6 million higher personnel costs as a result of the cost reduction plan, which was partially offset by $0.6 lower million advertising and glasses promotion costs, $0.1 million lower outside services costs and $0.1 million lower fulfillment shipping charges. We expect to incur additional selling and marketing expenses, aside from personnel related costs, as we increase our international marketing efforts, particularly in Asia, Latin America and Russia, to build our consumer electronics business worldwide and market future 3D films.

General and administrative. Our general and administrative expenses increased primarily due to $0.6 million higher depreciation expense, $0.4 million higher personnel costs as a result of the cost reduction plan and $0.3 million higher bad debt expense, which were partially offset by $0.4 million lower professional and outside services and $0.1 million lower sales and use taxes and property taxes. We expect to incur less general and administrative expenses primarily from reduced headcount and the associated personnel costs.

Historical operating expenses are not necessarily indicative of future expenses for a changing business.

Other

Interest expense, net.  Net interest expense was $0.5 million and $0.4 million for the three months ended December 31, 2013 and December 31, 2012, respectively. The increase in net interest expense was primarily due to increased borrowings under our Credit Agreement.

Income tax.  Our income tax expense for the three months ended December 31, 2013 was $1.6 million compared to $0.7 million for the three months ended December 31, 2012, primarily due to increased foreign revenue in countries subject to withholding and income taxes.

We have net operating losses that may potentially offset taxable income in the future. We expect to incur an increasing amount of income tax expenses that relate primarily to federal and state income tax and international operations. We file federal income tax returns and income tax returns in various state and foreign jurisdictions. Due to the net operating loss carryforwards, our United States federal and state returns are open to examination by the Internal Revenue Service and state jurisdictions for all years since inception.

Nine months ended December 31, 2013 compared to nine months ended December 31, 2012

Revenue

	Nine months ended
	December 31,			December 31,
(in thousands)	2013			2012			Amount		Percentage
Revenue:	Amount		% of Total	Amount		% of Total	change		change
License revenue
Domestic	$	39,935	25%	$	43,871	26%	$	(3,936)	(9%)
International	63,966		41%	62,628		37%	1,338		2%
Total license revenue	$	103,901	66%	$	106,499	63%	$	(2,598)	(2%)
Product and other
Domestic	$	38,385	24%	$	40,700	24%	$	(2,315)	(6%)
International	16,300		10%	22,904		13%	(6,604)		(29%)
Total product and other revenue	$	54,685	34%	$	63,604	37%	$	(8,919)	(14%)
Total revenue	$	158,586	100%	$	170,103	100%	$	(11,517)	(7%)

The decrease in net revenue recorded during the nine months ended December 31, 2013 compared to the nine months ended December 31, 2012 was primarily due to a decrease in net license revenues resulting from a decrease in box office performance, lower domestic eyewear usage and lower international eyewear sales. Our international markets comprised approximately 50% of gross revenue for the nine months ended December 31, 2013 as compared to 50% for the nine months ended December 30, 2012. The decrease in net revenues attributable to international markets was driven by both a decrease in box office performance and purchases of RealD eyewear.

24

For the nine months ended December 31, 2013, there were 24 motion pictures which contributed greater than $1.0 million of admission-based fees to net license revenue. The top ten motion pictures that contributed greater than $1.0 million of admission-based fees to net license revenue for the nine months ended December 31, 2013 included the following: Iron Man 3 ($9.2 million), Gravity ($8.1 million), Despicable Me 2 ($5.0 million), Monsters University ($4.8 million), The Hobbit 2: The Desolation of Smaug ($4.6 million), Man of Steel ($4.4 million), Thor: The Dark World ($4.0 million), World War Z ($3.8 million), Star Trek 2: Into Darkness ($3.5 million) and Frozen ($3.3 million).

For the nine months ended December 31, 2012, there were 22 motion pictures that contributed greater than $1.0 million of admission-based fees to net license revenue. The top ten motion pictures that contributed greater than $1.0 million of admission-based fees to net license revenue for the nine months ended December 31, 2012 included the following: The Avengers ($13.9 million), Ice Age: Continental Drift ($7.3 million), The Amazing Spider-Man  ($6.5 million), Madagascar 3: Europe’s Most Wanted  ($6.2 million), The Hobbit: An Unexpected Journey ($5.3 million),Men in Black III ($4.8 million), Brave ($4.3 million),Titanic (re-release) ($3.8 million), Prometheus ($3.7 million) and Wrath of the Titans ($3.2 million) .

Total license revenues comprised 66% and 63% of total revenues for the nine months ended December 31, 2013 and December 31, 2012, respectively. International license revenues comprised 62% of gross license revenues in the nine months ended December 31, 2013 as compared to 59% for the nine months ended December 31, 2012.

The decrease in our net product and other revenue in the nine months ended December 31, 2013 as compared to the nine months ended December 31, 2012, was primarily a result of a decrease in the volume of RealD eyewear sold to our domestic and international markets. The decrease in RealD eyewear volume internationally compared to the prior period resulted from a growing trend among consumers to reuse RealD eyewear for multiple viewings, as well as exhibitor buying patterns relative to the film slate and purchases by certain international exhibitors from alternative suppliers, including authorized resellers of RealD eyewear. International product revenues comprised 30% of total product revenues in the nine months ended December 31, 2013 as compared to 36% for the nine months ended December 31, 2012. International product and other revenues were 25% and 37% of international license revenue for the nine months ended December 31, 2013 and December 31, 2012, respectively.

Cost of Revenue

	Nine months ended
	December 31,			December 31,
(in thousands)	2013			2012			Amount		Percentage
	Amount		% of Revenue	Amount		% of Revenue	change		change
Revenue:
License revenue	$	103,901	66%	$	106,499	63%	$	(2,598)	(2%)
Product and other	54,685		34%	63,604		37%	(8,919)		(14%)
Total revenue	$	158,586	100%	$	170,103	100%	$	(11,517)	(7%)
Cost of revenue:
License	$	33,981	33%	$	34,819	33%	$	(838)	(2%)
Product and other	49,248		90%	65,366		103%	(16,118)		(25%)
Total cost of revenue	$	83,229	52%	$	100,185	59%	$	(16,956)	(17%)
Gross profit (loss):
License	$	69,920	67%	$	71,680	67%	$	(1,760)	(2%)
Product and other	5,437		10%	(1,762)		(3%)	7,199		(409%)
Total gross profit (loss)	$	75,357	48%	$	69,918	41%	$	5,439	8%

The nine months ended December 31, 2013 includes expenses discussed under the caption “Cost reduction plan”.

For the nine months ended December 31, 2013, our cost of revenue decreased primarily due to the costs associated with the maintenance of our global installed base as well as higher shipments of lower-cost recycled eyewear in our domestic markets. Cost of revenue decreased, as a percentage of revenue, to 52% for the nine months ended December 31, 2013, as compared to 59% for the nine months ended December 31, 2012 due to a reduction in license revenues as well as costs associated with the growth and maintenance of our global installed base as well as a reduction in the product mix of lower cost recycled eyewear. The percentage of usage of recycled eyewear may continue to decrease in future periods resulting in lower gross profit and gross margin.

License cost of revenue decreased $0.8 million year-over-year primarily as a result of a $2.5 million decrease in impairment expense, $0.8 million decrease in field support, $0.8 million decrease in obsolete inventory expense and $0.3 million decrease in warranty expense, which were partially offset by $2.9 million increase in depreciation expense and $0.5 million increase in manufacturing costs.  Included in license cost of sales for the nine months ended December 31, 2013 and December 31, 2012 is depreciation expense of $24.3 million and $21.4 million, respectively. Depreciation expense as a percentage of gross license revenue increased to 24% for the nine months ended December 31, 2013 from 20% for the nine months ended December 31, 2012.

25

During the nine months ended December 31, 2013, we determined that certain of our cinema systems were not recoverable and that the carrying value of the assets exceeded fair value, primarily due to the number of certain of our cinema system assets on hand, and the continuing shift in the mix in the deployment of cinema systems based on the type of digital projectors installed and theater configuration.  The fair value was primarily determined by evaluating the future cash flows expected to be generated from the cinema systems.  For the nine months ended December 31, 2013, impairment charged to cost of revenue for certain of the cinema systems totaled $3.5 million.

During the nine months ended December 31, 2012, we determined that a non-cancelable purchase commitment for certain cinema systems configurations in the aggregate amount of $3.5 million were not fully recoverable, primarily due to the initial investment costs which are expected to exceed the anticipated future cash flows for the related cinema systems. The fair value was primarily determined by evaluating the future cash flows expected to be generated from the cinema systems.  For the nine months ended December 31, 2012, impairment charged to cost of revenue for certain of the cinema systems, including the related outstanding purchase commitment, totaled $3.5 million.

Product and other gross profit increased $7.2 million year-over-year, primarily as a result of a reduction of average eyewear cost per unit expensed and a reduction of average eyewear revenue per unit sold. Product and other gross margin increased to a gross profit of 10% for the nine months ended December 31, 2013 as compared to a gross loss of (3%) for the nine months ended December 31, 2012.

Costs associated with our eyewear recycling program have been expensed in the period incurred.  Recycling costs totaled $5.7 million for the nine months ended December 31, 2013 and $5.7 million for the nine months ended December 31, 2012, and included the cost to transport RealD eyewear between theaters and the recycling production facility and costs to process the RealD eyewear for reuse.

Our cost of revenue as a percentage of net revenue, as well as our gross profit and gross margin, will be affected in the future by the relative mix of net license and net product revenue, the mix of domestic and international product revenues, the relative mix of products and any new revenue sources, impairment charges and the percentage of usage of recycled eyewear. Impairment charges in future periods may increase as a result of system upgrades and replacements as well as changes in product offerings and new technology. As the number of RealD-enabled screens and the number of 3D motion pictures and attendance increase, our total cost of revenue may continue to increase.

Operating Expenses

	Nine months ended
	December 31,		December 31,		Amount		Percentage
(in thousands)	2013		2012		change		change
Research and development	$	15,465	$	14,866	$	599	4%
Selling and marketing	20,295		18,872		1,423		8%
General and administrative	39,533		35,797		3,736		10%
Total operating expenses	$	75,293	$	69,535	$	5,758	8%

The nine months ended December 31, 2013 includes expenses discussed under the caption “Cost reduction plan”.

Research and development.  Our research and development expenses increased primarily due to $1.1 million higher depreciation and amortization, $0.5 million higher rent and occupancy and $0.3 million higher supplies expenses, which were partially offset by $1.9 million lower non-recurring engineering/prototype and $0.4 million lower professional consultant expenses. We expect to continue to increase our research and development expenses to support our anticipated growth in consumer electronics projects and initiatives, primarily for additional personnel, consultants and prototype and materials costs, as well as for continued investment in our cinema business.

Selling and marketing. Our selling and marketing expenses increased primarily due to $1.9 million higher personnel costs, $0.3 million higher trade shows, $0.3 million higher public relations expenses and $0.2 million higher promotional glasses cost, which were partially offset by $0.7 million lower advertising costs, $0.4 million lower fulfillment shipping cost and $0.3 million lower outside service expenses. We expect to incur additional selling and marketing expenses, aside from personnel related costs, as we increase our international marketing efforts, particularly in Asia, Latin America and Russia, to build our consumer electronics business worldwide and market future 3D films.

General and administrative. Our general and administrative expenses increased primarily due to a $1.4 million higher amortization and depreciation expense, $1.2 million higher professional and outside services, $0.7 million higher bad debt and $0.4 million higher rent.

Historical operating expenses are not necessarily indicative of future expenses for a changing business.

26

Other

Interest expense, net.  Net interest expense was $1.8 million and $1.0 million for the nine months ended December 31, 2013 and December 31, 2012, respectively. The increase in net interest expense was primarily due to increased borrowings under our Credit Agreement.

Income tax.  Our income tax expense for the nine months ended December 31, 2013 was $4.9 million compared to $4.2 million for the nine months ended December 31, 2012.

We have net operating losses that may potentially offset taxable income in the future. We expect to incur an increasing amount of income tax expenses that relate primarily to federal and state income tax and international operations. We file federal income tax returns and income tax returns in various state and foreign jurisdictions. Due to the net operating loss carryforwards, our United States federal and state returns are open to examination by the Internal Revenue Service and state jurisdictions for all years since inception.

Seasonality and quarterly performance

Our operations are generally subject to seasonal trends based on the number of 3D motion pictures released and the box office of those 3D motion pictures.  As is the case with other participants in the motion picture exhibition industry, we expect that our fiscal quarters during the summer period generally will tend to show stronger box office performance and higher revenues due to the summer movie-going season, when many of the largest grossing films in any given year are typically released.  By comparison the quarter ending in March traditionally does not benefit from the same box office performance due to the number and nature of the motion pictures released in this seasonal period.  We expect to experience seasonal fluctuations in results of operations as a result of these trends.  Our quarterly financial results have fluctuated in the past and may continue to fluctuate in the future based on a number of other factors in addition to these seasonal trends, many of which are beyond our control. Factors that may cause our operating results to vary or fluctuate include those discussed in Part II, Item 1A below under the caption “Risk factors.”

Liquidity and capital resources

Since our inception and through December 31, 2013, we have financed our operations through the proceeds we received in connection with our IPO, the sale of redeemable convertible preferred stock, borrowings under our previous credit facility agreement and our current Credit Agreement with City National and through the net cash provided by operating activities. Our cash flow from operating activities has historically been significantly impacted by the contractual payment terms and patterns related to the license of our RealD Cinema Systems and use and sale of our RealD eyewear, as well as significant investments in research, development, selling and marketing activities and corporate infrastructure.

Cash provided by operating activities is expected to be a primary recurring source of funds in future periods and will be driven by our expected revenue generated from the 3D motion pictures exhibited on our RealD Cinema Systems and an increase in the number of RealD-enabled screens, partially offset by an increase in working capital requirements associated with RealD Cinema Systems, logistics and recycling costs for our RealD eyewear. Depending on our operating performance in any given period and the installation rate of additional RealD Cinema Systems, including system upgrades and replacements, changes in product offerings and new technology, we expect to supplement our liquidity needs primarily with borrowings under our Credit Agreement described below.

On April 19, 2012, we entered into the Credit Agreement with City National pursuant to which the lenders thereunder made available to us the Revolving Facility and the Term Loan Facility. The Revolving Facility and the Term Loan Facility replaced existing revolving and term loan facilities provided under our pre-existing credit and security agreement with City National, which had been most recently amended on December 6, 2011.  Our obligations under our Credit Agreement are secured by a first priority security interest in substantially all of our tangible and intangible assets and are fully and unconditionally guaranteed by our subsidiaries, ColorLink and Stereographics.

During the first quarter of fiscal year 2013, we borrowed $25 million under the Term Loan Facility, resulting in $25 million being available for future draws. During the second quarter of fiscal 2014, we borrowed an additional $25 million, fully drawing down the Term Loan Facility. During the second quarter of fiscal 2013, we repaid $12.5 million of the Term Loan Facility. On December 31, 2013, we commenced the first of 12 quarterly installments of $3.1 million to repay the Term Loan Facility by September 30, 2016.

We intend to borrow additional amounts under our Credit Agreement facility to fund various growth initiatives, potentially including accelerated research and product development, acquisitions and capital expenditures.  We expect that we will maintain a significant amount of indebtedness on an ongoing basis.

27

The Revolving Facility matures on April 17, 2015 with $15.0 million drawn as of December 31, 2013.  Through December 31, 2013, the aggregate Term Loan Facility commitment of $50 million had been drawn in full and $15.6 million had been repaid, resulting in an outstanding balance of $34.4 million to be repaid in 11 remaining quarterly installments of $3.1 million through September 30, 2016.

The Revolving Facility provides for, at our option, Eurodollar Rate Loans, which bears interest at the London Interbank Offered Rate (“LIBOR”) plus two and one-half percent (2.50%) or Base Rate Loans, which bear interest at one and one-half percent (1.5%) plus the greatest of (a) the Federal Funds Rate plus 1/2 of 1%, (b) the Prime Rate, and (c) the Eurodollar Rate for a one month Interest Period on such day plus 1.00%.

Under the Credit Agreement, our business will be subject to certain limitations, including limitations on our ability to incur additional debt, make certain investments or acquisitions, enter into certain merger and consolidation transactions, and sell our assets other than in the ordinary course of business. We will also be required to maintain compliance with certain financial covenants, including a minimum fixed charge coverage ratio and a maximum leverage ratio. As of December 31, 2013, we were in compliance with all financial covenants in the Credit Agreement. If we fail to comply with any of the covenants or if any other event of default, as defined in the Credit Agreement, should occur, the bank lenders could elect to prevent us from borrowing and declare the indebtedness to be immediately due and payable. The “Cost reduction plan” (under separate caption above) does not result in lack of compliance with these covenants.

As of December 31, 2013, our primary sources of liquidity were our cash and cash equivalents of $29.6 million and funds available to use under the Credit Agreement consisting of the Revolving Facility of up to $75.0 million. No further draws remain on the Term Loan Facility.

Our cash equivalents primarily consist of money market funds and other marketable securities that mature within three months from the date of purchase. The carrying amount of cash equivalents reasonably approximates fair value due to the short maturities of these instruments. The primary objective of our investment activities is preservation of capital, fulfillment of liquidity needs and fiduciary control of cash and investments. We also seek to maximize income from our investments without assuming significant risk. We do not enter into investments for trading or speculative purposes.

We believe that our cash, cash equivalents, potential cash flows from operations, and our availability under our Credit Agreement will be sufficient to satisfy our currently anticipated cash requirements through at least the next 12 months.

The following table sets forth our major sources and (uses) of cash for each period as set forth below.

	Nine months ended
	December 31,		December 31,
(in thousands)	2013		2012
Operating activities	$	21,520	$	62,983
Investing activities	(19,236)		(21,965)
Financing activities	$	(3,959)	$	(38,245)

Cash flow from operating activities

The nine months ended December 31, 2013 includes payments discussed under the caption “Cost reduction plan”.

Operating activities provided cash inflow of $21.5 million during the nine months ended December 31, 2013. The cash flows primarily resulted from net loss adjusted for non-cash items and decrease in inventory, partially offset by an increase in accounts receivable and decreases in accounts payable and accrued expenses. Increase in accounts receivable were related to the timing of collections.  The decrease in inventories is primarily due to better box office performance than expected. Decreases in accounts payable and accrued expenses were related to the timing of payments.

Net cash inflows from operating activities during the nine months ended December 31, 2012 primarily resulted from a decrease in inventories, decreases in accounts receivable, and decreases in accounts payable and accrued expenses. The decrease in inventories is primarily due to the decreased volume of inventory purchases and usage of existing inventories. Decreases in accounts receivable was related to timing of collections. Decreases in accounts payable and accrued expenses were related to timing of payments due to theincreased cash flow from operations.

Cash flow from investing activities

For both the nine months ended December 31, 2013 and December 31, 2012, cash outflow for investing activities was primarily related to the purchase of component parts for our RealD Cinema Systems and other property, equipment and leasehold improvements. In the nine months ended December 31, 2013 and December 31, 2012, we received proceeds of $0.2 million and $2.5 million, respectively, as a result of the sale of digital projectors to certain of our motion picture exhibitors. Capital expenditures were $19.5 million for the nine months ended December 31, 2013 and $24.4 million for the nine months ended December 31, 2012. In the future, we will continue to invest in our business to grow sales and develop new products.

28

Cash flow from financing activities

Net cash inflows from financing activities for the nine months ended December 31, 2013 primarily resulted from $37.5 million of proceeds from the Credit Agreement and $1.7 million proceeds from issuance of stock option exercises and employee stock purchases, which was partially offset by $35.6 million of repayments to the Credit Agreement and $7.5 million of stock repurchases.

Net cash outflows from financing activities for the nine months ended December 31, 2012 resulted primarily from $25.0 million of repayments on our prior revolving and term loan facility, $12.5 million of repayments on the Credit Agreement, $47.8 million in stock repurchases, $1.2 million in payments of debt issuance costs and $1.0 million in distributions to a noncontrolling interest.

Debt issuance costs related to the completion of the Credit Agreement totaled $1.2 million and were recorded as a deferred charge.  The issuance costs are being amortized over the contractual life of the agreement and recorded as interest expense.

As of December 31, 2013, there was $49.4 million in debt outstanding under the Credit Agreement and $60.0 million available to borrow under the Credit Agreement. In the future, we may continue to utilize commercial financing, lines of credit and term loans for general corporate purposes, stock repurchases, including investing in technology.

For the nine months ended December 31, 2013 and December 31, 2012, proceeds from employee stock option exercises and employee stock plan purchases were $1.7 million and $1.7 million, respectively.  From time to time, we expect to receive cash from the exercise of employee stock options and warrants in our common stock. Proceeds from the exercise of employee stock options outstanding will vary from period to period based upon, among other factors, fluctuations in the market value of our common stock relative to the exercise price of such stock options and warrants.

On April 20, 2012, we announced that our board of directors had approved an authorization to repurchase up to $50 million of RealD common stock.  On December 14, 2012, our board approved a $25 million increase in our stock repurchase plan, increasing the $50 million repurchase plan announced on April 20, 2012 to $75 million. The number of shares to be repurchased and the timing of any potential repurchases will depend on factors such as the Company’s stock price, economic and market conditions, alternative uses of capital, and corporate and regulatory requirements.  Repurchases of common stock may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when RealD might otherwise be precluded from doing so under insider trading laws, and a variety of other methods, including open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods.  The repurchase program may be suspended or discontinued at any time.

Pursuant to the stock repurchase plan authorized by our board of directors, we have repurchased a total of 6,599,726 shares of common stock at an average price per share, including sales commissions, of $10.30 for an aggregate cost of $68.0 million inception to date. For the three months ended December 31, 2013, there were no stock repurchases. For the nine months ended December 31, 2013, we repurchased a total of 671,997 shares of common stock at an average price per share of $11.18, including sales commissions, for an aggregate cost of $7.5 million.

Off-balance sheet arrangements

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in those types of relationships. We enter into guarantees in the ordinary course of business related to the guarantee of our own performance and the performance of our subsidiaries.

Non-U.S. GAAP discussion

In addition to our U.S. GAAP results, we present Adjusted EBITDA as a supplemental measure of our performance. However, Adjusted EBITDA is not a recognized measurement under U.S. GAAP. We define Adjusted EBITDA as net income (loss) plus expenses for interest, income taxes, depreciation, amortization, impairment and stock-based compensation plus net foreign exchange loss (gain) plus expenses under our Credit Agreement for the non-U.S. GAAP category “restructuring charges, severance costs and reserves”. We do not consider the preceding adjustments to be indicative of our core operating performance. Management considers our core operating performance to be that which can be affected by our managers in any particular period through their management of the resources that affect our underlying revenue and profit generating operations that period. Non-U.S. GAAP adjustments to our results prepared in accordance with U.S. GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual, infrequent or non-recurring items.

29

Set forth below is a reconciliation of Adjusted EBITDA to net income for the three and nine months ended December 31, 2013 and December 31, 2012:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands)	2013		2012		2013		2012
Net loss	$	(155)	$	(4,159)	$	(6,355)	$	(5,443)
Add (deduct):
Interest expense, net	525		426		1,765		1,027
Income tax expense	1,614		694		4,881		4,242
Depreciation and amortization	10,318		8,194		30,082		24,130
Other (income) loss (1)	47		183		(227)		557
Share-based compensation expense (2)	4,487		4,871		13,605		13,965
Impairment of assets and intangibles (3)	764		680		3,547		6,581
Cost reduction plan (4)	3,657		-		3,657		-
Adjusted EBITDA (5)	$	21,257	$	10,889	$	50,955	$	45,059

(1)Includes gains and losses from foreign currency exchange and foreign currency forward contracts.

(2)Represents share-based compensation expense of nonstatutory and incentive stock options and restricted stock units and employee stock purchase plan to employees, non-employees, officers and directors.

(3)Represents impairment of long-lived assets, such as fixed assets, theatrical equipment and related purchase commitments and identifiable intangibles.

(4)Expenses under our Credit Agreement (previously filed with the SEC) for the non-U.S. GAAP category “restructuring charges, severance costs and reserves” (also see the “Cost reduction plan” caption above).

(5)Adjusted EBITDA is not a recognized measurement under U.S. GAAP. For a definition of Adjusted EBITDA and reconciliation to net income (loss), the comparable U.S. GAAP item, see the entirety of this “Non-U.S. GAAP discussion”.

We present Adjusted EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Adjusted EBITDA in developing our internal budgets, forecasts and strategic plans, in analyzing the effectiveness of our business strategies, in evaluating potential acquisitions, in making compensation decisions and in communications with our board of directors concerning our financial performance. Adjusted EBITDA also aligns with the similarly titled definition in our Credit Agreement and is used to determine compliance with financial covenants and our ability to engage in certain activities, such as incurring additional debt and making certain restricted payments. Adjusted EBITDA has limitations as an analytical tool which includes, among others, the following:

·Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;

·Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

·Adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments, on our debts;

·although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;

·non-cash compensation is and will remain a key element of our overall long-term incentive compensation package, although we exclude it as an expense when evaluating our ongoing operating performance for a particular period;

·Adjusted EBITDA does not reflect the impact of certain cash charges resulting from matters we consider not to be indicative ofour ongoing operations; and

·other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only as a supplement. Our consolidated financial statements and the notes to those statements included elsewhere are prepared in accordance with U.S. GAAP.

30

Critical accounting policies and estimates

This discussion is based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, estimates and judgments are evaluated, including those related to revenue recognition, revenue deductions, product returns, fair value of our common stock, share-based compensation, inventories, definite lived asset impairments, goodwill impairment and income taxes. These estimates and judgments are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, which form the basis for our judgments about the carrying values of assets and liabilities not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from these estimates.

We believe the following critical accounting policies, among others, affect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements.

Revenue recognition

We derive substantially all of our revenue from the license of our RealD Cinema Systems and the product sale of our RealD eyewear. We evaluate revenue recognition for transactions using the criteria set forth by the SEC in Staff Accounting Bulletin No. 104,  Revenue Recognition (SAB 104) and Accounting Standards Codification Topic 605, Revenue Recognition (ASC 605). The revenue recognition guidance states that revenue is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed or determinable and collectability is reasonably assured.

License revenue

License revenue is accounted for as an operating lease. License revenue is primarily derived under a per-admission, periodic fixed fee, or per-motion picture basis with motion picture exhibitors. Amounts received up front, less estimated allowances, are deferred and recognized over the lease term using the straight-line method. Additional lease payments that are contingent upon future events outside our control, including those related to admission and usage, are recognized as revenues when the contingency is resolved and we have no more obligations to our customers specific to the contingent payment received. Certain of our license revenue from leasing our RealD Cinema Systems is earned upon admission by the motion picture exhibitor’s consumers. Our licensees, however, do not report and pay for such license revenue until after the admission has occurred, which may be received subsequent to our fiscal period end. We estimate and record licensing revenue related to motion picture exhibitor consumer admissions in the quarter in which the admission occurs, but only when reasonable estimates of such amounts can be made. We determine that there is persuasive evidence of an arrangement upon the execution of a license agreement or upon the receipt of a licensee’s admissions report. Revenue is deemed fixed or determinable upon receipt of a licensee’s admissions report or evidence of a RealD box office showing by licensee. We determine collectability based on an evaluation of the licensee’s recent payment history.

Product revenue

We recognize product revenue, net of allowances, when title and risk of loss have passed and when there is persuasive evidence of an arrangement, the payment is fixed or determinable, and collectability of payment is reasonably assured. In the United States and Canada, certain of our product revenue from the sale of our RealD eyewear is earned upon admission and usage by the motion picture exhibitor’s consumers. Our customers, however, do not report admission or usage information until after the admission and usage has occurred, and such information may be received subsequent to our fiscal period end. We estimate and record such product revenue in the quarter in which the admission and usage occurs, but only when reasonable estimates of such amounts can be made.

Share-based compensation

We account for share-based awards granted to employees and directors by recording compensation expense based on estimated fair values. We estimate the fair value of share-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statements of operations. Share-based awards are attributed to expense using the straight-line method over the vesting period. We determine the value of each option award that contains a market condition using a Monte Carlo Simulation valuation model, while all other option awards are valued using the Black-Scholes valuation model as permitted under ASC 718, Compensation — Stock Compensation. The assumptions used in calculating the fair value of share-based payment awards represent our best estimates. Our estimates of the fair values of share-based awards granted and the resulting amounts of share-based compensation recognized may be impacted by certain variables including stock price volatility, employee stock option exercise behaviors, additional stock option grants, modifications, estimates of forfeitures, and the related income tax impact.

31

Share-based compensation expense for all share-based arrangements for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands)	2013		2012		2013		2012
Share-based compensation
Cost of revenue	$	181	$	120	$	722	$	565
Research and development	632		608		2,107		1,577
Selling and marketing	1,608		1,369		4,189		4,068
General and administrative	2,066		2,774		6,587		7,755
Total	$	4,487	$	4,871	$	13,605	$	13,965

Stock options granted generally vest over a four-year period, with 25% of the shares vesting after one year and monthly vesting thereafter. The options generally expire ten years from the date of grant. For the nine months ended December 31, 2013, we granted 0.7 million stock options at a weighted average grant date fair value of $7.22 per share.  For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to stock options and our employee stock purchase plan was $3.2 million and $3.8 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to stock options and our employee stock purchase plan was $10.3 million and $10.8 million, respectively.

For purposes of determining the expected term and in the absence of historical data relating to stock option exercises, we apply a simplified approach: the expected term of awards granted is presumed to be the mid-point between the vesting date and the end of the contractual term. We use the average volatility of similar, publicly traded companies as an estimate for expected volatility. The risk-free interest rate for periods within the expected or contractual life of the option, as applicable, is based on the United States Treasury yield curve in effect during the period the options were granted. Our expected dividend yield is zero.

Certain of our management-level employees receive performance stock options, which gives the recipient the right to receive common stock that is contingent upon achievement of specified pre-established performance goals over the performance period, which is generally three years subject to the recipient’s continued service with us. The performance goals for the performance stock options are based on the measurement of our total stockholder return, on a percentile basis, compared to a comparable group of companies. Depending on the outcome of the performance goals, the recipient may ultimately earn performance stock options equal to or less than the number of performance stock options granted.  In June 2013, our Chief Executive Officer’s fiscal year 2013 stock option grant was amended to retroactively change the vesting schedule of the stock option so that it now vests based upon the achievement of performance goals rather than based solely upon Mr. Lewis’ continued service with the Company.  The performance goal is based on the measurement of our total stockholder return, on a percentile basis, compared to a comparable group of companies.  The performance period for this performance stock option is between three and five years.  For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to performance stock options was $0 and $0.5 million, respectively.  For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to performance stock options was $0.5 million and $1.4 million, respectively.

The Monte Carlo Simulation valuation model is based on the length of the performance period, the percentile ranking of total stockholder return among peer companies and other provisions of the award. For purposes of determining the expected term and in the absence of historical data relating to stock option exercises, we apply a simplified approach: the expected term of awards granted is presumed to be the mid-point between the vesting date and the end of the contractual term. We use the average volatility of a peer group of companies as an estimate for expected volatility. The risk-free interest rate for periods within the expected or contractual life of the option, as applicable, is based on the United States Treasury yield curve in effect during the period the options were granted.

Certain of our management-level employees also receive performance stock units, which gives the recipient the right to receive common stock that is contingent upon achievement of specific pre-established performance goals over the performance period, which is generally two years subject to the recipient’s continued service with us.  The performance goals are based on achieving certain levels of total licensing revenue over the performance period.  Depending on the outcome of the performance goals, the recipient mayultimately earn performance stock units between 0% and 200% of the number of performance stock units granted.  For the three and nine months ended December 31, 2013, there was no share-based compensation expense related to performance stock units. For the three and nine months ended December 31, 2012, there was no share-based compensation expense related to performance stock units.

Certain of our employees, including certain management level employees, receive time-based restricted stock units. These restricted stock units vest over one to three years based upon a recipient’s continued service with us. For the nine months ended December 31, 2013, we granted 0.6 million restricted stock units at a weighted average grant date fair value of $12.29 per restricted stock unit. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to restricted stock units was $0.9 million and $0.5 million, respectively.  For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to restricted stock units was $2.2 million and $1.7 million, respectively.

32

Inventories

Domestically, we provide our RealD eyewear free of charge to motion picture exhibitors and then receive a fee from the motion picture studios for the usage of that RealD eyewear by the motion picture exhibitors’ consumers.

For RealD eyewear located at a motion picture exhibitor, we do not believe it is operationally practical to perform physical counts or request the motion picture exhibitor to perform physical counts and confirm quantities held to ensure that losses due to damage, destruction, and shrinkage are specifically recognized in the period incurred due to the number of domestic RealD-enabled screens and related usage of RealD eyewear. We believe that the cost to monitor shrinkage or usage significantly outweighs the financial reporting benefits of using a specific identification methodology of expensing. We believe that utilizing a composite method of expensing RealD eyewear inventory costs provides a rational and reasonable approach to ensuring that shrinkage is provided for in the period incurred and that inventory costs are expensed in the periods that reasonably reflect the periods in which the related revenue is recognized. In doing so, we believe the following methodology reasonably and generally reflects periodic income or loss under these facts and circumstances:

·For an estimated period of time following shipment to domestic motion picture exhibitors, no expense is recognized from the time of shipment until the delivery is made because the eyewear is in transit and unused.

·The inventory cost is expensed on a straight-line basis over an estimated usage period beginning with initial usage of the eyewear shipped. In estimating the expensing start date and related expense period, we consider various factors including, but not limited to, those relating to a 3D motion picture’s opening release date, a 3D motion picture’s expected release period, the number of currently playing 3D motion pictures, and the motion picture exhibitor’s buying and stocking patterns and practices.

We believe that the expensing methodology described above rationally and reasonably approximates the period the related usage occurs resulting in our RealD eyewear product revenue. The expensing start date following the date of shipment is meant to approximate the date at which usage begins. Additionally, as the expense recognition period has been and is expected to continue to be short, we believe it adequately recognizes inventory impairments due to loss and damage on a timely basis. We further believe that exposures due to loss or damage, if any, are considered normal shrinkage and a necessary and expected cost to generate the revenue per 3D motion picture earned through RealD eyewear usage. We continue to monitor the reasonableness of this methodology to ensure that it approximates the period over which the related RealD eyewear product revenue is earned and realizable. Costs of RealD eyewear that has shipped but has not yet been used and expensed per this methodology are reported as deferred costs-eyewear.

Impairment of long-lived assets

We review long-lived assets, such as property and equipment, cinema systems, digital projectors and intangibles, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Factors or circumstances that could indicate the occurrence of such events include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing operating or cash flow losses, or incurring costs in excess of amounts originally expected to acquire or construct an asset. If the asset is not recoverable, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.

For the three months ended December 31, 2013 and December 31, 2012, total impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $0.8 million and $0.7 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, total impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $3.5 million and $6.6 million, respectively.

Deferred tax asset valuation and tax exposures

As of December 31, 2013, we have determined based on the weight of the available evidence, both positive and negative, to provide for a valuation allowance against substantially all of the net deferred tax assets. The current deferred tax assets not reserved for by the valuation allowance are those in foreign jurisdictions or amounts that may be carried back in future years. If there is a change in circumstances that causes a change in judgment about the realizability of the deferred tax assets, we will adjust all or a portion of the applicable valuation allowance in the period when such change occurs.

We are subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, we may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, we adjust tax expense to reflect our ongoing assessments of such matters which require judgment and can materially increase or decrease its effective rate as well as impact operating results.

33

Significant judgment is required in determining the provision for income taxes, deferred tax assets and liabilities, the valuation allowance against our deferred tax assets and uncertainty in income tax positions. Our financial position and results of operations may be materially impacted if actual results significantly differ from these estimates or the estimates are adjusted in future periods.

Contingencies and assessments

We are subject to various loss contingencies and assessments arising in the course of our business, some of which relate to litigation, claims, property taxes and sales and use or goods and services tax assessments. We consider the likelihood of the loss or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss, contingencies and assessments. An estimated loss contingency or assessment is accrued when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted. Based on the information presently available, including discussion with counsel and other consultants, management believes that resolution of these matters will not have a material adverse effect on our business, consolidated results of operations, financial condition or cash flows.

Recent accounting pronouncements

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-10, “Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (Or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. The objective of ASU 2013-10 is to provide for the inclusion of the Fed Funds Effective Swap Rate (OIS) as a U.S. benchmark interest rate for hedge accounting purposes, in addition to direct Treasury obligations of the U.S. government (UST) and, for practical reasons, the London Interbank Offered Rate (LIBOR) swap rate. ASU 2013-10 is effective prospectively for qualifying new or redesignated hedging relationship entered into on or after July 17, 2013. Adoption of ASU 2013-10 did not have a material impact on our consolidated financial statements.

In July 2013, the FASB issued ASU 2013-11, “Income Taxes (Topic 740) Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which concludes that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset when settlement in this manner is available under the tax law.  The Company will adopt this amendment as of our 2015 fiscal year.  The result of adoption may be to reclassify certain long term liabilities to long term deferred tax assets and the adoption will not result in a change to the tax provision.  We do not expect the adoption of ASU 2013-11 to have a material impact on our consolidated financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We have operations both within the United States and internationally and we are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate, foreign exchange and inflation risks as well as changes in the general economic conditions in the countries where we conduct business. To reduce certain of these risks, we monitor the financial condition of our large customers and limit credit exposure by collecting in advance and setting credit limits, as we deem appropriate. In addition, our investment strategy currently has been to invest in financial instruments that are highly liquid, readily convertible into cash and which mature within three months from the date of purchase. We also enter into foreign exchange derivative hedging transactions as part of our risk management program. For accounting purposes, we do not designate any of our derivative instruments as hedges and we do not use derivatives for speculating trading purposes and are not a party to leveraged derivatives.

Interest rate risk

We are exposed to market risk related to changes in interest rates.

Our investments are considered cash equivalents and primarily consist of money market funds. At December 31, 2013, we had cash and cash equivalents of $29.6 million. The carrying amount of cash equivalents reasonably approximates fair value due to the short maturities of these instruments. The primary objective of our investment activities is preservation of capital, fulfillment of liquidity needs and fiduciary control of cash and investments. We also seek to maximize income from our investments without assuming significant risk. We do not enter into investments for trading or speculative purposes. Our investments are exposed to market risk due to a fluctuation in interest rates, which may affect our interest income and the fair market value of our investments. Due to the short-term nature of our investment portfolio, however, we do not believe an immediate 10% increase or decrease in interest rates would have a material effect on the fair market value of our portfolio, and therefore, we do not expect our operating results or cash flows to be materially affected by a sudden change in market interest rates.

34

We do not believe our cash equivalents have significant risk of default or illiquidity. While we believe our cash equivalents do not contain excessive risk, we cannot provide absolute assurance that in the future our investments will not be subject to adverse changes in market value. In addition, we maintain significant amounts of cash and cash equivalents at one or more financial institutions that are in excess of federally insured limits. We cannot be assured that we will not experience losses on these deposits.

The Revolving Facility provides for, at our option, Eurodollar Rate Loans, which bears interest at the London Interbank Offered Rate (“LIBOR”) plus two and one-half percent (2.50%) or Base Rate Loans, which bear interest at one and one-half percent (1.5%) plus the greatest of (a) the Federal Funds Rate plus 1/2 of 1%, (b) the Prime Rate, and (c) the Eurodollar Rate for a one month Interest Period on such day plus 1.00%. Changes in interest rates do not affect operating results or cash flows on our fixed rate borrowings but would impact our variable rate borrowings. At December 31, 2013, we had $49.4 million in borrowings outstanding under our Credit Agreement which bear interest at approximately 2.79%.

Foreign currency risk

We have foreign currency risks related to our revenue and operating expenses denominated in currencies other than the United States dollar. Our historical revenue has generally been denominated in United States dollars, and a significant portion of our current revenue continues to be denominated in United States dollars; however, we expect an increasing portion of our future revenue and operating expenses to be denominated in currencies other than the United States dollar, primarily the Euro, British pound sterling, Canadian dollar, Latin American currencies, Russian Ruble, Japanese yen, Chinese Yuan and Hong Kong dollar. Our operating expenses are generally denominated in the currencies of the countries in which our operations are located, primarily the United States and United Kingdom. Increases and decreases in our international revenue from movements in foreign exchange rates are partially offset by the corresponding increases or decreases in our international operating expenses. To further reduce our net exposure to foreign exchange rate fluctuations on our results of operations, we have entered into foreign currency forward contracts.

As of December 31, 2013, we had no outstanding forward contracts based in foreign currencies. We do not designate any of our forward contracts as hedges for accounting purposes. For both the three and nine months ended December 31, 2013, the net income related to the change in fair value of our foreign currency forward contracts was $0, respectively. For the three and nine months ended December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant.

As our international operations grow, our risks associated with fluctuation in currency rates will become greater, and we will continue to reassess our approach to managing this risk. In addition, currency fluctuations or a weakening United States dollar can increase the costs of our international expansion. As our international operations grow, we expect to conduct more of our business in currencies other than the U.S. dollar, thereby increasing risks associated with fluctuation in currency rates. Currency fluctuations or a weakening United States dollar can increase the costs of our international expansion.  As our exposure to currency risks grows, we will continue to reassess our risk management.

Inflation risk

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increase. Our inability or failure to do so could harm our business, financial condition and results of operations.

Counterparty risk

Our financial statements, including derivatives, are subject to counterparty credit risk, which we consider as part of the overall fair value measurement. We attempt to mitigate this risk through credit monitoring procedures.

ITEM 4.  CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

35

Subject to the limitations noted above, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the fiscal period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective to meet the objective for which they were designed and operate at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II.

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved in various legal proceedings from time to time arising from the normal course of business activities, including claims of alleged infringement of intellectual property rights, commercial, employment and other matters. Our management believes that losses in excess of the amounts accrued arising from such lawsuits are remote, but that litigation is necessarily uncertain and there is the potential for a material adverse effect on our financial statements if one or more matters are resolved in a particular period in an amount in excess of that anticipated by management.

ITEM 1A. RISK FACTORS

The following risk factors and other information included in this Quarterly Report on Form 10-Q should be carefully considered. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we presently deem less significant may also impair our business operations. If any of the following risks actually occur, our business, operating results and financial condition could be materially adversely affected, and you could lose all or part of your investment.

Risks relating to our business

If motion pictures that can be viewed with RealD Cinema Systems are not made or are not commercially successful, our revenue will decline.

Almost all of our revenue is currently dependent upon both the number of 3D motion pictures released and the commercial success of those 3D motion pictures. Although we have produced alternative content in 3D, such as the production of Carmen in 3D with London’s Royal Opera House, we are not actively developing 3D motion pictures or our own 3D content, and therefore, we rely on motion picture studios to produce and release 3D motion pictures compatible with our RealD Cinema Systems. There is no guarantee an increasing number of 3D motion pictures will be released or that motion picture studios will continue to produce 3D motion pictures at all. Motion picture studios may refrain from producing and releasing 3D motion pictures for any number of reasons, including their lack of commercial success, consumer preferences, the lower-cost to produce 2D motion pictures or the availability of other entertainment options.  The commercial success of a 3D motion picture depends on a number of factors that are outside of our control, including whether it achieves critical acclaim, timing of the release, cost, marketing efforts and promotional support for the release. In the past, consumer interest in 3D motion pictures was episodic and motion picture studios tended to use 3D motion pictures as a gimmick rather than as an artistic tool to enhance the viewing experience. Consumer preferences have recently trended towards viewing motion pictures in 2D rather than 3D resulting in weaker box office performance. Weaker box office performance of 3D motion pictures may result in motion picture studios producing fewer 3D motion pictures or motion picture exhibitors may reduce the frequency in which they show motion pictures in 3D or may decide not to show 3D motion pictures at peak movie-going hours. Poor box office performance of 3D motion pictures, disruption or reduction in 3D motion picture production or conversion of 2D motion pictures into 3D motion pictures, changes in release schedules, the inability to see 3D motion pictures at peak hours, cancellations of motion picture releases in 3D versions, a reduction in marketing efforts for 3D motion pictures by motion picture studios or a lack of consumer demand for 3D motion pictures could result in lower 3D motion picture attendance, which would substantially reduce our revenue, which declined in fiscal year 2013 compared to fiscal year 2012. Moreover, films can be subject to delays in production or changes in release schedule, and the slippage of a film’s release date from one accounting period to another could adversely affect our financial condition, results of operations and business.

36

If motion picture exhibitors do not continue to use our RealD Cinema Systems or experience financial difficulties, our growth and results of operations could be adversely affected.

Our primary licensees in the motion picture industry are motion picture exhibitors. Our license agreements with motion picture exhibitors do not obligate these licensees to deploy a specific number of our RealD Cinema Systems. We cannot predict whether any of our existing motion picture exhibitor licensees will continue to perform under their license agreements with us, whether they will renew their license agreements with us at the end of their term or whether we or any of our existing motion picture exhibitor licensees may now or in the future be in breach of those agreements. If motion picture exhibitors reduce or eliminate the number of 3D motion pictures that are exhibited in theaters, then motion picture studios may not produce and release 3D motion pictures and our revenue could be materially and adversely affected.

In addition, license revenue from AMC, Cinemark and Regal together comprised approximately 22% of our gross license revenue in the year ended March 31, 2013, 24% in the year ended March 23, 2012 and 23% in the year ended March 25, 2011. Any inability or failure by motion picture exhibitors to pay us amounts due in a timely fashion or at all could substantially reduce our cash flow and could materially and adversely impact our financial condition and results of operations.

A deterioration in our relationships with the major motion picture studios could adversely affect our business and results of operations.

The six major motion picture studios accounted for approximately 76% of domestic box office revenue and all 10 of the top 10 grossing 3D motion pictures in calendar year 2012. Such 3D motion pictures are also released internationally. In addition, for our domestic operations, these major motion picture studios pay us a per use fee for our RealD eyewear. To the extent that our relationship with any of these major motion picture studios deteriorates or any of these studios stop making motion pictures that can be viewed at RealD-enabled theater screens, refuse to co-brand with us, stop using or paying for the use of or reduce the amounts paid for our RealD eyewear in domestic markets, our costs could increase and our revenue could decline, which would adversely affect our business and results of operations. Additionally, if consumer demand for 3D motion pictures declines, then motion picture studios may reduce marketing the 3D aspect of 3D motion pictures which could reduce box office performance of 3D motion pictures and our revenue could be adversely affected.

If the deployment of our RealD Cinema Systems is delayed or not realized, our future prospects could be limited and our business could be adversely affected.

We have license agreements with motion picture exhibitors that give us the right, subject to certain exceptions, to deploy our RealD Cinema Systems if a location under contract is already equipped with our systems.  Under the terms of these agreements, the motion picture exhibitor licensees may choose to install additional 3D digital projector systems. However, our license agreements do not obligate our licensees to deploy a specific number of our RealD Cinema Systems. Numerous factors beyond our control could influence when and whether our RealD Cinema Systems will be deployed, including motion picture exhibitors’ ability to fund capital expenditures, or their decision to delay or abandon the conversion of their theaters to digital projection or reduce the number of 3D motion pictures exhibited in their theaters, and our ability to secure adequate supplies of components comprising our RealD Cinema System in any given period. If motion picture exhibitors delay, postpone or decide not to deploy RealD Cinema Systems at the number of screens they have announced, or we are unable to deploy our RealD Cinema Systems in a timely manner, our future prospects could be limited and our business could be adversely affected.

We have a history of net losses and may suffer losses in the future.

While we were profitable in the fiscal year ended March 23, 2012, we incurred net losses in our fiscal years ended 2013, 2011, 2010 and 2009.  Our revenues declined in our fiscal year 2013 as compared to the prior year.  If we cannot return to sustainable revenue growth and profitability, our financial condition will deteriorate, and we may be unable to achieve our business objectives.

Any inability to protect our intellectual property rights could reduce the value of our 3D technologies and other visual and our brands, which could adversely affect our financial condition, results of operations and business.

Our business is dependent upon our patents, trademarks, trade secrets, copyrights and other intellectual property rights. Effective intellectual property rights protection, however, may not be available under the laws of every country in which we and our licensees operate, such as China. For example, we believe competitors may be introducing cinema systems similar to our RealD Cinema Systems that potentially infringe on our intellectual property rights in China, Russia and other territories to unfairly compete against us.  The efforts we have taken to protect our proprietary rights may not be sufficient or effective. Any significant impairment of our intellectual property rights could harm our business or our ability to compete. In addition, protecting our intellectual property rights is costly and time consuming. It may not be practicable or cost effective for us to fully protect our intellectual property rights in some countries or jurisdictions. If we are unable to successfully identify and stop unauthorized use of our intellectual property, we could lose potential revenue and experience increased operational and enforcement costs, which could adversely affect our financial condition, results of operations and business.

37

It is possible that some of our 3D and other visual technologies may not be protectable by patents. In addition, given the costs of obtaining patent protection, we may choose not to protect particular innovations that later turn out to be important. Even where we do have patent protection, the scope of such protection may be insufficient to prevent third parties from designing around our particular patent claims or otherwise avoiding infringement. Furthermore, there is always the possibility that an issued patent may later be found to be invalid or unenforceable, or a competitor may attempt to engineer around our issued patent. Additionally, patents only offer a limited term of protection. Moreover, the intellectual property we maintain as trade secrets could be compromised by third parties, or intentionally or accidentally by our employees, which would cause us to lose the competitive advantage resulting from those trade secrets.

Any failure to maintain the security of information relating to our customers, employees, licensees and suppliers, whether as a result of cybersecurity attacks or otherwise, could expose us to litigation, government enforcement actions and costly response measures, and could disrupt our operations and harm our reputation.

In connection with the sales and marketing of our products and our entering into licensing arrangements with motion picture exhibitors, we may from time to time transmit confidential information. We also have access to, collect or maintain private or confidential information regarding our customers, employees, licensees and suppliers, as well as our business. We have procedures in place to safeguard such data and information and as a result of those procedures, to our knowledge, computer hackers have been unable to gain access to the information stored in our information systems. However, cyber-attacks are rapidly evolving and becoming increasingly sophisticated. It is possible that computer hackers and others might compromise our security measures or those that we do business with in the future and obtain the personal information of our customers, employees, licensees and suppliers or our business information. A security breach of any kind could expose us to risks of data loss, litigation, government enforcement actions and costly response measures, and could seriously disrupt our operations. Any resulting negative publicity could significantly harm our reputation which could cause us to lose market share and have an adverse effect on our financial results.

We may in the future be subject to intellectual property rights disputes that are costly to defend, could require us to pay damages and could limit our ability to use particular 3D and other visual technologies in the future.

We may be exposed to, or threatened with, future litigation or any other disputes by other parties alleging that our 3D and other visual technologies infringe their intellectual property rights. Any intellectual property disputes, regardless of their merit, could be time consuming, expensive to litigate or settle and could divert management resources and attention. An adverse determination in any intellectual property dispute could require us to pay damages and/or stop using our 3D and other visual technologies, trademarks, copyrighted works and other material found to be in violation of another party’s rights and could prevent us from licensing our 3D and other visual technologies to others. In order to avoid these restrictions and resolve the dispute, we may have to pay for a license. This license may not be available on reasonable terms, could require us to pay significant license fees and may significantly increase our operating expenses. A license also may not be available to us at all. As a result, we may be required to use and/or develop non-infringing alternatives, which could require significant effort and expense, or which may not be possible. If we cannot obtain a license or develop alternatives for any infringing aspects of our business, we may be forced to limit our 3D and other visual technologies and may be unable to compete effectively. In certain instances, we have contractually agreed to provide indemnification to licensees relating to our intellectual property. This may require us to defend or hold harmless motion picture exhibitors, consumer electronics manufacturers or other licensees. We have from time to time corresponded with one or more third parties regarding patent enforcement issues and in-bound and out-bound patent licensing opportunities. In addition, from time to time we may be engaged in disputes regarding the licensing of our intellectual property rights, including matters related to our license fee rates and other terms of our licensing arrangements. These types of disputes can be asserted by our licensees or prospective licensees or by other third parties as part of negotiations with us or in private actions seeking monetary damages or injunctive relief or in regulatory actions. Requests for monetary and injunctive remedies asserted in claims like these could be material and could have a significant impact on our business. Any disputes with our licensees, potential licensees or other third parties could materially and adversely affect our business, results of operations and prospects.

Our RealD Cinema Systems and other technologies are generally designed for use with third-party technologies and hardware, and if we are unable to maintain the ability of our RealD Cinema Systems and other technologies to work with these third-party technologies and hardware, our business and operating results could be adversely affected.

Our RealD Cinema Systems and other technologies are generally designed for use with third-party technologies and hardware, such as Christie projectors, Doremi servers, Harkness Hall screens and Sony Electronics 4K SXRD® digital cinema projectors. Third-party technologies and hardware may be modified, re-engineered or removed altogether from the marketplace. In addition, third-party technologies used to interact with our RealD Cinema Systems, RealD Format and other 3D and visual technologies can change without prior notice to us, which could result in increased costs or our inability to provide our 3D and other visual technologies to our licensees. If we are unable to maintain the ability of our RealD Cinema Systems, RealD Format and other 3D and visual technologies to work with these third-party technologies and hardware, our business and operating results could be adversely affected.

38

If we are unable to maintain our brand and reputation for providing high quality 3D technologies, our business, results of operations and prospects could be materially harmed.

Our business, results of operations and prospects depend, in part, on maintaining and strengthening our brand and reputation for providing high quality 3D technologies. If problems with our 3D technologies cause motion picture exhibitors, consumer electronics manufacturers or other licensees to experience operational disruption or failure or delays in the delivery of their products and services to their customers, our brand and reputation could be diminished. Maintaining and strengthening our brand and reputation may be particularly challenging as we enter business segments in which we have limited experience, such as 3D consumer electronics. If we fail to promote and maintain our brand and reputation successfully, our business, results of operations and prospects could be materially harmed.

Competition from other providers of 3D technologies to the motion picture industry could adversely affect our business.

The motion picture industry is highly competitive, particularly among providers of 3D technologies. Our primary competitors include Dolby, Sony, IMAX, MasterImage and Xpand, with IMAX increasing market share in recent periods. In addition, other companies, including motion picture exhibitors and studios and smaller competitors in international markets, may develop their own 3D technologies in the future. Consumers may also perceive the quality of 3D technologies delivered by some of our competitors to be equivalent or superior to our 3D technologies. In addition, some of our current or future competitors may enjoy competitive advantages, such as greater financial, technical, marketing and other resources than we do, greater market share and name recognition than we have or may have more experience or advantages in the business segments in which we compete that will allow them to offer lower prices or higher quality technologies, products or services. If we do not successfully compete with these providers of 3D technologies, we could lose market share and our business could be adversely affected. In addition, competition could force us to decrease prices and cause our margins to decline, which could adversely affect our business. Pricing pressures in both domestic and international motion picture exhibitor markets continue, and no assurance can be given that our margins in future periods will increase.

The introduction of new 3D and other visual technologies and changes in the way that our competitors operate could harm our business. If we fail to keep up with rapidly changing 3D and other visual technologies or the growth of new and existing opportunities, our 3D and other visual technologies could become less competitive or obsolete.

Due to technological advances and changing consumer tastes, numerous companies have developed, and are expected to continue to develop, new 3D and other visual technologies that may compete directly with or render our 3D and other visual technologies less competitive or obsolete. We believe that original equipment manufacturers may be working to develop laser-based projection technologies, which may compete with, be incompatible with or render our RealD Cinema Systems obsolete. Competitors may develop alternative 3D and other visual technologies that are more attractive to consumers, content producers and distributors, motion picture exhibitors, consumer electronics manufacturers and others, or more cost effective than our technologies, and compete with or render our 3D and other visual technologies less competitive or obsolete. As a result of this competition, we could lose market share, which could harm our business and operating results. We expect to continue to expend considerable resources on research and development in response to changes in the motion picture and consumer electronics industries, even in years such as 2013 where our revenues have declined, and our profitability may suffer adversely impacting our financial condition. However, we may not be able to develop and effectively market new 3D and other visual technologies that adequately or competitively address the needs of these changing industries, which could have a material and adverse effect on our business, results of operations and prospects.

If our 3D and other visual technologies fail to be widely adopted by or are not compatible with the needs of our licensees, our business prospects could be limited and our operating results could be adversely affected.

Our motion picture and consumer electronics licensees depend upon our 3D and other visual technologies being compatible with a wide variety of motion picture and consumer electronics systems, products and infrastructure. We make significant efforts to design our 3D and other visual technologies to address capability, quality and cost considerations so that they either meet or, where possible, exceed the needs of our licensees in the motion picture and consumer electronics industries. To have our 3D and other visual technologies widely adopted in the motion picture and consumer electronics industries, we must convince a broad spectrum of professional organizations worldwide, as well as motion picture studios and exhibitors and consumer electronics manufacturers who are members of such organizations, to adopt them and to ensure that our 3D and other visual technologies are compatible with their systems, products and infrastructure.

If our 3D and other visual technologies are not widely adopted or retained or if we fail to conform our 3D and other visual technologies to the expectations of, or standards set by, industry participants, they may not be compatible with other products and our business, operating results and prospects could be adversely affected. We expect that meeting and maintaining the needs of our licensees for compatibility with them will be significant to our business in the future. In addition, the market for broadcast technologies has traditionally been heavily regulated by governments or other regulatory bodies, and we expect this to continue to be the case in the future. If our 3D and other visual technologies are not compatible with the broadcasting infrastructure or governmental or regulatory requirements in particular geographic areas, our ability to compete in these markets could be adversely affected.

39

Other forms of entertainment may be more attractive to consumers than those using our 3D and other visual technologies, which could harm our growth and operating results.

We face competition for consumer attention from other forms of entertainment that may drive down motion picture box office and license revenue from motion picture exhibitors. We compete with a number of alternative motion picture distribution channels, such as cable, satellite, broadcast, packaged media and the Internet. There are also other forms of entertainment competing for consumers’ leisure time and disposable income such as concerts, amusement parks and sporting events. A significant increase in the popularity of these alternative motion picture channels and competing forms of entertainment could reduce the demand for theatrical exhibition of 3D motion pictures, including those viewed with our RealD Cinema Systems, or the use of 3D-enabled consumer electronics devices, any of which would have an adverse effect on our business and operating results.

Our limited operating history in 3D consumer electronics and the competition we face from companies with greater brand recognition and resources in the consumer electronics industry present risk to our ability to achieve success in this area.

Our 3D and other visual technologies have been made available to certain consumer electronics manufacturers and electronics component suppliers to enable 3D viewing on high definition televisions, laptops and other displays. We do not have exclusive arrangements with these consumer electronics manufacturers, and to date, we have not generated revenue of any material significance from these arrangements. 3D consumer electronics technologies are rapidly developing, as manufacturers are working to set standards and content producers and distributors are working on increasing the availability of new 3D content. However, the demand and income potential for our 3D and other visual technologies is unproven. In addition, because 3D consumer electronics technologies continue to quickly evolve, we have limited insight into trends that may emerge and affect our business, including whether consumers will widely adopt 3D-enabled visual display devices at all. We also face competition from companies that enjoy competitive advantages in the consumer electronics industry, including deeper relationships with consumer electronics manufacturers, more developed distribution channels and technologies that may be better suited for 3D consumer electronics products. Our competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, products, technologies or standards in 3D consumer electronics. In addition, our competitors may offer consumers superior technology or lower prices which may reduce the demand for visual display devices using our 3D and other visual technologies. As a result, our future prospects could be adversely affected if we make errors in predicting and reacting to relevant business trends and consumer demand, or if consumer electronics manufacturers choose not to use our 3D technologies in their display devices.

Our level of indebtedness reduces our financial flexibility and could impede our ability to operate.

On April 19, 2012, we entered the Credit Agreement with City National to provide the Company with the Revolving Facility and the Term Loan Facility, which increased our borrowing capacity to an aggregate of $125 million. The Revolving Facility and the Term Loan Facility replaced existing revolving and term loan facilities provided under our pre-existing credit and security agreement with City National, which had been most recently amended on December 6, 2011.  Our obligations under the Credit Agreement are secured by a first priority security interest in substantially all of our tangible and intangible assets and are fully and unconditionally guaranteed by our subsidiaries, ColorLink and Stereographics.

We intend to borrow additional amounts under the Credit Agreement to fund various growth initiatives, including accelerated research and product development, acquisitions, capital expenditures and stock repurchases. We expect that we will maintain a significant amount of indebtedness on an ongoing basis. The Revolving Facility matures on April 17, 2015. As of December 31, 2013, the aggregate Term Loan Facility commitment of $50 million was drawn in full and $15.6 million was repaid. Twelve quarterly payments of $3.1 million begin on December 31, 2013 and continue through September 30, 2016.

There is no assurance that we will be able to refinance our outstanding indebtedness, or if refinancing is available, that it can be obtained on terms we can afford. The capital markets have recently experienced a high degree of volatility. To the extent that volatility in the capital markets continues, our access to capital may become limited and its borrowing costs may materially increase.

The Credit Agreement requires us to pay a variable rate of interest, which will increase or decrease based on variations in certain financial indexes, and fluctuations in interest rates can significantly decrease our profits. We do not have any hedge or similar contracts that would protect us against changes in interest rates.

The amount of our indebtedness could have important consequences, including the following:

·requiring us to dedicate a substantial portion of our cash flow from operations to make payments on our debt, thereby reducing funds available for operations, future business opportunities and other purposes;

40

·limiting our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

·making it more difficult for us to satisfy our debt obligations, and any failure to comply with such obligations, including financial and other restrictive covenants, could result in an event of default under the agreements governing such indebtedness, which could lead to, among other things, an acceleration of our indebtedness or foreclosure on the assets securing our indebtedness, which could have a material adverse effect on our business or financial condition;

·limiting our ability to borrow additional funds, or to sell assets to raise funds, if needed, for working capital, capital expenditures, acquisitions or other purposes; and

·increasing our vulnerability to general adverse economic and industry conditions, including changes in interest rates.

Our indebtedness was $49.4 million as of December 31, 2013.  We may not generate sufficient cash flow from operations to service and repay our debt and related obligations and have sufficient funds left over to achieve or sustain profitability in our operations, meet our working capital and capital expenditure needs or compete successfully in our industry, particularly if we access our increased Revolving Facility and Term Loan Facility.

Our credit facilities impose, and the terms of any future indebtedness may impose, significant operating, financial and other restrictions on us and our subsidiaries.

Restrictions imposed by our credit facilities will limit or prohibit, among other things, our ability to:

·incur additional debt

·make certain investments or acquisitions

·enter into certain merger and consolidation transactions, and

·sell our assets other than in the ordinary course of business.

We are also required to maintain compliance with certain financial covenants, including a minimum fixed charge coverage ratio and a maximum leverage ratio. If we fail to comply with any of the covenants or if any other event of default, as defined in our credit facilities, should occur, the lenders could elect to prevent us from borrowing and declare the indebtedness to be immediately due and payable.

These restrictions could adversely affect our ability to finance our future operations or capital needs and pursue available business opportunities. A breach of any of these restrictions, including breach of financial covenants, could result in a default in respect of the related indebtedness. If a default occurs, the relevant lenders could elect to declare the indebtedness, together with accrued interest and fees, to be immediately due and payable and proceed against any collateral securing that indebtedness, which will constitute substantially all of our assets.

Our operating results may fluctuate from quarter to quarter, which may be different from analysts’ expectations and adversely affect our stock price.

Our operating results may fluctuate from quarter to quarter. Factors that have affected our operating results in the past, and are likely to affect our operating results in the future, include, among other things:

·the timing of when a 3D motion picture is released which tends to be based on specific consumer entertainment dynamics, which results in seasonal patterns, with the largest number of motion pictures being released in summer and early winter;

·the rate of installations of new RealD Cinema Systems, which we expect to decrease with the passage of time;

·the timing of capital expenditures and expenses, including depreciation expense of our RealD Cinema Systems deployed at a motion picture exhibitor’s premises (we expect capital expenditures to decrease, and depreciation expense to increase, as our RealD Cinema Systems business matures), digital projector depreciation expenses, RealD eyewear costs (including shipping, handling and recycling costs), field service and support costs, and occupancy costs, which may increase significantly, even in quarters when we do not experience a similar growth in revenue;

·the timing and accuracy of license fee reports which often include positive or negative corrective or retroactive license fees that cover extended periods of time; and

·competitive and pricing pressures that vary from market-to-market and place-to-place.

In addition, variances in our operating results from analysts’ expectations could adversely affect our stock price. See also “Management’s discussion and analysis of financial condition and results of operations—Seasonality and quarterly performance.”

41

If motion picture exhibitors do not continue converting analog theaters to digital or the pace of conversions slows, our future prospects could be limited and our business could be adversely affected.

Our RealD Cinema Systems only work in theaters equipped with digital cinema projection systems, which enable 3D motion pictures to be delivered, stored and projected electronically, and our systems are not compatible with analog motion picture projectors. Motion picture exhibitors have been converting projectors from analog to digital cinema over the last several years, giving us the opportunity to deploy our RealD Cinema Systems. After motion picture exhibitors convert their projectors to digital cinema, they must install a silver screen and our RealD Cinema System in order to display motion pictures in RealD 3D. The conversion by motion picture exhibitors of their projectors and screens from analog to digital cinema requires significant expense. As of December 31, 2012, approximately 85% of domestic theater screens had converted to digital and approximately 60% of the international theater screens had been converted. If the market for digital cinema develops more slowly than expected, or if the motion picture exhibitors we have agreements with delay or abandon the conversion of their theaters from analog theaters to digital, our ability to grow our revenue and our business could be adversely affected. While DCIP and Cinedigm financing provided funding for the digital conversion of domestic theater screens operated by many of our licensees, there has not been a similar effort to organize digital conversion in certain geographies outside North America. If the pace of digital conversion outside of the United States does not follow that which occurred inside the United States, our revenue may not grow or may decline, and our business could be adversely affected.

We have incurred and may in the future incur asset impairment charges.

An asset impairment charge may result from the occurrence of unexpected adverse events or management decisions that impact our estimates of expected cash flows generated from our long-lived assets. We review our long-lived assets for impairment, when events or changes in circumstances indicate the carrying value of an asset may not be recoverable. We may be required to recognize asset impairment charges in the future as a result of reductions in demand for specific technologies, a weak economic environment, challenging market conditions, events related to particular customers or asset type, or as a result of asset or portfolio sale decisions by management.

We face risks from doing business internationally that could harm our business, financial condition and results of operations.

We are dependent on international business for a significant portion of our total revenue. International gross revenue accounted for approximately 51% in fiscal year 2013, 49% in fiscal year 2012 and 55% in fiscal year 2011. We expect that our international business will continue to represent a significant portion of our total revenue for the foreseeable future. This future revenue will depend to a large extent on the continued use and expansion of our 3D technologies in the motion picture and consumer electronics industries worldwide. As a result, our business is subject to certain risks inherent in international business operations, many of which are beyond our control. These risks include:

·competitive and pricing pressures that vary from market-to-market and place-to-place;

·fluctuating foreign exchange rates and systems;

·laws and policies affecting trade, investment and taxes, including laws and policies relating to customs, duties, the repatriation of funds and withholding taxes and changes in these laws and our compliance with the foregoing;

·changes in local regulatory requirements, including restrictions on content;

·differing cultural tastes and attitudes;

·differing degrees of protection for intellectual property;

·the need to adapt our business model to local requirements;

·the instability of foreign economies and governments; and

·political instability, natural disaster, war or acts of terrorism.

Events or developments related to these and other risks associated with our international business operations could adversely affect our revenue from such operations, which could have a material and adverse effect on our business, financial condition and results of operations.

Our RealD eyewear may, in the future, be regulated by the Food and Drug Administration, or FDA, or by other state or foreign governmental or regulatory agencies, which could increase our costs and materially and adversely impact our profitability.

Currently, polarized 3D eyewear, including our RealD eyewear, is not regulated by the FDA, or by state or foreign governmental and regulatory agencies. However, certain eyewear, such as non-prescription reading glasses and sunglasses, are considered to be medical devices by the FDA and are subject to regulations imposed by the FDA and various state and foreign governmental and regulatory agencies. With the rising popularity of polarized 3D eyewear, there has been an increasing level of public scrutiny examining its potential health risks. Polarized 3D eyewear, including our RealD eyewear, may at some point be subject to federal, state or foreign regulations that could potentially restrict how our RealD eyewear is produced, used or marketed, and the cost of complying with those regulations may adversely affect our profitability.

42

If 3D viewing with active or passive eyewear is found to cause health risks or consumers believe that it does, demand for the 3D viewing experience may decrease or we may become subject to liability, any of which could adversely affect our results of operations, financial condition, business and prospects.

Research conducted by institutions unrelated to us has suggested that 3D viewing with active or passive eyewear may cause vision fatigue, eye strain, discomfort, headaches, motion sickness, dizziness, nausea, epileptic seizures, strokes, disorientation, perceptual after-effects, decreased postural stability or other health risks in some consumers. If these potential health risks are substantiated or consumers believe in their validity, demand for the 3D viewing experience in the theater, the home and elsewhere may decline. As a result, major motion picture studios and other content producers and distributors may refrain from developing 3D content, motion picture exhibitors may reduce the number of 3D-enabled screens (including RealD-enabled screens) they currently deploy or plan to deploy, or they may reduce the number of 3D motion pictures exhibited in their theaters, which would adversely affect our results of operations, financial condition and prospects. A decline in consumer demand may also lead consumer electronics manufacturers and content distributors to reduce or abandon the production of 3D products, which could adversely affect our prospects and financial condition.

In addition, if health risks associated with our RealD eyewear materialize, we may become subject to governmental regulation or product liability claims, including claims for personal injury. Successful assertion against us of one or a series of large claims could materially harm our business. Also, if our RealD eyewear is found to be defective, we may be required to recall it, which may result in substantial expense and adverse publicity that could adversely impact our sales, operating results and reputation. Potential product liability claims may exceed the amount of our insurance coverage or may be excluded under the terms of the policy, which could adversely affect our financial condition. In addition, we may also be required to pay higher premiums and accept higher deductibles in order to secure adequate insurance coverage in the future, which could materially and adversely affect our results of operations, financial condition and business. Even meritless product liability claims could be expensive to resolve and may divert our management’s attention.

Our agreements with motion picture studios domestically and motion picture exhibitors internationally require us to manage the supply chain of our RealD eyewear, and any interruption to the supply chain for our RealD eyewear components could adversely affect our results of operations, financial condition, business and prospects.

Our RealD eyewear is an integral part of our RealD Cinema Systems. We have entered into non-exclusive agreements with several manufacturers to produce RealD eyewear. We manage manufacturing, distribution and recycling of RealD eyewear for motion picture studios and exhibitors worldwide. Domestically, we generally provide our RealD eyewear free of charge to motion picture exhibitors and then receive a fee from the motion picture studios for the usage of that RealD eyewear by the motion picture exhibitors’ customers. Most international motion picture exhibitors and some domestic motion picture exhibitors purchase RealD eyewear directly from us and sell them to consumers as part of their admission or as a concession item. Any interruption in the supply of RealD eyewear from manufacturers, increase in shipping costs, logistics or recycling interruption, other disruption to our global supply chain or competitive pricing pressures could adversely affect our results of operations, financial condition, business and prospects. For example, in connection with recent major 3D motion picture releases and increased consumer demand, we have in the past exhausted our inventory of RealD eyewear and incurred increased shipping costs to accelerate delivery of new inventory.

Our RealD 3D eyewear business model in North America relies on fees from motion picture studios for the usage of RealD eyewear by motion picture exhibitors’ customers, the uncertainty and any potential dispute between motion picture studios and exhibitors could adversely affect our results of operations, financial condition, business and prospects.

Our RealD eyewear is an integral part of our RealD Cinema Systems. Domestically, we provide our RealD eyewear free of charge to motion picture exhibitors and then receive a fee from the motion picture studios for the usage of that RealD eyewear by the motion picture exhibitors’ customers. Most international motion picture exhibitors purchase RealD eyewear directly from us and sell them to customers as part of their admission or as a concession. We understand that at least one major motion picture studio is seeking a change to the 3D eyewear business model in North America to resemble the international model. While we support multiple business models for our RealD eyewear around the world, the uncertainty and any potential dispute between motion picture studios and exhibitors over the domestic eyewear business model could adversely affect our results of operations, financial condition, business and prospects. In addition, we expect that profitability in our RealD eyewear business, may not be sustainable, as motion picture studios with whom we do business seek to recover our cost savings and efficiencies in the form of reduced prices for eyewear.

43

Economic conditions beyond our control could reduce consumer demand for motion pictures and consumer electronics using our 3D technologies and, as a result, could materially and adversely affect our business, revenue and growth prospects.

The global economic environment since late 2008 has been volatile and continues to pose risks. The global economy could remain significantly challenged for an indeterminate period of time. Present economic conditions could lead to a decrease in discretionary consumer spending or consumer preference for lower cost 2D motion pictures, resulting in lower motion picture box office revenue. In the event of declining box office revenue, motion picture studios may be less willing to release 3D motion pictures and motion picture exhibitors less willing to license our RealD Cinema Systems or exhibit 3D motion pictures. Further, a decrease in discretionary consumer spending may adversely affect future demand for 3D consumer electronics products that may use our 3D technologies and consumer electronics manufacturers may decide to limit, delay or cease their use of our 3D technologies, any of which could cause our business, revenue and growth prospects to suffer.

The loss of members of our management or research and development teams could substantially disrupt our business operations.

Our success depends to a significant degree upon the continued individual and collective contributions of our management and research and development teams. A limited number of individuals have primary responsibility for managing our business, including our relationships with motion picture studios and exhibitors and consumer electronics manufacturers and the research and development of our 3D and other visual technologies. The loss of any of these individuals, including Michael V. Lewis, our Chairman and Chief Executive Officer, or our failure to attract and retain other qualified and experienced personnel on acceptable terms, could impair our ability to sustain and grow our business and could substantially disrupt our business operations. In addition, because we operate in a highly competitive industry, our hiring of qualified executives, scientists, engineers or other personnel may cause us or those persons to be subject to lawsuits alleging misappropriation of trade secrets, improper solicitation of employees, breach of contract or other claims.

Our ability to use our net operating loss carryforwards could be subject to additional limitation if our ownership has changed or will change by more than 50%, which could potentially result in increased future tax liability.

While currently subject to a full valuation allowance for purposes of preparing our consolidated financial statements (see the discussion above under the heading “Management’s discussion and analysis of financial condition and results of operations—Critical accounting policies and estimates—Deferred tax asset valuation and tax exposures”), we intend to use our U.S. net operating loss carryforwards to reduce any future U.S. corporate income tax liability associated with our operations. Section 382 of the U.S. Internal Revenue Code of 1986, as amended, generally imposes an annual limitation on the amount of net operating loss carryforwards that may be used to offset taxable income when a corporation has undergone significant changes in stock ownership. In that event, our ability to use our net operating loss carryforwards could be adversely affected. To the extent our use of net operating loss carryforwards is significantly limited under the rules of Section 382 (as a result of our IPO or otherwise), our income could be subject to U.S. corporate income tax earlier than it would if we were able to use net operating loss carryforwards, which could result in lower profits.

We may experience difficulties, delays or unexpected costs and not achieve anticipated cost savings from our recently implemented cost reduction plan.

As the result of 3D box office performance of certain motion pictures due to consumer preferences and the fact that our 3D cinema business is maturing in many markets like the United States where we expect equipment installations to begin to slow, we recently implemented a plan to reduce the overall costs of our global operations while continuing to make significant research and development (R&D) investments and build the framework for our future growth. As part of our cost reduction plan, we are reducing staff by approximately 20%, re-scoping and making other changes to certain R&D projects, reducing general and administrative expenses and streamlining certain manufacturing operations. As a result of our cost reduction plan, we expect to reduce costs beginning in fiscal year 2014.  Our ability to achieve anticipated savings is dependent upon various future developments, some of which are beyond our control. We may also not realize, in full or in part, the anticipated benefits and savings from our cost reduction efforts due to unforeseen difficulties, delays or unexpected costs. If we are unable to achieve the anticipated savings or benefits to our business in the expected time frame or other unforeseen events occur, our business and results of operations may be adversely affected. Further, if we were to experience unanticipated and unforeseen changes to our business, we may face further cost reduction measures and/or reorganization activities in the future.

In addition, part of our cost reduction plan involves an involuntary reduction in force. For our cost reduction plan to be successful and build our framework for future growth, we must continue to execute and deliver on our core business initiatives around the world with fewer human resources and losses of intellectual capital. We will need to manage complexities associated with a geographically diverse organization. We must also attract, retain and motivate key employees, including highly qualified management, scientific, manufacturing and sales and marketing personnel who are critical to our business. We may not be able to attract, retain or motivate qualified employees in the future and our inability to do so may adversely affect our business.

44

There may also be other risks associated with our cost reduction plan and we cannot guarantee that we will be able to successfully manage these or other risks. If we fail to execute on our initiatives in these ways or others, such failure could result in a material adverse effect on our business and results of operations.

Changes in accounting may affect the Company’s reported earnings and operating income.

U.S. GAAP and accompanying accounting pronouncements, implementation guidelines and interpretations for many aspects of the Company’s business, such as revenue recognition, film accounting, accounting for pensions and other postretirement benefits, accounting for income taxes, and treatment of goodwill or long lived assets, are highly complex and involve many subjective judgments. Changes in these rules, their interpretation, management’s estimates, or changes in the Company’s products or business could significantly change its reported future earnings and operating income and could add significant volatility to those measures, without a comparable underlying change in cash flow from operations.

Beginning in the first quarter of fiscal year 2014, we modified our definition of Adjusted EBITDA to align with the Adjusted EBITDA definition under our expanded credit facility. As a result, we no longer add back sales and use tax and property tax to calculate Adjusted EBITDA for financial reporting purposes.

We face risks in conducting business in China, Russia and other emerging economies.

We believe that various trends will increase our exposure to the risks of conducting business in emerging economies. For example, Greater China and Russia are among the Company’s largest and fastest growing market opportunities. As of March 31, 2013, our RealD Cinema Systems were deployed and operated in approximately 1,100 cinema screens in Greater China and approximately 100 cinema screens in Russia with an additional approximately 1,400 screens under contract within these markets. We believe that our sales of products and services in China, Russia and other emerging economies will expand in the future to the extent that the use of digital technologies increases in these countries, including in movies and theaters, and as consumers there become more affluent. We face many risks associated with operating in these emerging economies, in large part due to limited recognition and enforcement of contractual and intellectual property rights. As a result, we may experience difficulties in enforcing our intellectual property rights in these emerging economies, where intellectual property rights are not as respected as they are in the U.S., Hong Kong, Japan and Europe. We believe that it is critical that we strengthen existing relationships and develop new relationships with entertainment industry participants worldwide to increase our ability to enforce our intellectual property and contractual rights without relying solely on the legal systems in the countries in which we operate. If we are unable to develop, maintain, and strengthen these relationships, our revenue from these countries could be adversely affected.

Acquisition activities could result in operating difficulties, dilution to our stockholders and other harmful consequences.

We have built our business, in part, through acquisitions of intellectual property and other assets, including Stereographics in 2005 and ColorLink in 2007. We intend to selectively pursue strategic acquisitions in the future. Future acquisitions could divert management’s time and focus from operating our business. In addition, integrating an acquired company, business or technology is risky and may result in unforeseen operating difficulties and expenditures. Foreign acquisitions also involve unique risks related to integration of operations across different cultures and languages, currency risks and the particular economic, political and regulatory risks associated with specific countries.

We may not accurately assess the value or prospects of acquisition candidates, and the anticipated benefits from our future acquisitions may not materialize. In addition, future acquisitions or dispositions could result in potentially dilutive issuances of our equity securities, including our common stock, the incurrence of additional debt, contingent liabilities or amortization expenses, or write-offs of goodwill, any of which could materially harm our financial condition.

Our growth may place a strain on our resources, and we may continue to borrow money as our business grows.

We have experienced significant growth since we acquired ColorLink in 2007. The growth that we have experienced in the past, as well as any further growth that we experience, may place a significant strain on our resources and increase demands on our management, our information and reporting systems and our internal controls over financial reporting. Upon becoming a public company in July 2010, we began incurring additional general and administrative expenses to comply with the SEC reporting requirements, the listing standards of the New York Stock Exchange, or NYSE, and provisions of the Sarbanes-Oxley Act of 2002 and the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and will continue to incur additional research and development expenses. If we are unable to manage our growth effectively while maintaining appropriate internal controls, we may experience operating inefficiencies that could increase our costs or otherwise materially and adversely affect our financial position.

45

We face risks associated with international trade and currency exchange.

We maintain sales, marketing, and business operations in foreign countries. Consequently, we are exposed to fluctuations in exchange rates associated with the local currencies of our foreign business operations. Revenue from our foreign business operations in transactions denominated in local currencies, including the Chinese Yuan, significant. While we may also derive revenue from our foreign business operations in transactions denominated in U.S. dollars, a substantial portion of our costs from our foreign operations are denominated in the currency of that foreign location. Consequently, exchange rate fluctuations between the U.S. dollar and other currencies could have a material impact on our profitability.

Risks related to owning our common stock

The price of our common stock may fluctuate significantly, and you could lose all or part of your investment.

Shares of our common stock were sold in our IPO in July 2010 at a price of $16.00 per share, and, as of December 31, 2013, our common stock has subsequently traded as high as $35.60 and as low as $6.58. An active, liquid and orderly market for our common stock may not be sustained, which could depress the trading price of our common stock.

Volatility in the market price of our common stock may prevent you from being able to sell your shares at or above the price you paid for your shares or at all. The market price of our common stock could fluctuate significantly for various reasons, which include:

·our quarterly or annual earnings or those of our competitors;

·the public’s reaction to our press releases, our other public announcements and our filings with the SEC;

·changes in earnings estimates or recommendations by research analysts who track our common stock or the stock of our competitors;

·new laws or regulations or new interpretations of laws or regulations applicable to our business;

·changes in accounting standards, policies, guidance, interpretations or principles;

·changes in general conditions in the domestic and global economies or financial markets, including those resulting from war, incidents of terrorism or responses to such events;

·litigation involving our company or investigations or audits by regulators into the operations of our company or our competitors;

·strategic action by our competitors; and

·sales of common stock by our directors, executive officers and significant stockholders.

In addition, the stock market in general, and the market for technology and media companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of our common stock, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against these companies. If litigation is instituted against us, it could result in substantial costs and a diversion of our management’s attention and resources even if such litigation is without merit.

Sales of outstanding shares of our common stock (or shares of our common stock issued upon exercise of stock options) into the market in the future could cause the market price of our stock to drop significantly, even if our business is doing well.

As of December 31, 2013, we had 49,259,312 shares of common stock outstanding which are freely tradable, subject to prior registration or qualification for an exemption from registration, including, in the case of shares held by affiliates, compliance with the volume, manner of sale, notice and availability of public information provisions of Rule 144 under the Securities Act of 1933, as amended, or the Securities Act. Our co-founders and certain other pre-IPO stockholders also have registration rights which enable them to cause us to register for sale shares held by them in the public markets. If our existing security holders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, the trading price of our common stock could decline.

In addition, as of December 31, 2013, there were 10,523,897 shares underlying options and restricted stock that were issued and outstanding, and we have an aggregate of 2,025,465 shares of common stock reserved for future issuance under our equity incentive plan and employee stock purchase plan. These shares will become eligible for sale in the public market to the extent permitted by the provisions of various option and warrant agreements, maintenance of applicable registration statements and Rules 144 and 701 under the Securities Act. If additional shares are sold, or if it is perceived that they will be sold in the public market, the trading price of our stock could decline.

46

Our co-founders, directors, executive officers and principal stockholders have substantial control over us and could delay or prevent a change in corporate control.

As of March 31, 2013, our directors and executive officers, together with their affiliates, beneficially owned approximately 18% of our outstanding common stock. Of this 18%, approximately 12% was beneficially owned by Michael V. Lewis, our chairman and chief executive officer.

These stockholders, acting together, have the ability to control, or have significant influence over, the outcome of matters submitted to our stockholders for approval, including the election of directors and any merger, consolidation or sale of all or substantially all of our assets. In addition, these stockholders, acting together, have the ability to control, or have significant influence over, the management and affairs of our company. Accordingly, this concentration of ownership might harm the market price of our common stock by:

·delaying, deferring or preventing a change in corporate control;

·impeding a merger, consolidation, takeover or other business combination involving us; or

·discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.

As a public company, we are required to assess our internal control over financial reporting on an annual basis, and any future adverse results from such assessment could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock price.

As a public company, the Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we need to perform system and process evaluation and testing of our internal control over financial reporting to allow management and our independent registered public accounting firm to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Our testing, or the subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses. Our compliance with Section 404 requires that we expend significant management time on compliance-related issues. Moreover, if we are not able to comply with the requirements of Section 404 in a timely manner, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our common stock could decline and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which could require additional financial and management resources.

Your percentage ownership in us may be diluted by future issuances of capital stock, which could reduce your influence over matters on which stockholders vote.

Our board of directors has the authority, without action or vote of our stockholders, to issue all or any part of our authorized but unissued shares of common stock, including shares issuable upon the exercise of options, shares that may be issued to satisfy our obligations under our equity incentive plans, shares that may be issued in connection with our acquisition of other companies, assets or technology, or shares of our authorized but unissued preferred stock. Issuances of common stock or preferred voting stock could reduce your influence over matters on which our stockholders vote and, in the case of issuances of preferred stock, likely could result in your interest in us being subject to the prior rights of holders of that preferred stock. In addition, any future issuance of capital stock by us will dilute your economic interest in our company.

We currently do not intend to pay dividends on our common stock and, consequently, your only opportunity to achieve a return on your investment is if the price of our common stock appreciates.

We do not expect to pay dividends on shares of our common stock in the foreseeable future, and we intend to use cash generated from operations to continue to grow our business. Consequently, your only opportunity to achieve a positive return on your investment in us will be if the market price of our common stock appreciates.

If securities or industry analysts cease to publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

The trading market for our common stock depends in part on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable research about our business, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.

47

Provisions in our certificate of incorporation and bylaws and Delaware law may discourage, delay or prevent a change of control of our company or changes in our management and, therefore, may depress the trading price of our stock.

Our certificate of incorporation and bylaws contain provisions that could depress the trading price of our stock by acting to discourage, delay or prevent a change of control of our company or changes in our management that some of the stockholders of our company may deem advantageous. Some of these provisions:

·authorize the issuance of “blank check” preferred stock that our board of directors could issue to increase the number of outstanding shares to discourage a takeover attempt;

·provide for a classified board of directors (three classes) where only one-third of our board of directors is up for re-election at the annual stockholders meeting each year;

·provide that stockholders may only remove directors for cause;

·provide that stockholders may only remove directors prior to the expiration of their term upon a supermajority vote of at least 80% of our outstanding common stock;

·provide that any vacancy on our board of directors, including a vacancy resulting from an increase in the size of the board, may only be filled by the affirmative vote of a majority of our directors then in office, even if less than a quorum;

·provide that a special meeting of stockholders may only be called by our board of directors or by our chief executive officer;

·provide that action by written consent of the stockholders may be taken only if the board of directors first approves such action; provided that, notwithstanding the foregoing, we will hold an annual meeting of stockholders in accordance with NYSE rules, for so long as our shares are listed on NYSE, and as otherwise required by the bylaws;

·provide that the board of directors is expressly authorized to make, alter or repeal our bylaws; and

·establish advance notice requirements for nominations for elections to our board of directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.

We may also adopt a “poison pill” stockholder rights plan at any time in response to a potentially hostile bid or for any or no reason due to our available “blank check” preferred stock. Additionally, we are subject to Section 203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested” stockholder.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

On April 20, 2012, we announced that our board of directors had approved an authorization to repurchase up to $50.0 million of RealD common stock. On December 17, 2012, our board approved a $25 million increase in our stock repurchase plan, increasing the $50 million repurchase plan announced on April 20, 2012 to $75 million. The number of shares to be repurchased and the timing of any potential repurchases will depend on factors such as the Company’s stock price, economic and market conditions, alternative uses of capital, and corporate and regulatory requirements. Repurchases of common stock may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when RealD might otherwise be precluded from doing so under insider trading laws, and a variety of other methods, including open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The repurchase program may be suspended or discontinued at any time.

Pursuant to our stock repurchase plan authorized by our board of directors, we have repurchased a total of 6,599,726 shares of common stock at an average price per share of $10.30, including sales commissions, for an aggregate cost of $68.0 million inception to date. For the three months ended December 31, 2013, there were no stock repurchases.

48

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following exhibits are attached hereto and filed herewith:

EXHIBIT INDEX

		Incorporated by Reference
Exhibit  Number	Exhibit Description	Form	SEC File No.	Exhibit	Filing Date	Filed Herewith
3.1	Amended and Restated Certificate of Incorporation as filed with the Secretary of State of the State of Delaware on July 15, 2010.	10-Q	001-34818	3.1	July 29, 2011
3.2	Amended and Restated Bylaws as became effective on July 15, 2010.	10-Q	001-34818	3.2	July 29, 2011
3.3	Amended and Restated Bylaws as amended and restated June 5, 2013.	10-K	001-34818	3.3	June 6, 2013
4.1	Specimen of common stock certificate.	S-1/A	333-165988	4.1	May 26, 2010
4.2	Amended and Restated Investors’ Rights Agreement, dated December 24, 2007, by and among the registrant, the founders and the investors named therein.	S-1/A	333-165988	4.2	May 26, 2010
4.3	Amendment and Agreement to Amended and Restated Investors’ Rights Agreement, dated June 11, 2010, by and among the registrant and the other signatories thereto.	S-1/A	333-165988	4.6	June 29, 2010

49

4.4	Side letter, dated June 25, 2010, to Amended and Restated Investors’ Rights Agreement, as amended.	S-1/A	333-165988	4.8	June 29, 2010
10.1†	Separation Agreement and General Release with Minard Hamilton dated November 11,2013.					X
10.2†	Separation Agreement and General Release with Joseph Peixoto dated October 21, 2013.					X
31.1	Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					X
31.2	Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					X
32.1	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					X
32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					X
101.INS*	XBRL Instance Document.					X
101.SCH*	XBRL Taxonomy Extension Schema Document.					X
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document.					X
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document.					X
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document.					X
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document.					X

†Indicates a management contract or compensatory plan or arrangement.

*    Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

50

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

RealD Inc.
By:	/s/ Andrew A. Skarupa
	Andrew A. Skarupa
	Chief Financial Officer
	(Principal Financial Officer)

Date: February 5, 2014

51

EX-10.1

Exhibit 10.1

SEPARATION AGREEMENT AND

GENERAL RELEASE OF CLAIMS

THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS(the “Agreement”) is between RealD Inc., a Delaware corporation (the “Company”), and Joseph Peixoto (“Executive”) (together, the “Parties”), This Agreement is being provided to Executive on October 21, 2013, and shall be effective only if it has been executed by each of the Parties and the revocation period has expired without revocation as set forth in Section 7 below (the “Effective Date”).

WHEREAS, Executive is an employee of the Company and has served as its President, Worldwide Cinemas, pursuant to an employment agreement with the Company with an effective date of May 25, 2010 (the “Employment Agreement”) attached hereto as Exhibit 1; and

WHEREAS, the Company and Executive mutually agree that they desire that (i) Executive’s employment with the Company will terminate no later than the close of business on March 31, 2014 and such termination may be treated as a Qualifying Termination as provided under this Agreement, and (ii) Executive will release the Company and its affiliates from any and all claims as of the Effective Date and also as of the Termination Date (as defined herein).

NOW, THEREFORE, in consideration of the mutual promises contained herein, the Parties agree as follows:

1.Transition.  From the Effective Date through the Termination Date, Executive shall only be terminated for Cause (as defined in the Employment Agreement). The “Termination Date” means the earliest to occur of: (a) March 31, 2014, (b) the date of Executive’s death, (c) the date that Executive resigns his employment without Good Reason (as defined in the Employment Agreement) or (d) the date that the Company terminates Executive’s employment for Cause. Termination under either clauses (c) or (d) will not constitute a Qualifying Termination for purposes of this Agreement and will mean that the Executive is not eligible for any of the separation benefits under Section 4 of this Agreement. In such case, Executive shall be eligible to receive his Accrued Obligations (as defined in the Employment Agreement) up through and upon the Termination Date.

2.Qualifying Termination of Employment.  Executive and the Company acknowledge and agree that Executive’s employment with the Company will terminate in all cases as of the close of business on the Termination Date and that such termination will be treated as a Qualifying Termination by the Company, except as provided for terminations under clauses (c) and (d) of Section 1. As of the Termination Date, it is mutually agreed that Executive is no longer an employee or officer of the Company and no longer holds any positions or offices with the Company.

1

3.Separation Benefits.  In consideration for Executive’s general release of all claims set forth below and Executive’s other obligations under this Agreement and in satisfaction of all of the Company’s obligations to Executive, and further provided that: (i) this Agreement is signed by Executive and delivered to the Company on or before December 5, 2013, (ii) this Agreement is not revoked by Executive under Section 7 below and therefore becomes effective on or before December 13, 2013, (iii) Executive remains in continuing material compliance with all of the terms of this Agreement, (iv) the termination of Executive’s employment with the Company is treated as a Qualifying Termination by the Company, and (v) on or within 60 days after the Termination Date, Executive (or his estate, if applicable) timely re-executes a second general release of claims (in a form prescribed by the Company and which will be substantially the same as this Agreement) and Executive (or his estate, if applicable) timely delivers to the Company such second release and does not revoke it, then the Company agrees to provide (and continue to provide) the separation benefits specified in Section 4(a) below to Executive (or his estate, if applicable).

The Parties agree and acknowledge that (A) the separation payments and benefits provided under Section 4(a) are being provided in lieu of all post-employment benefits set forth in the Employment Agreement and any post-employment benefits under any other agreement, and (B) this Agreement as of its effective date hereby supersedes and replaces in their entirety any and all compensation, severance, separation, benefits and/or termination plans, policies, agreements and/or programs between Executive and Company (including, without limitation, the Employment Agreement).

In the event that the Company believes Executive is not in continuing material compliance with the terms of this Agreement, then the Company shall provide Executive with written notice of the same and the Company’s intention to terminate the separation benefits specified in Section 4(a) below within ninety (90) days of the date on which the Chief Executive Officer or the General Counsel of the Company first becomes aware of the initial existence of the condition(s) giving rise to such lack of material compliance. If the Company does not timely provide such notice during the applicable 90 days, then the Company will be deemed to have waived the right to assert any such breach with respect to such condition(s), provided that at least one of such persons with knowledge of the initial existence of the condition(s) remains in service with the Company through the conclusion of the ninety (90) day notice period. Notwithstanding the foregoing, in the event that the actions or inactions giving rise to such lack of material compliance are reasonably capable of being cured, the written notice from the Company shall provide Executive with at least twenty (20) days to cure such noncompliance, prior to the effective date of the termination of separation benefits specified in Section 4(a) below. During such twenty (20) day period, the Company will suspend payment(s) of the separation benefits specified in Section 4(a) below, and if the actions or inactions giving rise to such lack of material compliance are not timely cured, then the Company shall immediately terminate any and all such separation payments and benefits. If Executive cures the circumstances giving rise to such lack of material compliance within such twenty (20) day period, the Company shall remove the

2

suspension and continue to provide the separation payments and benefits specified in Section 4(a) below retroactive to the date of suspension.

4.Payments. Benefits and Taxes.

(a)Separation Benefits.  Subject to the timely satisfaction of all applicable conditions specified in this Agreement, the Company will provide to Executive the separation benefits specified in this Section 4(a) and the Executive acknowledges and agrees that such benefits represent the entirety of post-employment separation benefits to which Executive is eligible to receive:

(i)(I) For the first through sixth months after the Termination Date, cash severance payments in an aggregate amount equal to $312,500 with such amount being paid pursuant to the Company’s normal payroll practices in substantially equal installments over the first six (6) months following the Termination Date; provided, however, that the first such installment of cash severance shall be paid on the Company’s first payroll date that occurs on or after the 55th day following the Termination Date; and provided, further, that such first installment shall be in an amount that also includes the cash severance that would have otherwise been paid to Executive in the prior payroll cycles that occurred after the Termination Date but before the date of the first such payment under this Section 4(a)(i)(I); and (II) for the seventh through eighteenth months after the Termination Date, cash severance payments in an aggregate amount equal to $625,000 with such amount being paid pursuant to the Company’s normal payroll practices in substantially equal installments (all such cash severance amounts under subsections (I) and (II) above, “Cash Severance”).

(ii)The Company will continue to pay the cost (to the same extent that the Company was doing so immediately before the Termination Date) for all group employee benefit coverage continuation under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) to the same extent provided by the Company’s group plans immediately before the Termination Date for twelve (12) months after the Termination Date or until Executive becomes eligible for group insurance benefits from another employer, whichever occurs first, provided that Executive timely elects COBRA coverage (“COBRA Benefits”). Executive agrees (i) at any time either before or during the period of time Executive is receiving benefits under this Section 4(a), to inform the Company promptly in writing if Executive becomes eligible to receive group health coverage from another employer; and (ii) that Executive may not increase the number of designated dependents, if any, during this time unless Executive does so at Executive’s own expense. The period of such COBRA Benefits shall be considered part of Executive’s COBRA coverage entitlement period, and may, for tax purposes, be considered income to Executive.

(iii)Notwithstanding the Qualifying Termination contemplated herein, Executive shall continue to be eligible for a pro-rated cash “Performance Bonus” for fiscal year 2014 under the Company’s Management Incentive Plan as if the Qualifying Termination had not occurred, all as may be approved by the Compensation Committee of the Board of Directors in

3

its sole discretion. This Performance Bonus, if any, shall be paid to Executive no later than June 15, 2014 in accordance with the Company’s standard bonus payment practices.

(iv)With respect to all equity incentive grants that have been made to Executive under the Company’s 2004 Stock Incentive Plan and 2010 Stock Incentive Plan (collectively, the “Equity Grants”), and subject to the approval of the Compensation Committee of the Board of Directors, (i) each of the Equity Grants shall continue to vest for a period of twelve months following the Termination Date; and (ii) the date by which Executive must exercise any options that constitute Equity Grants shall be extended from 12 months following the Termination Date to 24 months following the Termination Date. In all other respects, the terms and conditions of the Equity Grants shall remain as is and in full force and effect.

(b)Taxes.  Any tax obligations of Executive and tax liability therefore, including without limitation, any penalties or interest based upon such tax obligations, that arise from the benefits and payments made to Executive shall be Executive’s sole responsibility and liability. All payments or benefits made under this Agreement to Executive shall be subject to applicable tax withholding laws and regulations and Executive shall be required to timely and fully satisfy any such withholding as a condition of receipt of any payments or benefits. The terms of Section 12 of the Employment Agreement are also applicable to this Agreement and to all payments and benefits provided hereunder.

(c)WARN Payments.  The separation payments to Executive hereunder shall be considered as including any and all payments by the Company that could or in fact become payable in connection with the Executive’s termination of employment pursuant to any applicable legal requirements, including, without limitation, the Worker Adjustment and Retraining Notification Act (the “WARN” Act), California Labor Code sections 1400-1408, or any other similar foreign, federal or state law.

(d)Full Payment.  Except with respect to any Excluded Claims (as defined below), Executive represents and warrants to the Company that, as of the Effective Date, the payments set forth in Section 4(a) herein constitute all payments or obligations owed by the Company to Executive in connection with any severance, retention or a change in control plan or arrangement.

(e)Internal Revenue Code Section Provisions.  The terms of Sections 3(d)(iv) and 13 of the Employment Agreement are also applicable to this Agreement and to all payments and benefits provided hereunder.

5.Executive’s Representations, Warranties and Covenants.

(a)Executive reaffirms and agrees that: (i) he will continue to be bound by, and will continue to comply with, all of the terms and conditions and covenants in Section 7 of the Employment Agreement; and (ii) the Employee Invention Assignment and Confidentiality Agreement, dated May 25, 2010, between the Company and Executive, attached as Exhibit 2,

4

shall continue in full force and effect until the six (6) month anniversary of the Termination Date.

(b)Executive represents and warrants to the Company that, as of the Effective Date, Executive has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Executive from complying with the provisions hereof, and further certifies that Executive will not enter into any such conflicting agreement.

(c)Executive represents and warrants to the Company that, as of the Effective Date, Executive has not filed any claim against the Company or its affiliates and has not assigned to any third party any claims against the Company or its affiliates. Executive also acknowledges that he has no work-related injury, illness, disease or condition, and that he has not been unlawfully denied any family or medical leave or otherwise subjected to unlawful interference in that regard.

(d)Executive acknowledges that Executive has had the opportunity to fully review this Agreement and, if Executive so chooses, to consult with counsel, and is fully aware of Executive’s rights and obligations under this Agreement.

(e)Executive will not at any time during the period of his employment with the Company or at any time thereafter, make (or direct anyone else to make) any disparaging statements (oral or written) about the Company, or any of its affiliated entities, officers, directors, employees, stockholders, representatives or agents, or any of the Company’s products or services or work-in-progress, that are harmful to their businesses, business reputations or personal reputations.

6.Executive’s Release of Claims.  In exchange for the Company’s promises set forth herein, all of which are good and valuable consideration, Executive hereby covenants not to sue and releases and forever discharges the Company, its owners, parents, subsidiaries, attorneys, insurers, agents, employees, stockholders, directors, officers, affiliates, predecessors and successors of and from any and all rights, claims, actions, demands, causes of action, obligations, attorneys’ fees, costs, damages, and liabilities of whatever kind or nature, in law or in equity, that Executive may have (whether known or not known) (collectively, “Claims”), accruing to Executive as of the Effective Date, that Executive has ever had, including but not limited to, Claims based on and/or arising under Title VII of the Civil Rights Act of 1964, as amended, The Americans with Disabilities Act, The Family Medical Leave Act, The Equal Pay Act, The Employee Retirement Income Security Act, The Fair Labor Standards Act, and/or the California Fair Employment and Housing Act; The California Constitution, The California Government Code, The California Labor Code, The Industrial Welfare Commission’s Orders, the Worker Adjustment and Retraining Notification Act, California Labor Code sections 1400-1408, and any and all other Claims Executive may have under any other federal, state or local Constitution, Statute, Ordinance and/or Regulation; and all other Claims arising under common law, including but not limited to, tort, express and/or implied contract and/or quasi-contract, arising out of or, in

5

any way, related to Executive’s previous relationship with the Company as an employee. Furthermore, Executive acknowledges that Executive is waiving and releasing any rights Executive may have under the Older Workers Benefit Protection Act and Age Discrimination in Employment Act of 1967 (“ADEA”), as amended, and that this waiver and release is knowing and voluntary. Executive acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive further acknowledges that Executive has been advised by this writing that in accordance with ADEA:

(a)Executive should consult with an attorney prior to executing this Agreement;

(b)Executive has at least forty-five (45) days within which to consider this Agreement;

(c)If Executive decides not to use all of the 45-day review period, Executive knowingly and voluntarily waives any claim that he was not given or did not use the full 45-day review period before signing this Agreement;

(d)Modification of this Agreement, whether material or immaterial, shall not restart the running of the 45-day review period;

(e)Executive has up to seven (7) days following the execution of this Agreement by Executive to revoke the Agreement by timely providing written notice of revocation to the Company; and

(f)This Agreement shall not be effective until the revocation period in Section 7(c) has expired without revocation by Executive.

The Company and Executive agree that the release set forth in this Section 7 shall be and remain in effect in all respects as a complete general release as to the matters released. Notwithstanding anything to the contrary herein, the Parties agree that Executive is not waiving any Claims he may have that arise from or are incurred in connection with any of the following matters (collectively, the “Excluded Claims”). (i) the Company’s breach of its obligations under Section 4(a) above; (ii) claims for indemnification under Section 2802 of the California Labor Code, under the Company’s Certificate of Incorporation, Articles of Incorporation or by-laws, pursuant to that certain Indemnification Agreement (as amended from time to time) dated May 25, 2010 and with an effective date of April 10, 2010, and under any insurance policy of the Company or the established policies of the Company or any affiliate thereof expressly providing for such indemnity between Executive and the Company or any affiliate thereof; (iii) claims for any vested benefits under the terms of any of the Company’s pension, profit sharing, health, welfare, stock option, restricted stock, stock incentive, deferred compensation, supplemental compensation and any other welfare, benefit or other plan of the Company; (iv) claims for workers’ compensation benefits; and (v) any transactions or agreements entered into, and any occurrences, acts or omissions occurring, after the Effective Date.

6

7.Civil Code Section 1542.  Each of Executive and the Company acknowledge that they are familiar with the provisions of California Civil Code Section 1542, which provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.

Executive, being aware of said Code section, agree to expressly waive any rights Executive may have thereunder (except with respect to Excluded Claims), as well as under any other statute or common law principles of similar effect.

8.Company’s Representations, Warranties and Covenants.

(a)Executive shall be paid his FY2014 bonus, if any, at the same time other Company executives are paid their bonuses, provided that such payment is approved by the Compensation Committee of the Board of Directors in accordance with the Company’s Management Incentive Plan.

(b)For the six (6) month period following the Termination Date, Company shall continue to provide Executive with office space in Company’s Beverly Hills offices, and Executive shall be permitted to keep any computers, cell phones, tablets and other similar items (“Equipment”) previously provided to him by Company. At the conclusion of such six (6) month period, Executive shall have the option to purchase the Equipment from Company.

9.Labor Code Section 206.5.  Executive acknowledges that, as of his execution of this Agreement, other than the amounts that are expressly set forth herein to be paid in accordance with this Agreement and his unpaid salary accrued from the Company’s most recent payroll payment and which will be paid at the next Company payroll payment, he has received timely payment in full for all compensation (of any sort, including, but not limited to, wages, bonuses, incentive compensation, stock options and vacation) earned by him during his employment with the Company, and for all reimbursement of expenses (of any sort) incurred by him during his employment with the Company and for which reimbursement would be required. In light of the payment by the Company of all wages due, or to become due to Executive, California Labor Code Section 206.5 is not applicable to the Parties hereto. That section provides in pertinent part as follows:

No employer shall require the execution of any release of any claim or right on account of wages due, or to become due, or made as an advance on wages to be earned, unless payment of such wages has been made.

7

10.Governing Law.  This Agreement will be governed by the internal substantive laws, but not the choice of law rules, of the State of California.

11.Assignment.  This Agreement and all rights under this Agreement will be binding upon and inure to the benefit of and be enforceable by the Parties hereto and their respective owners, agents, officers, stockholders, employees, directors, attorneys, insurers, subsidiaries, parents, affiliates, successors, personal or legal representatives, executors, administrators, heirs, distributes, devisees, legatees and assigns. This Agreement is personal in nature, and none of the Parties to this Agreement will, without the written consent of the other, assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity; except that the rights and obligations of the Company under this Agreement may be assigned (without the consent of Executive) to an entity which becomes the successor to the Company as the result of a merger or other corporate reorganization or similar transaction or sale of substantially all the assets to a successor which continues the business of the Company or any other subsidiary of the Company.

12.Notices.  The terms of Section 11 of the Employment Agreement are also applicable to this Agreement.

13.Integration and Interpretation.  This Agreement, Exhibit 2 and the surviving provisions of the Employment Agreement, represent the entire agreement and understanding between the parties as to the subject matter hereof and supersede all prior agreements whether written or oral including, without limitation, all provisions of the Employment Agreement that are not referenced herein as continuing to be applicable. The terms of this Agreement have been voluntarily agreed to by Executive and Company, and the language used in this Agreement shall be deemed to be the language chosen to express the mutual intent of the Parties. This Agreement shall be construed without regard to any presumption or rule requiring construction against Company or Executive, or in favor of the Party receiving a particular benefit under this Agreement.

14.Modification.  This Agreement may only be amended in a writing signed by Executive and an authorized representative of the Company and which expressly references that this Agreement is being amended. No waiver, alteration or modification of any of the provisions of this Agreement will be binding unless in writing and signed by the Party against whom enforcement of the change or modification is sought. Failure or delay on the part of either Party hereto to enforce any right, power or privilege hereunder will not be deemed to constitute a waiver thereof. Additionally, a waiver by either Party or a breach of any promise hereof by the other Party will not operate as or be construed to constitute a waiver of any subsequent breach by such other Party.

15.Severability.  Whenever possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will

8

not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

16.No Representations.  Each Party represents that it has had the opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement. Neither Party has relied upon any representations or statements made by any other Party hereto which are not specifically set forth in this Agreement. By entering into this Agreement, the Company is not acknowledging or admitting any fault, wrongdoing, or liability on its part in any way.

17.Authority.  The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through Executive to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

18.Voluntary Execution of Agreement.  Executive acknowledges and agrees that this Agreement is an individually-negotiated Agreement and that he is not being separated as a result of any exit incentive program, plan or practice of the Company. This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims. The Parties acknowledge that:

(a)They have read this Agreement;

(b)They have been represented in the preparation, negotiation and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel;

(c)They understand the terms and consequences of this Agreement and of the releases it contains; and

(d)They are fully aware of the legal and binding effect of this Agreement.

19.Execution in Multiple Counterparts.  This Agreement may be executed in multiple counterparts, each of which when together shall be deemed to constitute the executed original,

9

and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of the undersigned.

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the dates shown below.

JOSEPH PEIXOTO		REALD INC.
By:	/s/ Joseph Peixoto	By:	/s/ Michael V. Lewis
			Michael V. Lewis
			Chief Executive Officer
Date:	October 21, 2013	Date:	October 22, 2013

10

EX-10.2

Exhibit 10.2

SEPARATION AGREEMENT AND

GENERAL RELEASE OF CLAIMS

THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS(the “Agreement”) is between RealD Inc., a Delaware corporation (the “Company”), and Minard Hamilton (“Executive”) (together, the “Parties”). This Agreement is being provided to Executive on November 11, 2013, and shall be effective only if it has been executed by each of the Parties and the revocation period has expired without revocation as set forth in Section 7 below (the “Effective Date”).

WHEREAS, Executive is an employee of the Company and has served as its Executive Vice-President, Mobile and Consumer, pursuant to an employment agreement with the Company with an effective date of February 6, 2013 (the “Employment Agreement”) attached hereto as Exhibit l; and

WHEREAS, the Company and Executive mutually agree that they desire that (i) Executive’s employment with the Company will terminate no later than the close of business on February 6, 2014 and such termination may be treated as a Qualifying Termination as provided under this Agreement, and (ii) Executive will release the Company and its affiliates from any and all claims as of the Effective Date and also as of the Termination Date (as defined herein).

NOW, THEREFORE, in consideration of the mutual promises contained herein, the Parties agree as follows:

1.Transition.  From the Effective Date through the Termination Date, Executive shall only be terminated for Cause (as defined in the Employment Agreement). The “Termination Date” means the earliest to occur of: (a) February 6, 2014, (b) the date of Executive’s death, (c) the date that Executive resigns his employment without Good Reason (as defined in the Employment Agreement) or (d) the date that the Company terminates Executive’s employment for Cause. Termination under either clauses (c) or (d) will not constitute a Qualifying Termination for purposes of this Agreement and will mean that the Executive is not eligible for any of the separation benefits under Section 4 of this Agreement. In such case, Executive shall be eligible to receive his Accrued Obligations (as defined in the Employment Agreement) up through and upon the Termination Date. The parties acknowledge and agree that, for the period from the Effective Date through the Termination Date, Executive shall not be required to report to the Company’s offices but shall make himself available by telephone as shall be reasonably requested by one or more Company personnel.

2.Qualifying Termination of Employment.  Executive and the Company acknowledge and agree that Executive’s employment with the Company will terminate in all cases as of the close of business on the Termination Date and that such termination will be

1

treated as a Qualifying Termination by the Company, except as provided for terminations under clauses (c) and (d) of Section 1. As of the Termination Date, it is mutually agreed that Executive is no longer an employee or officer of the Company and no longer holds any positions or offices with the Company.

3.Separation Benefits. In consideration for Executive’s general release of all claims set forth below and Executive’s other obligations under this Agreement and in satisfaction of all of the Company’s obligations to Executive, and further provided that: (i) this Agreement is signed by Executive and delivered to the Company on or before December 25, 2013, (ii) this Agreement is not revoked by Executive under Section 7 below and therefore becomes effective on or before January 1, 2014, (iii) Executive remains in continuing material compliance with all of the terms of this Agreement, (iv) the termination of Executive’s employment with, the Company is treated as a Qualifying Termination by the Company, and (v) on or within 60 days after the Termination Date, Executive (or his estate, if applicable) timely re-executes a second general release of claims (in a form prescribed by the Company and which will be substantially the same as this Agreement) and Executive (or his estate, if applicable) timely delivers to the Company such second release and does not revoke it, then the Company agrees to provide (and continue to provide) the separation benefits specified in Section 4(a) below to Executive (or his estate, if applicable).

The Parties agree and acknowledge that (A) the separation payments and benefits provided under Section 4(a) are being provided in lieu of all post-employment benefits set forth in the Employment Agreement and any post-employment benefits under any other agreement, and (B) this Agreement as of its effective date hereby supersedes and replaces in their entirety any and all compensation, severance, separation, benefits and/or termination plans, policies, agreements and/or programs between Executive and Company (including, without limitation, the Employment Agreement).

In the event that the Company believes Executive is not in continuing material compliance with the terms of this Agreement, then the Company shall provide Executive with written notice of the same and the Company’s intention to terminate the separation benefits specified in Section 4(a) below within ninety (90) days of the date on which the Chief Executive Officer or the General Counsel of the Company first becomes aware of the initial existence of the condition(s) giving rise to such lack of material compliance. If the Company does not timely provide such notice during the applicable 90 days, then the Company will be deemed to have waived the right to assert any such breach with respect to such condition(s), provided that at least one of such persons with knowledge of the initial existence of the condition(s) remains in service with the Company through the conclusion of the ninety (90) day notice period. Notwithstanding the foregoing, in the event that the actions or inactions giving rise to such lack of material compliance are reasonably capable of being cured, the written notice from the Company shall provide Executive with at least twenty (20) days to cure such noncompliance, prior to the effective date of the termination of separation benefits specified in Section 4(a) below. During such twenty (20) day period, the Company will suspend payment(s) of the separation benefits specified in Section 4(a) below, and if the actions or inactions giving rise to such lack of material

2

compliance are not timely cured, then the Company shall immediately terminate any and all such separation payments and benefits. If Executive cures the circumstances giving rise to such lack of material compliance within such twenty (20) day period, the Company shall remove the suspension and continue to provide the separation payments and benefits specified in Section 4(a) below retroactive to the date of suspension.

4.Payments, Benefits and Taxes.

(a)Separation Benefits.  Subject to the timely satisfaction of all applicable conditions specified in this Agreement, the Company will provide to Executive the separation benefits specified in this Section 4(a) and the Executive acknowledges and agrees that such benefits represent the entirety of post-employment separation benefits to which Executive is eligible to receive:

(i)cash severance payments in an aggregate amount equal to $300,000 with such amount being paid pursuant to the Company’s normal payroll practices in substantially equal installments over the first twelve (12) months following the Termination Date (“Cash Severance”), provided, however, that the first such installment of cash severance shall be paid on the Company’s first payroll date that occurs on or after the 55th day following the Termination Date; and provided, further, that such first installment shall be in an amount that also includes the cash severance that would have otherwise been paid to Executive in the prior payroll cycles that occurred after the Termination Date but before the date of the first such payment under this Section

(ii)The Company will continue to pay the cost (to the same extent that die Company was doing so immediately before the Termination Date) for all group employee benefit coverage continuation under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) to the same extent provided by the Company’s group plans immediately before the Termination Date for twelve (12) months after the Termination Date or until Executive becomes eligible for group insurance benefits from another employer, whichever occurs first, provided that Executive timely elects COBRA coverage (“COBRA Benefits”). Executive agrees (i) at any time either before or during the period of time Executive is receiving benefits under this Section 4(a), to inform the Company promptly in writing if Executive becomes eligible to receive group health coverage from another employer; and (ii) that Executive may not increase the number of designated dependents, if any, during this time unless Executive does so at Executive’s own expense. The period of such COBRA Benefits shall be considered part of Executive’s COBRA coverage entitlement period, and may, for tax purposes, be considered income to Executive.

(iii)With respect to all equity incentive grants that have been made to Executive under the Company’s 2010 Stock Incentive Plan (collectively, the “Equity Grants”), the terms and conditions of the Equity Grants shall remain as is and in full force and effect.

3

(b)Taxes.  Any tax obligations of Executive and tax liability therefore, including without limitation, any penalties or interest based upon such tax obligations, that arise from the benefits and payments made to Executive shall be Executive’s sole responsibility and liability. All payments or benefits made under this Agreement to Executive shall be subject to applicable tax withholding laws and regulations and Executive shall be required to timely and fully satisfy any such withholding as a condition of receipt of any payments or benefits. The terms of Section 12 of the Employment Agreement are also applicable to this Agreement and to all payments and benefits provided hereunder.

(c)WARN Payments.  The separation payments to Executive hereunder shall be considered as including any and all payments by the Company that could or in fact become payable in connection with the Executive’s termination of employment pursuant to any applicable legal requirements, including, without limitation, the Worker Adjustment and Retraining Notification Act (the “WARN” Act), California Labor Code sections 1400-1408, or any other similar foreign, federal or state law.

(d)Full Payment.  Except with respect to any Excluded Claims (as defined below), Executive represents and warrants to the Company that, as of the Effective Date, the payments set forth in Section 4(a) herein constitute all payments or obligations owed by the Company to Executive in connection with any severance, retention or a change in control plan or arrangement.

(e)Internal Revenue Code Section Provisions.  The terms of Sections 3(d)(iv) and 13 of the Employment Agreement are also applicable to this Agreement and to all payments and benefits provided hereunder.

5.Executive’s Representations, Warranties and Covenants.

(a)Executive reaffirms and agrees that he will continue to be bound by, and will continue to comply with, all of the terms and conditions and covenants in Section 7 of the Employment Agreement and the Employee Invention Assignment Agreement between the Company Executive, attached hereto as Exhibit 2.

(b)Executive represents and warrants to the Company that, as of the Effective Date, Executive has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Executive from complying with the provisions hereof, and further certifies that Executive will not enter into any such conflicting agreement.

(c)Executive represents and warrants to the Company that, as of the Effective Date, Executive has not filed any claim against the Company or its affiliates and has not assigned to any third party any claims against the Company or its affiliates. Executive also acknowledges that he has no work-related injury, illness, disease or condition, and that he has not been

4

unlawfully denied any family or medical leave or otherwise subjected to unlawful interference in that regard.

(d)Executive acknowledges that Executive has had the opportunity to fully review this Agreement and, if Executive so chooses, to consult with counsel, and is fully aware of Executive’s rights and obligations under this Agreement.

(e)Executive will not at any time during the period of his employment with the Company or at any time thereafter, make (or direct anyone else to make) any disparaging statements (oral or written) about the Company, or any of its affiliated entities, officers, directors, employees, stockholders, representatives or agents, or any of the Company’s products or services or work-in-progress, that are harmful to their businesses, business reputations or personal reputations.

6.Executive’s Release of Claims.  In exchange for the Company’s promises set forth herein, all of which are good and valuable consideration, Executive hereby covenants not to sue and releases and forever discharges the Company, its owners, parents, subsidiaries, attorneys, insurers, agents, employees, stockholders, directors, officers, affiliates, predecessors and successors of and from any and all rights, claims, actions, demands, causes of action, obligations, attorneys’ fees, costs, damages, and liabilities of whatever kind or nature, in law or in equity, that Executive may have (whether known or not known) (collectively, “Claims”), accruing to Executive as of the Effective Date, that Executive has ever had, including but not limited to, Claims based on and/or arising under Title VII of the Civil Rights Act of 1964, as amended, The Americans with Disabilities Act, The Family Medical Leave Act, The Equal Pay Act, The Employee Retirement Income Security Act, The Fair Labor Standards Act, and/or the California Fair Employment and Housing Act; The California Constitution, The California Government Code, The California Labor Code, The Industrial Welfare Commission’s Orders, the Worker Adjustment and Retraining Notification Act, California Labor Code sections 1400-1408, and any and all other Claims Executive may have under any other federal, state or local Constitution, Statute, Ordinance and/or Regulation; and all other Claims arising under common law, including but not limited to, tort, express and/or implied contract and/or quasi-contract, arising out of or, in any way, related to Executive’s previous relationship with the Company as an employee. Furthermore, Executive acknowledges that Executive is waiving and releasing any rights Executive may have under the Older Workers Benefit Protection Act and Age Discrimination in Employment Act of 1967 (“ADEA”), as amended, and that this waiver and release is knowing and voluntary. Executive acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive further acknowledges that Executive has been advised by this writing that in accordance with ADEA:

(a)Executive should consult with an attorney prior to executing this Agreement;

(b)Executive has at least forty-five (45) days within which to consider this Agreement;

5

(c)If Executive decides not to use all of the 45-day review period, Executive knowingly and voluntarily waives any claim that he was not given or did not use the full 45-day review period before signing this Agreement;

(d)Modification of this Agreement, whether material or immaterial, shall not restart the running of the 45-day review period;

(e)Executive has up to seven (7) days following the execution of this Agreement by Executive to revoke the Agreement by timely providing written notice of revocation to the Company; and

(f)This Agreement shall not be effective until the revocation period in Section 7(c) has expired without revocation by Executive.

The Company and Executive agree that the release set forth in this Section 7 shall be and remain in effect in all respects as a complete general release as to the matters released. Notwithstanding anything to the contrary herein, the Parties agree that Executive is not waiving any Claims he may have that arise from or are incurred in connection with any of the following matters (collectively, the “Excluded Claims”), (i) the Company’s breach of its obligations under Section 4(a) above; (ii) claims for indemnification under Section 2802 of the California Labor Code, under the Company’s Certificate of Incorporation, Articles of Incorporation or by-laws, pursuant to that certain Indemnification Agreement (as amended from time to time) between Company and Executive dated as of February 6, 2013, and under any insurance policy of the Company or the established policies of the Company or any affiliate thereof expressly providing for such indemnity between Executive and the Company or any affiliate thereof; (iii) claims for any vested benefits under the terms of any of the Company’s pension, profit sharing, health, welfare, stock option, restricted stock, stock incentive, deferred compensation, supplemental compensation and any other welfare, benefit or other plan of the Company; (iv) claims for workers’ compensation benefits; and (v) any transactions or agreements entered into, and any occurrences, acts or omissions occurring, after the Effective Date.

7.Civil Code Section 1542.  Each of Executive and the Company acknowledge that they are familiar with the provisions of California Civil Code Section 1542, which provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.

6

Executive, being aware of said Code section, agree to expressly waive any rights Executive may have thereunder (except with respect to Excluded Claims), as well as under any other statute or common law principles of similar effect.

8.[Reserved].

9.Labor Code Section 206.5.  Executive acknowledges that, as of his execution of this Agreement, other than the amounts that are expressly set forth herein to be paid in accordance with this Agreement and his unpaid salary accrued from the Company’s most recent payroll payment and which will be paid at the next Company payroll payment, he has received timely payment in full for all compensation (of any sort, including, but not limited to, wages, bonuses, incentive compensation, stock options and vacation) earned by him during his employment with the Company, and for all reimbursement of expenses (of any sort) incurred by him during his employment with the Company and for which reimbursement would be required. In light of the payment by the Company of all wages due, or to become due to Executive, California Labor Code Section 206.5 is not applicable to the Parties hereto. That section provides in pertinent part as follows:

No employer shall require the execution of any release of any claim or right on account of wages due, or to become due, or made as an advance on wages to be earned, unless payment of such wages has been made.

10.Governing Law.  This Agreement will be governed by the internal substantive laws, but not the choice of law rules, of the State of California.

11.Assignment.  This Agreement and all rights under this Agreement will be binding upon and inure to the benefit of and be enforceable by the Parties hereto and their respective owners, agents, officers, stockholders, employees, directors, attorneys, insurers, subsidiaries, parents, affiliates, successors, personal or legal representatives, executors, administrators, heirs, distributes, devisees, legatees and assigns. This Agreement is personal in nature, and none of the Parties to this Agreement will, without the written consent of the other, assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity; except that the rights and obligations of the Company under this Agreement may be assigned (without the consent of Executive) to an entity which becomes the successor to the Company as the result of a merger or other corporate reorganization or similar transaction or sale of substantially all the assets to a successor which continues the business of the Company or any other subsidiary of the Company.

12.Notices.  The terms of Section 11 of the Employment Agreement are also applicable to this Agreement.

13.Integration and Interpretation.  This Agreement, Exhibit 2 and the surviving provisions of the Employment Agreement, represent the entire agreement and understanding

7

between the parties as to the subject matter hereof and supersede all prior agreements whether written or oral including, without limitation, all provisions of the Employment Agreement that are not referenced herein as continuing to be applicable. The terms of this Agreement have been voluntarily agreed to by Executive and Company, and the language used in this Agreement shall be deemed to be the language chosen to express the mutual intent of the Parties. This Agreement shall be construed without regard to any presumption or rule requiring construction against Company or Executive, or in favor of the Party receiving a particular benefit under this Agreement.

14.Modification.  This Agreement may only be amended in a writing signed by Executive and an authorized representative of the Company and which expressly references that this Agreement is being amended. No waiver, alteration or modification of any of the provisions of this Agreement will be binding unless in writing and signed by the Party against whom enforcement of the change or modification is sought. Failure or delay on the part of either Party hereto to enforce any right, power or privilege hereunder will not be deemed to constitute a waiver thereof. Additionally, a waiver by either Party or a breach of any promise hereof by the other Party will not operate as or be construed to constitute a waiver of any subsequent breach by such other Party.

15.Severability. Whenever possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

16.No Representations.  Each Party represents that it has had the opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement. Neither Party has relied upon any representations or statements made by any other Party hereto which are not specifically set forth in this Agreement. By entering into this Agreement, the Company is not acknowledging or admitting any fault, wrongdoing, or liability on its part in any way.

17.Authority.  The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through Executive to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

18.Voluntary Execution of Agreement.  Executive acknowledges and agrees that this Agreement is an individually-negotiated Agreement and that he is not being separated as a result

8

of any exit incentive program, plan, or practice of the Company. This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims. The Parties acknowledge that:

(a)They have read this Agreement;

(b)They have been represented in the preparation, negotiation and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel;

(c)They understand the terms and consequences of this Agreement and of the releases it contains; and

(d)They are fully aware of the legal and binding effect of this Agreement.

19.Execution in Multiple Counterparts.  This Agreement may be executed in multiple counterparts, each of which when together shall be deemed to constitute the executed original, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of the undersigned.

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the dates shown below.

MINARD HAMILTON		REALD INC.
By:	/s/ Minard Hamilton	By:	/s/ Craig Gatarz
			Craig Gatarz
			EVP and General Counsel
Date:	12/16/13	Date:	12/17/13

9

EX-31.1

EXHIBIT 31. 1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael V. Lewis, certify that:

(1)I have reviewed this Quarterly Report on Form 10-Q of RealD Inc.;

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: February 5, 2014

/s/ Michael V. Lewis
	Michael V. Lewis
	Chief Executive Officer and
	Chairman of the Board of Directors (Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Andrew A. Skarupa, certify that:

(1)I have reviewed this Quarterly Report on Form 10-Q of RealD Inc.;

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  February 5, 2014

/s/ Andrew A. Skarupa
	Andrew A. Skarupa
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RealD Inc. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael V. Lewis, Chief Executive Officer of the Company and Chairman of the Board of Directors, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Michael V. Lewis

Michael V. Lewis

Chief Executive Officer and

Chairman of the Board of Directors

(Principal Executive Officer)

February 5, 2014

This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RealD Inc. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Andrew A. Skarupa, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Andrew A. Skarupa

Andrew A. Skarupa

Chief Financial Officer

(Principal Financial Officer)

February 5, 2014

This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

XML

Income taxes (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income taxes
Income tax expense	$ 1,614	$ 694	$ 4,881	$ 4,242

XML

Summary of significant accounting policies (Details 2) (USD $) In Millions, unless otherwise specified				9 Months Ended
	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2013 Designated as hedging instrument item	Dec. 31, 2013 Foreign currency forward contract Not designated as hedging instrument Level 2 item
Derivative instruments
Number of derivative instruments			0	0
Foreign currency forward contracts, maturity period				6 months
Gross receivable				$ 0
Gross payable				0
Accounts receivable: value added tax (VAT) receivables
Allowance for doubtful accounts and customer credits	3.7	2.6
Inventories and deferred costs-eyewear
Inventory reserve	$ 0.2	$ 0.4

XML

Property and equipment, RealD Cinema Systems and digital projectors

9 Months Ended

Dec. 31, 2013

Property and equipment, RealD Cinema Systems and digital projectors

Property and equipment, RealD Cinema Systems and digital projectors

3. Property and equipment, RealD Cinema Systems and digital projectors

Property and equipment, RealD Cinema Systems and digital projectors consist of the following:

	December 31,		March 31,
(in thousands)	2013		2013
RealD Cinema Systems	$	204,706	$	194,527
Digital projectors - held for sale	436		1,634
Leasehold improvements	17,373		14,442
Machinery and equipment	6,297		6,198
Furniture and fixtures	1,310		1,122
Computer equipment and software	9,604		7,628
Construction in process	1,136		2,637
Total	$	240,862	$	228,188
Less accumulated depreciation	(103,093)		(77,079)
Property and equipment, RealD Cinema Systems and digital projectors, net	$	137,769	$	151,109

Depreciation expense amounted to $10.0 million and $8.2 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Depreciation expense amounted to $29.1 million and $24.0 million for the nine months ended December 31, 2013 and December 31, 2012, respectively.

During the nine months ended December 31, 2013, we received $0.2 million in cash from motion picture exhibitor customers for the sale of digital projectors. During the nine months ended December 31, 2012, we received $2.5 million in cash from motion picture exhibitor customers for the sale of digital projectors that was included in accounts receivable as of March 23, 2012.

XML

Borrowings and Credit Agreement (Details) (USD $)	0 Months Ended	9 Months Ended			3 Months Ended		9 Months Ended								0 Months Ended		3 Months Ended			9 Months Ended
	Apr. 19, 2012	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2013 Revolving Facility	Dec. 31, 2012 Revolving Facility	Dec. 31, 2013 Revolving Facility	Dec. 31, 2012 Revolving Facility	Dec. 31, 2013 Revolving Facility LIBOR	Dec. 31, 2013 Revolving Facility Prime Rate	Dec. 31, 2013 Revolving Facility Base Rate - Federal Funds Rate	Dec. 31, 2013 Revolving Facility Base Rate - Eurodollar Rate	Dec. 31, 2013 Revolving Facility Base Rate	Apr. 19, 2012 Revolving Facility Maximum	Jan. 02, 2014 Term Loan Facility item	Dec. 31, 2013 Term Loan Facility item	Sep. 30, 2013 Term Loan Facility	Sep. 21, 2012 Term Loan Facility	Jun. 22, 2012 Term Loan Facility	Dec. 31, 2013 Term Loan Facility	Jun. 30, 2013 Term Loan Facility	Apr. 19, 2012 Term Loan Facility Maximum
Borrowings and Credit Agreement
Borrowing capacity														$ 75,000,000								$ 50,000,000
Borrowings drawn		37,500,000	47,500,000				15,000,000										25,000,000		25,000,000
Available borrowing capacity																					25,000,000
Borrowings repaid		35,625,000	37,500,000															12,500,000		15,600,000
Amount outstanding																34,400,000				34,400,000
Number of installments for periodic payment of debt															11	12
Amount of periodic payment of debt																3,100,000
Debt issuance costs	1,200,000
Calculation of the current and non-current portion of the Credit Agreement
Current portion of Credit Agreement		12,500,000		1,042,000
Credit Agreement, net of current portion		36,875,000		46,458,000
Total Credit Agreement		49,375,000		47,500,000	49,400,000		49,400,000
Future minimum Credit Agreement obligations
Fiscal year 2014		3,125,000
Fiscal year 2015		12,500,000
Fiscal year 2016		27,500,000
Fiscal year 2017		6,250,000
Variable rate basis									LIBOR	Prime Rate	Federal Funds Rate	Eurodollar Rate for a one month Interest Period	Base Rate
Interest rate added to base rate (as a percent)									2.50%		0.50%	1.00%	1.50%
Interest rate (as a percent)					2.79%		2.79%
Interest expense					$ 500,000	$ 400,000	$ 1,800,000	$ 1,000,000

XML

Cost reduction plan (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended				3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Cost of revenue	Dec. 31, 2013 Cost of revenue	Dec. 31, 2013 Research and development	Dec. 31, 2013 Research and development	Dec. 31, 2013 Selling and marketing	Dec. 31, 2013 Selling and marketing	Dec. 31, 2013 General and administrative	Dec. 31, 2013 General and administrative	Dec. 31, 2013 Employee severance	Dec. 31, 2013 Lease	Dec. 31, 2013 Net leasehold improvements item	Mar. 31, 2014 Estimated	Dec. 31, 2013 Estimated	Dec. 31, 2013 Estimated Leasehold improvements	Mar. 31, 2014 Estimated Cost of revenue	Dec. 31, 2013 Estimated Cost of revenue	Dec. 31, 2013 Estimated Research and development	Mar. 31, 2014 Estimated Selling and marketing	Dec. 31, 2013 Estimated Selling and marketing	Mar. 31, 2014 Estimated General and administrative	Dec. 31, 2013 Estimated General and administrative	Dec. 31, 2013 Estimated Employee severance	Dec. 31, 2013 Estimated Facility closing	Dec. 31, 2013 Estimated Net leasehold improvements
Cost reduction plan
Percentage of staff reduced under the cost reduction plan																									20.00%
Charges related to staff reduced	$ 3,657			$ 842		$ 755		$ 1,104		$ 956					$ 1,191	$ 4,848			$ 842	$ 755	$ 891	$ 1,995	$ 300	$ 1,256	$ 4,900
Charges related to manufacturing facilities not in operations															435	435		435	435	0		0		0		500
Total charges associated with the cost reduction plan	3,657	3,657		842	842	755	755	1,104	1,104	956	956					5,349			1,343	755		1,995		1,256
Estimated charges resulting from implementation of the cost reduction plan
Personnel	3,657			842		755		1,104		956					1,191	4,848			842	755	891	1,995	300	1,256	4,900
Lease															435	435		435	435	0		0		0		500
Impairment		3,547	6,581												66	66	7,000	66	66	0		0		0
Total	3,657	3,657		842	842	755	755	1,104	1,104	956	956					5,349			1,343	755		1,995		1,256
Summary of currently incurred charges resulting from implementation of the cost reduction plan within accrued expenses and other liabilities
Cost reduction plan liabilities	1,652	1,652
Expensed	3,657	3,657		842	842	755	755	1,104	1,104	956	956					5,349			1,343	755		1,995		1,256
Paid	2,005	2,005		350	350	657	657	454	454	544	544	2,005
Impairment		3,547	6,581												66	66	7,000	66	66	0		0		0
Payments excluding non-cash impairment
Q3 FY2014	2,005	2,005		350	350	657	657	454	454	544	544	2,005
Q4 FY2014												1,843	32
FY2015												667	227
FY2016												333	132
FY2017													44
Total												$ 4,848	$ 435														$ 300
Number of quarters for which capital expenditures are estimated														2

XML

Commitments and contingencies (Details) (Purchase Commitment, USD $) In Millions, unless otherwise specified	9 Months Ended
	Dec. 31, 2013
Indemnities and commitments
Future obligations	$ 8.0
Revolving supply commitments	90 days
Maximum
Indemnities and commitments
Payment required under the cancellation penalty provisions as a percentage of the unused contract	20.00%

XML

Share-based compensation (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Share-based compensation
Share-based compensation expense	$ 4,487	$ 4,871	$ 13,605	$ 13,965
Cost of revenue
Share-based compensation
Share-based compensation expense	181	120	722	565
Research and development
Share-based compensation
Share-based compensation expense	632	608	2,107	1,577
Selling and marketing
Share-based compensation
Share-based compensation expense	1,608	1,369	4,189	4,068
General and administrative
Share-based compensation
Share-based compensation expense	$ 2,066	$ 2,774	$ 6,587	$ 7,755

XML

Summary of significant accounting policies

9 Months Ended

Dec. 31, 2013

Summary of significant accounting policies

Summary of significant accounting policies

2. Summary of significant accounting policies

Accounting period

On November 14, 2012, our Board of Directors approved a change in our accounting periods from the previous configuration of four 13-week periods for a total of 52 weeks per year to calendar quarter end accounting periods. This change in accounting period commenced in the third quarter ended December 31, 2012 of fiscal year 2013.

Our fiscal year 2014 began on April 1, 2013, consisting of four 3-month periods for a total of 12 months, and will end on March 31, 2014 as compared to fiscal year 2013, which began on March 24, 2012 and ended on March 31, 2013. The fiscal 2014 third quarter began on October 1, 2013 and ended on December 31, 2013 as compared to the fiscal 2013 third quarter, which began on September 22, 2012 and ended on December 31, 2012. As a result, the three months and nine months ended December 31, 2013 are nine days shorter and eight days shorter than the three months and nine months ended December 31, 2012, respectively.

Use of estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.

Earnings (loss) per share of common stock

Basic income per share of common stock is computed by dividing the net income (loss) attributable to our common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income attributable to our common stockholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under our employee stock purchase plan and unvested restricted stock units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method.

The calculation of the basic and diluted loss per share of common stock for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands, except share and per share data)	2013		2012		2013		2012
Numerator:
Net loss	$	(155)	$	(4,159)	$	(6,355)	$	(5,443)
Net (income) loss attributable to noncontrolling interest	(116)		(1)		(101)		89
Net loss attributable to RealD Inc. common stockholders	$	(271)	$	(4,160)	$	(6,456)	$	(5,354)
Denominator:
Weighted-average common shares outstanding (basic)	49,325		51,062		49,459		53,157
Effect of dilutive securities	–		–		–		–
Weighted-average common shares outstanding (diluted)	49,325		51,062		49,459		53,157
Loss per common share:
Basic	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)
Diluted	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)

The weighted-average number of anti-dilutive shares excluded from the calculation of diluted loss per common share for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended		Nine months ended
	December 31,	December 31,	December 31,	December 31,
(in thousands)	2013	2012	2013	2012
Options, employee stock purchase plan, restricted stock units and warrants to purchase common stock	9,144	9,439	9,538	8,095

Due to the loss attributable to our common stockholders in the three and nine months ended December 31, 2013, basic loss per share of common stock and diluted loss per share of common stock are the same because the effect of potentially dilutive securities would be antidilutive.

Derivative instruments

Our derivative instruments are recorded at fair value in other current assets and other liabilities, respectively, in the condensed consolidated balance sheets. Changes in fair value are reported as a component of other income or loss on our condensed consolidated statements of operations. For all periods presented, none of our derivative instruments were designated as hedging instruments. We do not use foreign currency option or foreign exchange forward contracts for speculative or trading purposes.

We purchase foreign currency forward contracts, generally with maturities of six months or less, to reduce the volatility of cash flows primarily related to forecasted payments and expenses denominated in certain foreign currencies. As of December 31, 2013, we had no outstanding forward contracts. As of March 31, 2013, the carrying amounts of our foreign currency forward contracts were not significant and were classified as Level 2 fair value instruments, which was determined based on observable inputs that were corroborated by market data. For both the three months ended December 31, 2013 and December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant. For both the nine months ended December 31, 2013 and December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant. Foreign currency master agreements typically allow the netting of receivables and payables. The gross receivable balances and the gross payable balances were $0 as of December 31, 2013 and not significant as of March 31, 2013.

Accounts receivable

Accounts receivable consists of trade receivables, value-added tax (VAT) receivables and other receivables. We extend credit to our customers, who are primarily in the movie production and exhibition businesses. We provide for the estimated accounts receivable that will not be collected. These estimates are based on an analysis of historical bad debts, customer concentrations, customer creditworthiness, current economic trends and changes in the customers’ payment terms and their economic condition. Collection of accounts receivable may be affected by changes in economic or other industry conditions and may, accordingly, impact our overall credit risk. The allowance for doubtful accounts and customer credits totaled $3.7 million and $2.6 million as of December 31, 2013 and March 31, 2013, respectively.

Inventories and deferred costs-eyewear

Inventories and deferred costs-eyewear represent RealD eyewear and are substantially all finished goods. Inventories and deferred costs-eyewear are valued at the lower of cost (first-in, first-out method) or market value. At each balance sheet date, we evaluate ending inventories and deferred costs-eyewear for net realizable value. We also evaluate inventories for excess quantities and obsolescence. These evaluations include analyses of expected future average selling prices, projections of future demand and technology changes. In order to state inventories at the lower of cost or market, we maintain reserves against such inventories. If our analyses indicate that market is lower than cost, a write-down of inventories is recorded in cost of revenue in the period the loss is identified. As of December 31, 2013 and March 31, 2013, the inventory reserve as a result of our net realizable value analyses was $0.2 million and $0.4 million, respectively.

Domestically, we provide our RealD eyewear free of charge to motion picture exhibitors and then receive a fee from the motion picture studios for the usage of that RealD eyewear by the motion picture exhibitors’ consumers.

For RealD eyewear located at a motion picture exhibitor, we do not believe that it is operationally practical to perform physical counts or request the motion picture exhibitor to perform physical counts and confirm quantities held to ensure that losses due to damage, destruction and shrinkage are specifically recognized in the period incurred due to the number of domestic RealD-enabled screens and the related usage of RealD eyewear. We believe that the cost to monitor shrinkage or usage significantly outweighs the financial reporting benefits of using a specific identification methodology of expensing. We believe that utilizing a composite method of expensing RealD eyewear inventory costs provides a rational and reasonable approach to ensuring that shrinkage is provided for in the period incurred and that inventory costs are expensed in the periods that reasonably reflect the periods in which the related revenue is recognized. In doing so, we believe the following methodology reasonably and generally reflects periodic income or loss under these facts and circumstances:

· For an estimated period of time following shipment to domestic motion picture exhibitors, no expense is recognized from the time of shipment until the delivery is made because the eyewear is in transit and unused.

· The inventory cost is expensed on a straight-line basis over an estimated usage period beginning with initial usage of the eyewear shipped. In estimating the expensing start date and related expense period, we consider various factors including, but not limited to, those relating to a 3D motion picture’s opening release date, a 3D motion picture’s expected release period, the number of currently playing 3D motion pictures, and the motion picture exhibitor’s buying and stocking patterns and practices.

We believe that the expensing methodology described above rationally and reasonably approximates the period the related usage occurs resulting in our RealD eyewear product revenue. The expensing start date following the date of shipment is meant to approximate the date at which usage begins. Additionally, as the expense recognition period has been and is expected to continue to be short, we believe it adequately recognizes inventory impairments due to loss and damage on a timely basis. We further believe that exposures due to loss or damage, if any, are considered normal shrinkage and a necessary and expected cost to generate the revenue per 3D motion picture earned through RealD eyewear usage. We continue to monitor the reasonableness of this methodology to ensure that it approximates the period over which the related RealD eyewear product revenue is earned and realizable. Costs of RealD eyewear that has shipped but has not yet been used and expensed per this methodology are reported as deferred costs-eyewear.

Impairment of long-lived assets

We review long-lived assets, such as property and equipment, cinema systems, digital projectors and intangibles, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Factors or circumstances that could indicate the occurrence of such events include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing operating or cash flow losses, or incurring costs in excess of amounts originally expected to acquire or construct an asset. If the asset is not recoverable, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.

During the nine months ended December 31, 2012, we determined that a non-cancelable purchase commitment for certain cinema systems configurations in the aggregate amount of $3.5 million were not fully recoverable, primarily due to the initial investment costs which are expected to exceed the anticipated future cash flows for the related cinema systems. For the nine months ended December 31, 2012, impairment charged to cost of revenue for the related outstanding purchase commitment totaled $3.5 million.

For the three months ended December 31, 2013 and December 31, 2012, impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $0.8 million and $0.7 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $3.5 million and $6.6 million, respectively.

Revenue recognition

We derive substantially all of our revenue from the license of our RealD Cinema Systems and the product sale of our RealD eyewear. We evaluate revenue recognition for transactions using the criteria set forth by the SEC in Staff Accounting Bulletin No. 104, Revenue Recognition (SAB 104) and Accounting Standards Codification Topic 605, Revenue Recognition (ASC 605). The revenue recognition guidance states that revenue is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed or determinable and collectability is reasonably assured. We record revenue net of estimated allowances.

License revenue

License revenue is accounted for as an operating lease. License revenue is primarily derived under per-admission, periodic fixed fee, or per-motion picture basis with motion picture exhibitors. Amounts received up front, less estimated allowances, are deferred and recognized over the lease term using the straight-line method. Additional lease payments that are contingent upon future events outside our control, including those related to admission and usage, are recognized as revenues when the contingency is resolved and we have no more obligations to our customers specific to the contingent payment received. Certain of our license revenue from leasing our RealD Cinema Systems is earned upon admission by the motion picture exhibitor’s consumers. Our licensees, however, do not report and pay for such license revenue until after the admission has occurred, which may be received subsequent to our fiscal period end. We estimate and record licensing revenue related to motion picture exhibitor consumer admissions in the quarter in which the admission occurs, but only when reasonable estimates of such amounts can be made. We determine that there is persuasive evidence of an arrangement upon the execution of a license agreement or upon the receipt of a licensee’s admissions report. Revenue is deemed fixed or determinable upon receipt of a licensee’s admissions report or evidence of a RealD box office showing by licensee. We determine collectability based on an evaluation of the licensee’s recent payment history.

Product revenue

We recognize product revenue, net of allowances, when title and risk of loss have passed and when there is persuasive evidence of an arrangement, the payment is fixed or determinable, and collectability of payment is reasonably assured. In the United States and Canada, certain of our product revenue from the sale of our RealD eyewear is earned upon admission and usage by the motion picture exhibitor’s consumers. Our customers, however, do not report admission or usage information until after the admission and usage has occurred, and such information may be received subsequent to our fiscal period end. We estimate and record such product revenue in the quarter in which the admission and usage occurs, but only when reasonable estimates of such amounts can be made.

Comprehensive income (loss)

Comprehensive income (loss) is comprised of net income (loss) and other comprehensive income (loss). The only component of other comprehensive income or loss is unrealized foreign currency translation gains (losses). There were no reclassifications out of accumulated other comprehensive income (loss) during the three and nine months ended December 31, 2013 and December 31, 2012.

Shipping and handling costs

Amounts billed to customers for shipping and handling costs are included in revenue. Shipping and handling costs that we incur consist primarily of packaging and transportation charges and are recorded in cost of revenue. Shipping and handling costs recognized in cost of revenue were $1.6 million and $1.6 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Shipping and handling costs recognized in cost of revenue were $5.5 million and $6.3 million for the nine months ended December 31, 2013 and December 31, 2012, respectively.

Recent accounting pronouncements

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-10, “Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (Or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. The objective of ASU 2013-10 is to provide for the inclusion of the Fed Funds Effective Swap Rate (OIS) as a U.S. benchmark interest rate for hedge accounting purposes, in addition to direct Treasury obligations of the U.S. government (UST) and, for practical reasons, the London Interbank Offered Rate (LIBOR) swap rate. ASU 2013-10 is effective prospectively for qualifying new or redesignated hedging relationship entered into on or after July 17, 2013. Adoption of ASU 2013-10 did not have a material impact on our consolidated financial statements.

In July 2013, the FASB issued ASU 2013-11, “Income Taxes (Topic 740) Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which concludes that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset when settlement in this manner is available under the tax law.  The Company will adopt this amendment as of our 2015 fiscal year. The result of adoption may be to reclassify certain long term liabilities to long term deferred tax assets and the adoption will not result in a change to the tax provision. We do not expect the adoption of ASU 2013-11 to have a material impact on our consolidated financial statements.

XML

Share-based compensation (Details 2) (USD $) In Thousands, except Share data in Millions, unless otherwise specified	3 Months Ended		9 Months Ended			3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		1 Months Ended		3 Months Ended		9 Months Ended				3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Stock options	Dec. 31, 2013 Stock options and employee stock purchase plan	Dec. 31, 2012 Stock options and employee stock purchase plan	Dec. 31, 2013 Stock options and employee stock purchase plan	Dec. 31, 2012 Stock options and employee stock purchase plan	Dec. 31, 2013 Performance stock options	Dec. 31, 2012 Performance stock options	Dec. 31, 2013 Performance stock options	Dec. 31, 2012 Performance stock options	Jun. 30, 2013 Performance stock options Minimum Chief Executive Officer	Jun. 30, 2013 Performance stock options Maximum Chief Executive Officer	Dec. 31, 2013 Performance stock units	Dec. 31, 2012 Performance stock units	Dec. 31, 2013 Performance stock units	Dec. 31, 2012 Performance stock units	Dec. 31, 2013 Performance stock units Minimum	Dec. 31, 2013 Performance stock units Maximum	Dec. 31, 2013 Restricted stock units	Dec. 31, 2012 Restricted stock units	Dec. 31, 2013 Restricted stock units	Dec. 31, 2012 Restricted stock units	Dec. 31, 2013 Restricted stock units Minimum	Dec. 31, 2013 Restricted stock units Maximum
Share-based compensation
Vesting period					4 years																					1 year	3 years
Percentage of shares that vest after one year from the date of grant					25.00%
Period from grant date after which awards begin to vest					1 year
Term of options					10 years
Granted (in shares)					0.7
Weighted average grant date fair value (in dollars per share)					$ 7.22
Granted (in shares)																								0.6
Weighted average grant date fair value (in dollars per share)																								$ 12.29
Share-based compensation expense (in dollars)	$ 4,487	$ 4,871	$ 13,605	$ 13,965		$ 3,200	$ 3,800	$ 10,300	$ 10,800	$ 0	$ 500	$ 500	$ 1,400			$ 0	$ 0	$ 0	$ 0			$ 900	$ 500	$ 2,200	$ 1,700
Performance period												3 years		3 years	5 years			2 years
Percentage of options earned depending on outcome of performance goals																				0.00%	200.00%

XML

Condensed consolidated balance sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Current assets:
Cash and cash equivalents	$ 29,621	$ 31,020
Accounts receivable, net	50,831	45,472
Inventories	9,351	15,430
Deferred costs - eyewear	472	538
Prepaid expenses and other current assets	5,782	3,973
Total current assets	96,057	96,433
Property and equipment, net	23,913	25,002
Cinema systems, net	113,728	125,379
Digital projectors, net-held for sale	128	728
Goodwill	10,657	10,657
Other intangibles, net	6,468	7,417
Deferred income taxes	3,001	3,001
Other assets	4,917	5,031
Total assets	258,869	273,648
Current liabilities:
Accounts payable	6,856	22,737
Accrued expenses and other liabilities	26,608	25,013
Deferred revenue	8,171	9,916
Income taxes payable	1,668	603
Deferred income taxes	2,895	2,860
Current portion of Credit Agreement	12,500	1,042
Total current liabilities	58,698	62,171
Credit Agreement, net of current portion	36,875	46,458
Deferred revenue, net of current portion	7,309	10,392
Other long-term liabilities and customer deposits	5,106	5,438
Total liabilities	107,988	124,459
Commitments and contingencies
Equity (deficit)
Common stock, $0.0001 par value, 200,000 shares authorized; 49,259 and 49,365 shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively	347,976	332,694
Accumulated deficit	(196,813)	(182,846)
Accumulated other comprehensive income	391	115
Total RealD Inc. stockholders' equity	151,554	149,963
Noncontrolling interest	(673)	(774)
Total equity	150,881	149,189
Total liabilities and equity	$ 258,869	$ 273,648

XML

Condensed consolidated statements of cash flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities
Net loss	$ (6,355)	$ (5,443)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation and amortization	30,082	24,130
Deferred income tax	35	(49)
Non-cash interest expense	281	342
Non-cash stock compensation	13,605	13,965
Gain on sale of fixed assets	103	44
Impairment of long-lived assets and related purchase commitments	3,547	6,581
Changes in operating assets and liabilities:
Accounts receivable	(5,359)	6,361
Inventories	6,079	26,465
Prepaid expenses and other current assets	(1,809)	(2,372)
Deferred costs - eyewear	66	581
Other assets	114	(661)
Accounts payable	(15,848)	(5,595)
Accrued expenses and other liabilities	1,314	(2,092)
Other long-term liabilities and customer deposits	(572)	1,767
Income taxes receivable/payable	1,065	(176)
Deferred revenue	(4,828)	(865)
Net cash provided by operating activities	21,520	62,983
Cash flows from investing activities
Purchases of property and equipment	(3,805)	(11,665)
Purchases of cinema systems and related components	(15,646)	(12,774)
Proceeds from sale of fixed assets	215	2,474
Net cash used in investing activities	(19,236)	(21,965)
Cash flows from financing activities
Proceeds from credit facility	37,500	47,500
Repayments on credit facility	(35,625)	(37,500)
Payments of debt issuance costs		(1,167)
Proceeds from exercise of stock options	1,374	1,070
Proceeds from employee stock purchase plan	303	611
Repurchases of common stock	(7,511)	(47,759)
Distributions to noncontrolling interests		(1,000)
Net cash used in financing activities	(3,959)	(38,245)
Effect of currency exchange rate changes on cash and cash equivalent	276
Net increase (decrease) in cash and cash equivalents	(1,399)	2,773
Cash and cash equivalents, beginning of period	31,020	24,894
Cash and cash equivalents, end of period	$ 29,621	$ 27,667

XML

Related-party transactions (Details) (USD $)	0 Months Ended	3 Months Ended	9 Months Ended		0 Months Ended			3 Months Ended	9 Months Ended	0 Months Ended
	May 19, 2011 Joshua Greer item	Dec. 31, 2012 Joshua Greer	Dec. 31, 2012 Joshua Greer	Jul. 16, 2011 Joshua Greer	May 19, 2011 Joshua Greer Time-based vesting stock option	May 19, 2011 Joshua Greer Second stock option	May 29, 2012 DCH	Dec. 31, 2012 DCH	Dec. 31, 2012 DCH	May 29, 2012 DCH Maximum	May 29, 2012 DCH Minimum item
Related-party transactions
Cash severance amount	$ 450,000
Number of equal installments of cash severance to be paid	10
Maximum period of reimbursement by the entity for insurance coverage under COBRA under the terms of the separation agreement	18 months
Pro-rated cash performance bonus as a percentage of salary to be paid pursuant to the terms of the separation agreement	30.00%
Percentage of annual salary used for determining pro-rated cash performance bonus	80.00%
Number of shares which had vesting periods accelerated under the terms of the separation agreement					105,000
Term of exercising options following the end of the term of the consulting agreement					6 months
Number of shares forfeited pursuant to the terms of the separation agreement						105,000
Amount to be paid annually as per the consulting agreement				275,000
Amount paid pursuant to the separation agreement		0	225,000
Amount paid pursuant to the consulting agreement		0	148,958
Number of applications for which consulting services provided											1
Tenure of agreement							4 months
Fixed monthly compensation payable per agreement							20,000
Additional extension to the tenure of agreement										2 months
Notice period for additional extension to the tenure of agreement							10 days
Compensation paid								$ 60,000	$ 80,239

XML

Share-based compensation (Tables)

9 Months Ended

Dec. 31, 2013

Share-based compensation

Schedule of share-based compensation expense for all share-based arrangements

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands)	2013		2012		2013		2012
Share-based compensation
Cost of revenue	$	181	$	120	$	722	$	565
Research and development	632		608		2,107		1,577
Selling and marketing	1,608		1,369		4,189		4,068
General and administrative	2,066		2,774		6,587		7,755
Total	$	4,487	$	4,871	$	13,605	$	13,965

XML

Summary of significant accounting policies (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2013 item	Dec. 31, 2012	Dec. 31, 2013 item	Dec. 31, 2012	Mar. 31, 2013 item
Accounting period
Number of period in an accounting period	4		4		4
Length of quarter			3 months		91 days
Length of fiscal year			12 months		364 days
Number of days by which period of current quarter is short as compared to third quarter of 2012	9 days
Number of days by which period of nine months is short as compared to nine months ended December 31, 2012			8 days
Numerator:
Net loss	$ (155)	$ (4,159)	$ (6,355)	$ (5,443)
Net (income) loss attributable to noncontrolling interest	(116)	(1)	(101)	89
Net loss attributable to RealD Inc. common stockholders	$ (271)	$ (4,160)	$ (6,456)	$ (5,354)
Denominator:
Weighted-average common shares outstanding (basic)	49,325	51,062	49,459	53,157
Weighted-average common shares outstanding (diluted)	49,325	51,062	49,459	53,157
Loss per common share:
Basic (in dollars per share)	$ (0.01)	$ (0.08)	$ (0.13)	$ (0.10)
Diluted (in dollars per share)	$ (0.01)	$ (0.08)	$ (0.13)	$ (0.10)
Options, employee stock purchase plan, restricted stock units and warrants to purchase common stock
Loss per share of common stock
Weighted-average number of anti-dilutive shares excluded from the calculation of diluted loss per common share	9,144	9,439	9,538	8,095

XML

Business and basis of presentation

9 Months Ended

Dec. 31, 2013

Business and basis of presentation

Business and basis of presentation

1. Business and basis of presentation

RealD Inc. is a leading global licensor of 3D and other visual technologies. Except where specifically noted or the context otherwise requires, the use of terms such as the “Company” or “RealD” in this Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2013 refers to RealD Inc. and its subsidiaries.

The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and include all adjustments (consisting of only normal recurring adjustments, unless otherwise indicated), necessary for a fair presentation of our condensed consolidated financial statements. Interim results are not necessarily indicative of results for any subsequent quarter, the full fiscal year or any future periods. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended March 31, 2013.

The condensed consolidated financial statements include the accounts of RealD, its wholly owned subsidiaries and its majority owned subsidiaries. We do not have any interests in variable interest entities. For consolidated subsidiaries that are not wholly owned but are majority owned, the subsidiaries’ assets, liabilities, and operating results are included in their entirety in the accompanying condensed consolidated financial statements. The noncontrolling interests in those assets, liabilities, and operations are reflected as non-controlling interest in the condensed consolidated balance sheets under equity and condensed consolidated statements of operations.

All significant intercompany balances and transactions have been eliminated in consolidation.

XML

Condensed consolidated balance sheets (Parenthetical) (USD $) In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Condensed consolidated balance sheets
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	49,259	49,365
Common stock, shares outstanding	49,259	49,365

XML

Summary of significant accounting policies (Policies)

9 Months Ended

Dec. 31, 2013

Summary of significant accounting policies

Accounting period

Accounting period

On November 14, 2012, our Board of Directors approved a change in our accounting periods from the previous configuration of four 13-week periods for a total of 52 weeks per year to calendar quarter end accounting periods. This change in accounting period commenced in the third quarter ended December 31, 2012 of fiscal year 2013.

Our fiscal year 2014 began on April 1, 2013, consisting of four 3-month periods for a total of 12 months, and will end on March 31, 2014 as compared to fiscal year 2013, which began on March 24, 2012 and ended on March 31, 2013. The fiscal 2014 third quarter began on October 1, 2013 and ended on December 31, 2013 as compared to the fiscal 2013 third quarter, which began on September 22, 2012 and ended on December 31, 2012. As a result, the three months and nine months ended December 31, 2013 are nine days shorter and eight days shorter than the three months and nine months ended December 31, 2012, respectively.

Use of estimates

Use of estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.

Earnings (loss) per share of common stock

Earnings (loss) per share of common stock

Basic income per share of common stock is computed by dividing the net income (loss) attributable to our common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income attributable to our common stockholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under our employee stock purchase plan and unvested restricted stock units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method.

Derivative instruments

Derivative instruments

Our derivative instruments are recorded at fair value in other current assets and other liabilities, respectively, in the condensed consolidated balance sheets. Changes in fair value are reported as a component of other income or loss on our condensed consolidated statements of operations. For all periods presented, none of our derivative instruments were designated as hedging instruments. We do not use foreign currency option or foreign exchange forward contracts for speculative or trading purposes.

We purchase foreign currency forward contracts, generally with maturities of six months or less, to reduce the volatility of cash flows primarily related to forecasted payments and expenses denominated in certain foreign currencies. As of December 31, 2013, we had no outstanding forward contracts. As of March 31, 2013, the carrying amounts of our foreign currency forward contracts were not significant and were classified as Level 2 fair value instruments, which was determined based on observable inputs that were corroborated by market data. For both the three months ended December 31, 2013 and December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant. For both the nine months ended December 31, 2013 and December 31, 2012, the net loss related to the change in fair value of our foreign currency forward contracts was not significant. Foreign currency master agreements typically allow the netting of receivables and payables. The gross receivable balances and the gross payable balances were $0 as of December 31, 2013 and not significant as of March 31, 2013.

Accounts receivable

Accounts receivable

Accounts receivable consists of trade receivables, value-added tax (VAT) receivables and other receivables. We extend credit to our customers, who are primarily in the movie production and exhibition businesses. We provide for the estimated accounts receivable that will not be collected. These estimates are based on an analysis of historical bad debts, customer concentrations, customer creditworthiness, current economic trends and changes in the customers’ payment terms and their economic condition. Collection of accounts receivable may be affected by changes in economic or other industry conditions and may, accordingly, impact our overall credit risk. The allowance for doubtful accounts and customer credits totaled $3.7 million and $2.6 million as of December 31, 2013 and March 31, 2013, respectively.

Inventories and deferred costs-eyewear

Inventories and deferred costs-eyewear

Inventories and deferred costs-eyewear represent RealD eyewear and are substantially all finished goods. Inventories and deferred costs-eyewear are valued at the lower of cost (first-in, first-out method) or market value. At each balance sheet date, we evaluate ending inventories and deferred costs-eyewear for net realizable value. We also evaluate inventories for excess quantities and obsolescence. These evaluations include analyses of expected future average selling prices, projections of future demand and technology changes. In order to state inventories at the lower of cost or market, we maintain reserves against such inventories. If our analyses indicate that market is lower than cost, a write-down of inventories is recorded in cost of revenue in the period the loss is identified. As of December 31, 2013 and March 31, 2013, the inventory reserve as a result of our net realizable value analyses was $0.2 million and $0.4 million, respectively.

Domestically, we provide our RealD eyewear free of charge to motion picture exhibitors and then receive a fee from the motion picture studios for the usage of that RealD eyewear by the motion picture exhibitors’ consumers.

For RealD eyewear located at a motion picture exhibitor, we do not believe that it is operationally practical to perform physical counts or request the motion picture exhibitor to perform physical counts and confirm quantities held to ensure that losses due to damage, destruction and shrinkage are specifically recognized in the period incurred due to the number of domestic RealD-enabled screens and the related usage of RealD eyewear. We believe that the cost to monitor shrinkage or usage significantly outweighs the financial reporting benefits of using a specific identification methodology of expensing. We believe that utilizing a composite method of expensing RealD eyewear inventory costs provides a rational and reasonable approach to ensuring that shrinkage is provided for in the period incurred and that inventory costs are expensed in the periods that reasonably reflect the periods in which the related revenue is recognized. In doing so, we believe the following methodology reasonably and generally reflects periodic income or loss under these facts and circumstances:

· For an estimated period of time following shipment to domestic motion picture exhibitors, no expense is recognized from the time of shipment until the delivery is made because the eyewear is in transit and unused.

· The inventory cost is expensed on a straight-line basis over an estimated usage period beginning with initial usage of the eyewear shipped. In estimating the expensing start date and related expense period, we consider various factors including, but not limited to, those relating to a 3D motion picture’s opening release date, a 3D motion picture’s expected release period, the number of currently playing 3D motion pictures, and the motion picture exhibitor’s buying and stocking patterns and practices.

We believe that the expensing methodology described above rationally and reasonably approximates the period the related usage occurs resulting in our RealD eyewear product revenue. The expensing start date following the date of shipment is meant to approximate the date at which usage begins. Additionally, as the expense recognition period has been and is expected to continue to be short, we believe it adequately recognizes inventory impairments due to loss and damage on a timely basis. We further believe that exposures due to loss or damage, if any, are considered normal shrinkage and a necessary and expected cost to generate the revenue per 3D motion picture earned through RealD eyewear usage. We continue to monitor the reasonableness of this methodology to ensure that it approximates the period over which the related RealD eyewear product revenue is earned and realizable. Costs of RealD eyewear that has shipped but has not yet been used and expensed per this methodology are reported as deferred costs-eyewear.

Impairment of long-lived assets

Impairment of long-lived assets

We review long-lived assets, such as property and equipment, cinema systems, digital projectors and intangibles, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Factors or circumstances that could indicate the occurrence of such events include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing operating or cash flow losses, or incurring costs in excess of amounts originally expected to acquire or construct an asset. If the asset is not recoverable, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.

During the nine months ended December 31, 2012, we determined that a non-cancelable purchase commitment for certain cinema systems configurations in the aggregate amount of $3.5 million were not fully recoverable, primarily due to the initial investment costs which are expected to exceed the anticipated future cash flows for the related cinema systems. For the nine months ended December 31, 2012, impairment charged to cost of revenue for the related outstanding purchase commitment totaled $3.5 million.

For the three months ended December 31, 2013 and December 31, 2012, impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $0.8 million and $0.7 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, impairment charges for all impaired RealD Cinema Systems charged to cost of revenue totaled $3.5 million and $6.6 million, respectively.

Revenue recognition

Revenue recognition

We derive substantially all of our revenue from the license of our RealD Cinema Systems and the product sale of our RealD eyewear. We evaluate revenue recognition for transactions using the criteria set forth by the SEC in Staff Accounting Bulletin No. 104, Revenue Recognition (SAB 104) and Accounting Standards Codification Topic 605, Revenue Recognition (ASC 605). The revenue recognition guidance states that revenue is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed or determinable and collectability is reasonably assured. We record revenue net of estimated allowances.

License revenue

License revenue is accounted for as an operating lease. License revenue is primarily derived under per-admission, periodic fixed fee, or per-motion picture basis with motion picture exhibitors. Amounts received up front, less estimated allowances, are deferred and recognized over the lease term using the straight-line method. Additional lease payments that are contingent upon future events outside our control, including those related to admission and usage, are recognized as revenues when the contingency is resolved and we have no more obligations to our customers specific to the contingent payment received. Certain of our license revenue from leasing our RealD Cinema Systems is earned upon admission by the motion picture exhibitor’s consumers. Our licensees, however, do not report and pay for such license revenue until after the admission has occurred, which may be received subsequent to our fiscal period end. We estimate and record licensing revenue related to motion picture exhibitor consumer admissions in the quarter in which the admission occurs, but only when reasonable estimates of such amounts can be made. We determine that there is persuasive evidence of an arrangement upon the execution of a license agreement or upon the receipt of a licensee’s admissions report. Revenue is deemed fixed or determinable upon receipt of a licensee’s admissions report or evidence of a RealD box office showing by licensee. We determine collectability based on an evaluation of the licensee’s recent payment history.

Product revenue

We recognize product revenue, net of allowances, when title and risk of loss have passed and when there is persuasive evidence of an arrangement, the payment is fixed or determinable, and collectability of payment is reasonably assured. In the United States and Canada, certain of our product revenue from the sale of our RealD eyewear is earned upon admission and usage by the motion picture exhibitor’s consumers. Our customers, however, do not report admission or usage information until after the admission and usage has occurred, and such information may be received subsequent to our fiscal period end. We estimate and record such product revenue in the quarter in which the admission and usage occurs, but only when reasonable estimates of such amounts can be made.

Comprehensive income (loss)

Comprehensive income (loss)

Comprehensive income (loss) is comprised of net income (loss) and other comprehensive income (loss). The only component of other comprehensive income or loss is unrealized foreign currency translation gains (losses). There were no reclassifications out of accumulated other comprehensive income (loss) during the three and nine months ended December 31, 2013 and December 31, 2012.

Shipping and handling costs

Shipping and handling costs

Amounts billed to customers for shipping and handling costs are included in revenue. Shipping and handling costs that we incur consist primarily of packaging and transportation charges and are recorded in cost of revenue. Shipping and handling costs recognized in cost of revenue were $1.6 million and $1.6 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Shipping and handling costs recognized in cost of revenue were $5.5 million and $6.3 million for the nine months ended December 31, 2013 and December 31, 2012, respectively.

Recent accounting pronouncements

Recent accounting pronouncements

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-10, “Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (Or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. The objective of ASU 2013-10 is to provide for the inclusion of the Fed Funds Effective Swap Rate (OIS) as a U.S. benchmark interest rate for hedge accounting purposes, in addition to direct Treasury obligations of the U.S. government (UST) and, for practical reasons, the London Interbank Offered Rate (LIBOR) swap rate. ASU 2013-10 is effective prospectively for qualifying new or redesignated hedging relationship entered into on or after July 17, 2013. Adoption of ASU 2013-10 did not have a material impact on our consolidated financial statements.

In July 2013, the FASB issued ASU 2013-11, “Income Taxes (Topic 740) Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which concludes that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset when settlement in this manner is available under the tax law.  The Company will adopt this amendment as of our 2015 fiscal year. The result of adoption may be to reclassify certain long term liabilities to long term deferred tax assets and the adoption will not result in a change to the tax provision. We do not expect the adoption of ASU 2013-11 to have a material impact on our consolidated financial statements.

XML

Document and Entity Information	9 Months Ended
	Dec. 31, 2013	Jan. 29, 2014
Document and Entity Information
Entity Registrant Name	RealD Inc.
Entity Central Index Key	0001327471
Document Type	10-Q
Document Period End Date	Dec. 31, 2013
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		49,267,815
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

XML

Summary of significant accounting policies (Tables)

9 Months Ended

Dec. 31, 2013

Summary of significant accounting policies

Schedule of calculation of the basic and diluted loss per share of common stock

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands, except share and per share data)	2013		2012		2013		2012
Numerator:
Net loss	$	(155)	$	(4,159)	$	(6,355)	$	(5,443)
Net (income) loss attributable to noncontrolling interest	(116)		(1)		(101)		89
Net loss attributable to RealD Inc. common stockholders	$	(271)	$	(4,160)	$	(6,456)	$	(5,354)
Denominator:
Weighted-average common shares outstanding (basic)	49,325		51,062		49,459		53,157
Effect of dilutive securities	–		–		–		–
Weighted-average common shares outstanding (diluted)	49,325		51,062		49,459		53,157
Loss per common share:
Basic	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)
Diluted	$	(0.01)	$	(0.08)	$	(0.13)	$	(0.10)

Schedule of weighted-average number of anti-dilutive shares excluded from the calculation of diluted loss per common share

	Three months ended		Nine months ended
	December 31,	December 31,	December 31,	December 31,
(in thousands)	2013	2012	2013	2012
Options, employee stock purchase plan, restricted stock units and warrants to purchase common stock	9,144	9,439	9,538	8,095

XML

Condensed consolidated statements of operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Revenue:
License	$ 35,619	$ 30,334	$ 103,901	$ 106,499
Product and other	19,819	16,605	54,685	63,604
Total revenue	55,438	46,939	158,586	170,103
Cost of revenue:
License	11,472	10,523	33,981	34,819
Product and other	16,696	15,497	49,248	65,366
Total cost of revenue	28,168	26,020	83,229	100,185
Gross profit	27,270	20,919	75,357	69,918
Operating expenses:
Research and development	5,236	5,376	15,465	14,866
Selling and marketing	6,842	6,053	20,295	18,872
General and administrative	13,161	12,346	39,533	35,797
Total operating expenses	25,239	23,775	75,293	69,535
Operating income (loss)	2,031	(2,856)	64	383
Interest expense, net	(525)	(426)	(1,765)	(1,027)
Other income (loss)	(47)	(183)	227	(557)
Income (loss) before income taxes	1,459	(3,465)	(1,474)	(1,201)
Income tax expense	1,614	694	4,881	4,242
Net loss	(155)	(4,159)	(6,355)	(5,443)
Net (income) loss attributable to noncontrolling interest	(116)	(1)	(101)	89
Net loss attributable to RealD Inc. common stockholders	$ (271)	$ (4,160)	$ (6,456)	$ (5,354)
Loss per common share:
Basic (in dollars per share)	$ (0.01)	$ (0.08)	$ (0.13)	$ (0.10)
Diluted (in dollars per share)	$ (0.01)	$ (0.08)	$ (0.13)	$ (0.10)
Shares used in computing loss per common share:
Basic (in shares)	49,325	51,062	49,459	53,157
Diluted (in shares)	49,325	51,062	49,459	53,157

XML

Commitments and contingencies

9 Months Ended

Dec. 31, 2013

Commitments and contingencies

Commitments and contingencies

6. Commitments and contingencies

Indemnities and commitments

During the ordinary course of business, we make certain indemnities and commitments under which we may be required to make payments in relation to certain transactions. These indemnities include indemnities of certain customers and licensees of our technologies, and indemnities to our directors and officers to the maximum extent permitted under the laws of the State of California. The duration of these indemnities and commitments varies, and in certain cases, is indefinite. The majority of these indemnities and commitments do not provide for any limitation of the maximum potential future payments we could be obligated to make. We have not recorded any liability for these indemnities and commitments in the accompanying condensed consolidated balance sheets. We do, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is reasonably probable and estimable.

We have entered into contracts with certain of our vendors. Future obligations under such contracts totaled $8.0 million at December 31, 2013 and include revolving 90-day supply commitments. Many of the contracts contain cancellation penalty provisions requiring payment of up to 20.0% of the unused contract.

Contingencies and assessments

We are subject to various loss contingencies and assessments arising in the course of our business, some of which relate to litigation, claims, property taxes and sales and use tax or goods and services tax assessments. We consider the likelihood of the loss or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies and assessments. An estimated loss contingency or assessment is accrued when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted. Based on the information presently available, including discussion with counsel and other consultants, management believes that resolution of these matters will not have a material adverse effect on our business, consolidated results of operations, financial condition or cash flows.

XML

Borrowings and Credit Agreement

9 Months Ended

Dec. 31, 2013

Borrowings and Credit Agreement

Borrowings and Credit Agreement

5. Borrowings and Credit Agreement

On April 19, 2012, we entered into a credit agreement (the “Credit Agreement”) with City National Bank, a national banking association (“City National”).  Pursuant to the Credit Agreement, the lenders thereunder will make available to us:

· a revolving credit facility (including a letter of credit sub-facility) in a maximum amount not to exceed $75 million (the “Revolving Facility”); and

· a delayed-draw term loan facility in a maximum amount not to exceed $50 million (the “Term Loan Facility”). During the first quarter of fiscal year 2013, we borrowed $25 million under the Term Loan Facility, resulting in $25 million being available for future draws. During the second quarter of fiscal 2014, we borrowed an additional $25 million, fully drawing down the Term Loan Facility. During the second quarter of fiscal 2013, we repaid $12.5 million of the Term Loan Facility. On December 31, 2013, we commenced the first of 12 quarterly installments of $3.1 million to pay off the Term Loan Facility by September 30, 2016.

The Revolving Facility and the Term Loan Facility replaced existing revolving and term loan facilities provided under our pre-existing credit and security agreement with City National, which had been most recently amended on December 6, 2011.

Debt issuance costs related to the completion of the Credit Agreement totaled $1.2 million and were recorded as a deferred charge.  The issuance costs are being amortized over the contractual life of the agreement and recorded as interest expense.

Our obligations under the Credit Agreement are secured by a first priority security interest in substantially all of our tangible and intangible assets and are fully and unconditionally guaranteed by our subsidiaries, ColorLink Inc., a Delaware corporation (“ColorLink”), and Stereographics Corporation, a California corporation (“Stereographics”). In connection with our execution of the Credit Agreement, on April 19, 2012, each of ColorLink and Stereographics entered into a general continuing guaranty (the “Guaranty”) in favor of City National and the lenders under the Credit Agreement, pursuant to which they irrevocably and unconditionally guaranteed our obligations under the Credit Agreement and all related loan documents. In addition, on April 19, 2012, we, ColorLink and Stereographics entered into a security agreement in favor of City National and the lenders under the Credit Agreement, pursuant to which they granted a security interest in substantially all of their assets to secure their obligations under the Credit Agreement, the Guaranty and the related loan documents.

As of December 31, 2013, there were $49.4 million in borrowings under the Credit Agreement. The current and non-current portions of the Credit Agreement due as of December 31, 2013 and March 31, 2013 were as follows:

	December 31,		March 31,
	2013		2013
(in thousands)	(unaudited)
Current portion of Credit Agreement	$	12,500	$	1,042
Credit Agreement, net of current portion	36,875		46,458
Total Credit Agreement	$	49,375	$	47,500

The Revolving Facility matures on April 17, 2015 with $15.0 million drawn as of December 31, 2013. Through December 31, 2013, the aggregate Term Loan Facility commitment of $50 million had been drawn in full and $15.6 million had been repaid, resulting in an outstanding balance of $34.4 million to be repaid in 11 remaining quarterly installments of $3.1 million through September 30, 2016.

At December 31, 2013, our future minimum Credit Agreement obligations were as follows:

(in thousands)
Fiscal year 2014	$	3,125
Fiscal year 2015	12,500
Fiscal year 2016	27,500
Fiscal year 2017	6,250
Total	$	49,375

Under the Credit Agreement, our business is subject to certain limitations, including limitations on our ability to incur additional debt, make certain investments or acquisitions, enter into certain merger and consolidation transactions, and sell our assets other than in the ordinary course of business. We are also required to maintain compliance with certain financial covenants, including a minimum fixed charge coverage ratio and a maximum leverage ratio. As of December 31, 2013, we were in compliance with all financial covenants in our Credit Agreement. If we fail to comply with any of the covenants or if any other event of default, as defined in our Credit Agreement, should occur, the bank lenders could elect to prevent us from borrowing and declare the indebtedness to be immediately due and payable.

The Revolving Facility provides for, at our option, Eurodollar Rate Loans, which bears interest at the London Interbank Offered Rate (“LIBOR”) plus two and one-half percent (2.50%) or Base Rate Loans, which bear interest at one and one-half percent (1.5%) plus the greatest of (a) the Federal Funds Rate plus 1/2 of 1%, (b) the Prime Rate, and (c) the Eurodollar Rate for a one month Interest Period on such day plus 1.00%.

The borrowings outstanding under the Credit Agreement bear interest at approximately 2.79%. Interest expense related to our borrowings under our Credit Agreement was $0.5 million and $0.4 million for the three months ended December 31, 2013 and December 31, 2012, respectively. Interest expense related to our borrowings under our Credit Agreement was $1.8 million and $1.0 million for the nine months ended December 31, 2013 and December 31, 2012, respectively. Interest expense for fiscal year 2013 includes that expensed under the previous credit and security agreements.

XML

Equity (Tables)

9 Months Ended

Dec. 31, 2013

Equity

Summary of the changes in total equity

	RealD Inc.
	stockholders’		Noncontrolling		Total
(in thousands)	deficit		interest		equity (deficit)
Balance, March 31, 2013	$	149,963	$	(774)	$	149,189
Share-based compensation	13,605		-		13,605
Exercise of stock options	1,374		-		1,374
Purchase and distribution of stock under employee stock purchase plan	303		-		303
Purchases of treasury stock	(7,511)		-		(7,511)
Other comprehensive loss, net of tax	276		-		276
Net loss	(6,456)		101		(6,355)
Balance, December 31, 2013	$	151,554	$	(673)	$	150,881

XML

Property and equipment, RealD Cinema Systems and digital projectors (Tables)

9 Months Ended

Dec. 31, 2013

Property and equipment, RealD Cinema Systems and digital projectors

Schedule of property and equipment of RealD Cinema Systems and digital projectors

	December 31,		March 31,
(in thousands)	2013		2013
RealD Cinema Systems	$	204,706	$	194,527
Digital projectors - held for sale	436		1,634
Leasehold improvements	17,373		14,442
Machinery and equipment	6,297		6,198
Furniture and fixtures	1,310		1,122
Computer equipment and software	9,604		7,628
Construction in process	1,136		2,637
Total	$	240,862	$	228,188
Less accumulated depreciation	(103,093)		(77,079)
Property and equipment, RealD Cinema Systems and digital projectors, net	$	137,769	$	151,109

XML

Equity

9 Months Ended

Dec. 31, 2013

Equity

Equity

9. Equity

A summary of the changes in total equity for the nine months ended December 31, 2013 was as follows:

	RealD Inc.
	stockholders’		Noncontrolling		Total
(in thousands)	deficit		interest		equity (deficit)
Balance, March 31, 2013	$	149,963	$	(774)	$	149,189
Share-based compensation	13,605		-		13,605
Exercise of stock options	1,374		-		1,374
Purchase and distribution of stock under employee stock purchase plan	303		-		303
Purchases of treasury stock	(7,511)		-		(7,511)
Other comprehensive loss, net of tax	276		-		276
Net loss	(6,456)		101		(6,355)
Balance, December 31, 2013	$	151,554	$	(673)	$	150,881

On April 20, 2012, we announced that our board of directors had approved an authorization to repurchase up to $50 million of our common stock. On December 14, 2012, our board of directors approved a $25 million increase in our stock repurchase plan, increasing the $50 million repurchase plan announced on April 20, 2012 to $75 million. The number of shares to be repurchased and the timing of any potential repurchases will depend on factors such as the Company’s stock price, economic and market conditions, alternative uses of capital, and corporate and regulatory requirements. Repurchases of common stock may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when RealD might otherwise be precluded from doing so under insider trading laws, and a variety of other methods, including open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The repurchase program may be suspended or discontinued at any time.

Pursuant to the stock repurchase plan authorized by our board of directors, we have repurchased a total of 6,599,726 shares of common stock at an average price per share of $10.30, including sales commissions, for an aggregate cost of $68.0 million inception to date. For the three months period ended December 31, 2013, there were no stock repurchases. For the nine months period ended December 31, 2013, we repurchased a total of 671,997 shares of common stock at an average price per share of $11.18, including sales commissions, for an aggregate cost of $7.5 million.

XML

Share-based compensation

9 Months Ended

Dec. 31, 2013

Share-based compensation

Share-based compensation

7. Share-based compensation

We account for share-based payment awards granted to employees and directors by recording compensation expense based on estimated fair values. We estimate the fair value of share-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statements of operations. Share-based awards are attributed to expense using the straight-line method over the vesting period. We determine the value of each option award that contains a market condition using a Monte Carlo Simulation valuation model, while all other option awards are valued using the Black-Scholes valuation model as permitted under ASC 718,  Compensation — Stock Compensation. The assumptions used in calculating the fair value of share-based payment awards represent our best estimates. Our estimates of the fair values of stock options granted and the resulting amounts of share-based compensation recognized may be impacted by certain variables including stock price volatility, employee stock option exercise behaviors, additional stock option grants modifications, estimates of forfeitures, and the related income tax impact.

Share-based compensation expense for all share-based arrangements for the three and nine months ended December 31, 2013 and December 31, 2012 was as follows:

	Three months ended				Nine months ended
	December 31,		December 31,		December 31,		December 31,
(in thousands)	2013		2012		2013		2012
Share-based compensation
Cost of revenue	$	181	$	120	$	722	$	565
Research and development	632		608		2,107		1,577
Selling and marketing	1,608		1,369		4,189		4,068
General and administrative	2,066		2,774		6,587		7,755
Total	$	4,487	$	4,871	$	13,605	$	13,965

Stock options granted generally vest over a four-year period, with 25% of the shares vesting after one year and monthly vesting thereafter. The options generally expire ten years from the date of grant. For the nine months ended December 31, 2013, we granted 0.7 million stock options at a weighted average grant date fair value of $7.22 per share. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to stock options and our employee stock purchase plan was $3.2 million and $3.8 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to stock options and our employee stock purchase plan was $10.3 million and $10.8 million, respectively.

Certain of our management-level employees receive performance stock options, which gives the recipient the right to receive common stock that is contingent upon achievement of specified pre-established performance goals over the performance period, which is generally three years subject to the recipient’s continued service with us. The performance goals for the performance stock options are based on the measurement of our total stockholder return, on a percentile basis, compared to a comparable group of companies. Depending on the outcome of the performance goals, the recipient may ultimately earn performance stock options equal to or less than the number of performance stock options granted. In June 2013, our Chief Executive Officer’s fiscal year 2013 stock option grant was amended to retroactively change the vesting schedule of the stock option so that it now vests based upon the achievement of performance goals rather than based solely upon Mr. Lewis’ continued service with the Company. The performance goal is based on the measurement of our total stockholder return, on a percentile basis, compared to a comparable group of companies. The performance period for this performance stock option is between three and five years. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to performance stock options was $0 and $0.5 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to performance stock options was $0.5 million and $1.4 million, respectively.

Certain of our management-level employees also receive performance stock units, which gives the recipient the right to receive common stock that is contingent upon achievement of specific pre-established performance goals over the performance period, which is generally two years subject to the recipient’s continued service with us. The performance goals are based on achieving certain levels of total licensing revenue over the performance period.  Depending on the outcome of the performance goals, the recipient may ultimately earn performance stock units between 0% and 200% of the number of performance stock units granted. For the three and nine months ended December 31, 2013, there was no share-based compensation expense related to performance stock units. For the three and nine months ended December 31, 2012, there was no share-based compensation expense related to performance stock units.

Certain of our employees, including certain management level employees, receive time-based restricted stock units. These restricted stock units vest over one to three years based upon a recipient’s continued service with us. For the nine months ended December 31, 2013, we granted 0.6 million restricted stock units at a weighted average grant date fair value of $12.29 per restricted stock unit. For the three months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to restricted stock units was $0.9 million and $0.5 million, respectively. For the nine months ended December 31, 2013 and December 31, 2012, share-based compensation expense related to restricted stock units was $2.2 million and $1.7 million, respectively.

XML

Income taxes

9 Months Ended

Dec. 31, 2013

Income taxes

Income taxes

8. Income taxes

Our income tax expense for the three months ended December 31, 2013 and December 31, 2012 was $1.6 million and $0.7 million, respectively. Our income tax expense for the nine months ended December 31, 2013 and December 31, 2012 was $4.9 million and $4.2 million, respectively. We have net operating losses that may potentially be offset against future earnings. We file federal income tax returns and income tax returns in various state and foreign jurisdictions. Due to the net operating loss carryforwards, our United States federal and state returns are open to examination by the Internal Revenue Service and state jurisdictions for all years since inception.

As of December 31, 2013, we have determined based on the weight of the available evidence, both positive and negative, to provide for a valuation allowance against substantially all of the net deferred tax assets. The current deferred tax assets not reserved for by the valuation allowance are those in foreign jurisdictions or amounts that may be carried back in future years. If there is a change in circumstances that causes a change in judgment about the realizability of the deferred tax assets, we will adjust all or a portion of the applicable valuation allowance in the period when such change occurs.

XML

Related-party transactions

9 Months Ended

Dec. 31, 2013

Related-party transactions

Related-party transactions

10. Related-party transactions

On May 19, 2011, we entered into a separation agreement and general release of claims with Joshua Greer, a former director and executive officer of the Company. Pursuant to the terms of the separation agreement, Mr. Greer will receive the following benefits: (i) cash severance of $450,000 paid in ten equal installments, with the first such installment paid on October 15, 2011; (ii) reimbursement from us for insurance coverage under COBRA for 18 months following July 15, 2011 or such earlier time as Mr. Greer becomes eligible for insurance through another employer; (iii) a pro-rated cash performance bonus for fiscal year 2012 (to be paid no later than June 15, 2012), in an amount equal to 30% of 80% of Mr. Greer’s salary, computed assuming that Mr. Greer had remained as our president through the end of fiscal year 2012; and (iv) acceleration of a time-based vesting stock option for 105,000 shares granted to Mr. Greer on July 15, 2010 as of July 15, 2011, which will remain exercisable for 6 months following the end of the term of the consulting agreement that we entered into with Mr. Greer on the same date.  A second stock option for 105,000 shares granted to Mr. Greer on July 15, 2010 was entirely forfeited and cancelled without consideration.  We entered into a consulting agreement with Mr. Greer pursuant to which Mr. Greer will be paid $275,000 per year commencing as of July 16, 2011.  The consulting agreement with Mr. Greer expired on July 16, 2012. On June 21, 2012, Mr. Greer notified us of his resignation from our board of directors to be effective on July 16, 2012 upon the expiration of the consulting agreement.

For the three months and nine months ended December 31, 2012, we paid Mr. Greer $0 and $225,000 pursuant to his separation agreement and $0 and $148,958 pursuant to his consulting agreement, respectively.

We entered into a consulting agreement, effective as of May 29, 2012 (the “DCH Agreement”), with DCH Consultants LLC (“DCH”), an entity controlled by Mr. David Habiger. Mr. Habiger is a member of the Company’s Board of Directors, its Nominating and Corporate Governance Committee, and its Compensation Committee.

Pursuant to the DCH Agreement, DCH provided certain consulting services regarding the application of one or more of our technologies in the consumer electronics industry. The DCH Agreement had a term of 4 months and DCH was entitled to receive aggregate fixed compensation of $20,000 per month during the term of the DCH Agreement. Although we had the right to extend the engagement for up to two additional months on the same terms, by providing DCH with 10 days written notice prior to the end of the original term, we did not extend the DCH Agreement and it expired as of September 29, 2012.

During the year ended March 31, 2013, we paid DCH $80,239 pursuant to the DCH Agreement.

XML

Equity (Details) (USD $)	0 Months Ended		3 Months Ended		9 Months Ended		20 Months Ended
	Dec. 14, 2012	Apr. 20, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Balance					$ 149,189,000
Share-based compensation					13,605,000
Exercise of stock options					1,374,000
Purchase and distribution of stock under employee stock purchase plan					303,000
Purchases of treasury stock					(7,511,000)
Other comprehensive loss, net of tax			71,000		276,000
Net loss			(155,000)	(4,159,000)	(6,355,000)	(5,443,000)
Balance			150,881,000		150,881,000		150,881,000
Stock repurchased
Value of common stock authorized to be repurchased	75,000,000	50,000,000
Increase in the value of common stock authorized to be repurchased	25,000,000
Number of shares of common stock repurchased			0		671,997		6,599,726
Average price per share of common stock (in dollars per share)					$ 11.18		$ 10.30
Value of common stock repurchased					7,500,000		68,000,000
RealD Inc. stockholders' deficit
Balance					149,963,000
Share-based compensation					13,605,000
Exercise of stock options					1,374,000
Purchase and distribution of stock under employee stock purchase plan					303,000
Purchases of treasury stock					(7,511,000)
Other comprehensive loss, net of tax					276,000
Net loss					(6,456,000)
Balance			151,554,000		151,554,000		151,554,000
Noncontrolling interest
Balance					(774,000)
Net loss					101,000
Balance			$ (673,000)		$ (673,000)		$ (673,000)

XML

Borrowings and Credit Agreement (Tables)

9 Months Ended

Dec. 31, 2013

Borrowings and Credit Agreement

Schedule of the current and non-current portions of the Credit Agreement

	December 31,		March 31,
	2013		2013
(in thousands)	(unaudited)
Current portion of Credit Agreement	$	12,500	$	1,042
Credit Agreement, net of current portion	36,875		46,458
Total Credit Agreement	$	49,375	$	47,500

Schedule of future minimum Credit Agreement obligations

At December 31, 2013, our future minimum Credit Agreement obligations were as follows:

(in thousands)
Fiscal year 2014	$	3,125
Fiscal year 2015	12,500
Fiscal year 2016	27,500
Fiscal year 2017	6,250
Total	$	49,375

XML

Summary of significant accounting policies (Details 3) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Comprehensive income (loss)
Reclassifications out of accumulated other comprehensive income (loss)	$ 0	$ 0	$ 0	$ 0
Shipping and handling costs
Shipping and handling costs	1.6	1.6	5.5	6.3
RealD Cinema Systems
Impairment of long-lived assets
Impairment charges	0.8	0.7	3.5	6.6
Cinema systems configurations under non-cancellable purchase commitment
Impairment of long-lived assets
Aggregate amount of non-cancellable purchase agreement for certain cinema systems configurations				3.5
Impairment charges				$ 3.5

XML

Condensed consolidated statements of comprehensive income (loss) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Condensed consolidated statements of comprehensive income (loss)
Net loss	$ (155)	$ (4,159)	$ (6,355)	$ (5,443)
Other comprehensive income, net of tax:
Foreign currency translation gains	71		276
Other comprehensive income, net of tax	71		276
Comprehensive loss	$ (84)	$ (4,159)	$ (6,079)	$ (5,443)

XML

Cost reduction plan

12 Months Ended

Mar. 31, 2013

Cost reduction plan

Cost reduction plan

4. Cost reduction plan

During fiscal year 2014, we implemented a plan to reduce the overall costs of our global operations while continuing to make significant research and development investments and build the framework for our future growth. This cost reduction plan is primarily a response to the 3D box office performance of certain motion pictures due to consumer preference and the fact that our 3D cinema business is maturing in many markets like the United States where we expect equipment installations to begin to slow, and the resulting impact on our financial results and operations. We are also re-scoping and making other changes to certain research and development projects, reducing general and administrative expenses and streamlining certain manufacturing operations. These actions are intended to rationalize the further expansion of our global cinema platform by focusing on emerging growth markets, streamlining our manufacturing facilities to achieve cost efficiencies while meeting the future commercial demands of our customers and focusing our research and development efforts on technologies that will enable us to expand our visual technology product offerings.

An element of that plan is to reduce our workforce by approximately 20%, resulting in termination charges of approximately $4.9 million. Further, we expect to incur approximately $0.5 million in other charges principally related to the accrual of losses for a lease for certain manufacturing facilities that will no longer be used in our operations. Therefore, the total charges associated with the cost reduction plan currently are estimated to be approximately $5.4 million. The following table summarizes the currently estimated charges resulting from implementation of the cost reduction plan:

	Estimated termination and implementation charges
(in thousands)	Personnel		Lease		Impairment		Total
Cost of revenue	$	842	$	435	$	66	$	1,343
Research and development	755		0		0		755
Selling and marketing	1,995		0		0		1,995
General and administrative	1,256		0		0		1,256
Total	$	4,848	$	435	$	66	$	5,349

Total expenses incurred in relation to the cost reduction plan were $3.7 million for both the three months and nine months ended December 31, 2013. The following table summarizes the activity resulting from implementation of the cost reduction plan within accrued expenses and other liabilities:

	Three and nine months ended December 31, 2013
(in thousands)	Beginning liability		Expensed		Paid		Ending liability
Cost reduction plan liabilities	$	-	$	3,657	$	2,005	$	1,652

We have initiated many of the above-noted cost reduction actions and plan to act on the remaining areas by the end of fiscal year 2014. We estimate that most of the remaining expenses will be incurred during the fourth quarter of fiscal year 2014 but lease and impairment charges might not occur until fiscal year 2015. Certain office space includes approximately $7.0 million in leasehold improvements within fixed assets, which could become subject to an impairment assessment upon a future change in circumstances.

	Termination and implementation expenses
	Q3 FY2014 Actual		Q4 FY2014 Estimate
(in thousands)	Personnel		Personnel		Lease		Impairment
Cost of revenue	$	842	$	-	$	435	$	66
Research and development	755		-		-		-
Selling and marketing	1,104		891		-		-
General and administrative	956		300		-		-
Total	$	3,657	$	1,191	$	435	$	66

The cash payments are estimated as follows:

	Payments excluding non-cash impairment
(in thousands)	Personnel		Lease
Q3 FY2014 Actual	$	2,005	$	-
Q4 FY2014 Estimate	1,843		32
FY2015 Estimate	667		227
FY2016 Estimate	333		132
FY2017 Estimate	-		44
Total	$	4,848	$	435

Capital expenditures for leasehold improvements, net of landlord allowance, are estimated to total $0.3M during the next two quarters for the relocated manufacturing operations. The resultant estimated annual effect on cost of revenue through June 30, 2024 is insignificant.

There is no guarantee that termination and implementation costs will not exceed the estimates, or that any net cost reduction will actually be achieved.

The Company records the cost reduction plan activities in accordance with the Accounting Standards Codification (ASC), including ASC 420 Exit or Disposal Cost Obligations, ASC 712 Compensation—Nonretirement Postemployment Benefits and ASC 360 Property, Plant, and Equipment (Impairment or Disposal of Long-Lived Assets).

XML

Property and equipment, RealD Cinema Systems and digital projectors (Details) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	$ 240,862,000		$ 240,862,000		$ 228,188,000
Less accumulated depreciation	(103,093,000)		(103,093,000)		(77,079,000)
Property and equipment, RealD Cinema Systems and digital projectors, net	137,769,000		137,769,000		151,109,000
Depreciation expense	10,000,000	8,200,000	29,100,000	24,000,000
Cash received from motion picture exhibitor customers for the sale of digital projectors			215,000	2,474,000
RealD Cinema Systems
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	204,706,000		204,706,000		194,527,000
Digital projectors - held for sale
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	436,000		436,000		1,634,000
Leasehold improvements
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	17,373,000		17,373,000		14,442,000
Machinery and equipment
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	6,297,000		6,297,000		6,198,000
Furniture and fixtures
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	1,310,000		1,310,000		1,122,000
Computer equipment and software
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	9,604,000		9,604,000		7,628,000
Construction in process
Property and equipment, RealD Cinema Systems and digital projectors
Property and equipment, RealD Cinema Systems and digital projectors, gross	$ 1,136,000		$ 1,136,000		$ 2,637,000

XML

Cost reduction plan (Tables)

9 Months Ended

Dec. 31, 2013

Cost reduction plan

Summary of currently estimated charges resulting from the cost reduction plan implementation

	Estimated termination and implementation charges
(in thousands)	Personnel		Lease		Impairment		Total
Cost of revenue	$	842	$	435	$	66	$	1,343
Research and development	755		0		0		755
Selling and marketing	1,995		0		0		1,995
General and administrative	1,256		0		0		1,256
Total	$	4,848	$	435	$	66	$	5,349

Summary of currently incurred charges resulting from implementation of the cost reduction plan within accrued expenses and other liabilities

	Three and nine months ended December 31, 2013
(in thousands)	Beginning liability		Expensed		Paid		Ending liability
Cost reduction plan liabilities	$	-	$	3,657	$	2,005	$	1,652

Summary of actual and estimate charges resulting from the cost reduction plan implementation

	Termination and implementation expenses
	Q3 FY2014 Actual		Q4 FY2014 Estimate
(in thousands)	Personnel		Personnel		Lease		Impairment
Cost of revenue	$	842	$	-	$	435	$	66
Research and development	755		-		-		-
Selling and marketing	1,104		891		-		-
General and administrative	956		300		-		-
Total	$	3,657	$	1,191	$	435	$	66

Schedule of cash payments excluding non-cash impairment

	Payments excluding non-cash impairment
(in thousands)	Personnel		Lease
Q3 FY2014 Actual	$	2,005	$	-
Q4 FY2014 Estimate	1,843		32
FY2015 Estimate	667		227
FY2016 Estimate	333		132
FY2017 Estimate	-		44
Total	$	4,848	$	435